Translational Imaging of Pulmonary Gas-Exchange Using  Hyperpolarized 129Xe Magnetic Resonance Imaging by Kaushik, Suryanarayanan Sivaram
  
 
Translational Imaging of Pulmonary Gas-Exchange Using  
Hyperpolarized 129Xe Magnetic Resonance Imaging 
by 
Suryanarayanan Sivaram Kaushik 
Department of Biomedical Engineering 
Duke University 
 
Date:_______________________ 
Approved: 
 
___________________________ 
Bastiaan Driehuys, Supervisor 
 
___________________________ 
G. Allan Johnson 
 
___________________________ 
Kathy Nightingale 
 
___________________________ 
W. Michael Foster 
 
___________________________ 
H. Page McAdams 
 
Dissertation submitted in partial fulfillment of 
the requirements for the degree of Doctor 
of Philosophy in the Department of 
Biomedical Engineering in the Graduate School 
of Duke University 
 
2014 
 
  
 
 
ABSTRACT 
Translational Imaging of Pulmonary Gas-Exchange Using  
Hyperpolarized 129Xe Magnetic Resonance Imaging 
by 
Suryanarayanan Sivaram Kaushik 
Department of Biomedical Engineering 
Duke University 
 
Date:_______________________ 
Approved: 
 
___________________________ 
Bastiaan Driehuys, Supervisor 
 
___________________________ 
G. Allan Johnson 
 
___________________________ 
Kathy Nightingale 
 
___________________________ 
W. Michael Foster 
 
___________________________ 
H. Page McAdams 
 
An abstract of a dissertation submitted in partial 
fulfillment of the requirements for the degree 
of Doctor of Philosophy in the Department of 
Biomedical Engineering in the Graduate School of 
Duke University 
 
2014 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright by 
Suryanarayanan Sivaram Kaushik  
2014 
 
  
iv
Abstract 
 
Pulmonary diseases are becoming a large and unsustainable economic burden in 
the US. For example, chronic obstructive pulmonary disease (COPD) is now the third 
leading cause of death in the US, and the hospitalization costs for asthma are on the or-
der of $29 Billion. Despite these staggering numbers, the diagnosis and treatment of 
pulmonary diseases still rely on pulmonary function tests, which are notoriously insen-
sitive to subtle changes in lung function and pathology of the small airways. This insen-
sitivity has further stymied the development of new therapies to treat pulmonary dis-
eases. To this end, it is being increasingly recognized that overcoming these barriers re-
quires creating imaging biomarkers of pulmonary function. Specifically, imaging the 
lung using hyperpolarized (HP) gas MRI provides a non-invasive means to assess pul-
monary function 3-dimensionally in a single breath.  
The work presented in this thesis began just as the field of HP gas MRI was mak-
ing the transition from the supply-limited 3He gas, which produced exquisite images, to 
129Xe, which offered infinite supply, but posed significant imaging challenges. However, 
once we had demonstrated that 129Xe ventilation MRI could be optimized to obtain the 
kind of image quality that was historically seen with 3He, we began evaluating addition-
al contrast mechanisms that are unique to 129Xe MRI. The aim was to extend the imaging 
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capabilities beyond simple ventilation to provide a more comprehensive picture of pul-
monary function. This thesis is thus centered on extending hyperpolarized (HP) 129Xe 
MRI to probe the most fundamental function of the lung – gas-exchange.  
Efficient gas-exchange requires the diffusive transfer of gases across the alveolar-
capillary barrier as dictated by Fick’s first law. To this end, the first factor controlling 
gas-exchange is the alveolar surface area, which can be assessed by exploiting the diffu-
sivity of 129Xe within the airspaces. In the case of emphysema, which often accompanies 
COPD, the associated destruction of lung tissue reduces the alveolar surface area for gas 
exchange. Subsequently, this increases the distance that xenon can diffuse within the al-
veolus. Thus, by using diffusion-weighted imaging of the gas-phase of 129Xe, one can ex-
tract its ‘apparent diffusion coefficient’ (ADC) that is sensitive to the alveolar surface ar-
ea. Developing this contrast mechanism and applying it in COPD patients is the focus of 
chapter 3.   
However, the bulk of my thesis is devoted to exploiting perhaps the most inter-
esting properties of xenon MRI – its solubility and tissue-specific frequency shifts. When 
inhaled, the bulk of HP 129Xe stays in the alveolar spaces, but its moderate solubility in 
the pulmonary tissues causes a small fraction of this xenon to diffuse into the pulmonary 
barrier tissues and plasma, and further into the red blood cells (RBC). When xenon en-
ters either of these compartments, it experiences a unique shift in its resonance frequen-
cy that allows it to be separately detected from xenon remaining in the gas-phase. These 
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additional unique resonances are collectively called the dissolved-phase of xenon and 
are comprised of a barrier resonance, shifted by 198 ppm, and an RBC resonance shifted 
by 217 ppm from the gas-phase. Since xenon follows the same pathway to the RBCs as 
oxygen does, imaging 129Xe in the dissolved phase offers a potentially ideal non-invasive 
probe to study pulmonary gas exchange. 
As this thesis work began, direct, single-breath imaging of the dissolved-phase of 
129Xe was just starting to be attempted. However, technical challenges of imaging this 
tiny signal had limited dissolved-phase imaging from being established on a reliable and 
reproducible footing. Additionally, as the gas-phase provides the source magnetization 
for the dissolved-phase 129Xe signal, it was realized that making dissolved phase MRI 
truly quantitative would require acquiring both the gas and dissolved-phase distribu-
tions in a single breath. Chapters 4 and 5 focus on these topics, and detail the changes to 
3D radial acquisition strategies needed to acquire both the gas and dissolved-phase im-
ages in a single breath.  
Once 3D images of 129Xe gas transfer were realized on a reliable footing, the next 
challenge was to obtain independent measurements of the 129Xe transfer to the barrier 
and RBCs. We approached this problem by first using non-spatially localized 129Xe spec-
troscopy to characterize gas exchange on a global basis. The principle behind this ap-
proach lay in the fact that the application of an RF pulse to 129Xe in the RBCs depletes its 
magnetization. However, as the resonances of xenon are in dynamic exchange, this de-
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pleted magnetization is replenished by the xenon with fresh magnetization diffusing in 
from the airspaces. While this replenishment is rapid in a healthy lung, where the barrier 
thickness is < 1µm, this recovery can be significantly delayed if the thickness increases 
by even a few microns. This hypothesis was tested by acquiring dissolved-phase 129Xe 
spectra in healthy volunteers and subjects with idiopathic pulmonary fibrosis (IPF). The 
degree of RBC signal recovery was quantified using the ratio of the RBC and barrier res-
onances, which was found to be reduced by a factor of more than 3 in IPF. This work, 
which is discussed in chapter 6, demonstrated that 129Xe gas-transfer spectroscopy can 
detect diffusion-limitation even on a whole-lung basis.  
By combining the insights from 3D dissolved-phase imaging and the spectro-
scopic separation of 129Xe in RBC and barrier, this work culminated in demonstrating a 
method to acquire 3D images of all three 129Xe resonances in a single breath. This is the 
focus of chapter 7 of this thesis, which details the implementation of a 1-point Dixon ac-
quisition strategy to create independent images of the 129Xe in barrier and RBCs. The ef-
ficacy of these 129Xe-RBC images was evaluated in patients with IPF, and compared to 
healthy volunteers these images exhibited significantly greater gas-transfer defects. 
In short, this thesis work has taken the first technical steps to demonstrate that 
HP 129Xe MRI can provide a non-invasive, ionizing radiation free method to probe venti-
lation, microstructural changes and most importantly, gas-exchange. The imaging tools 
provided by HP 129Xe MRI see applications in studying a wide range of pulmonary dis-
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eases from COPD to pulmonary vascular diseases. Broadly, 129Xe MRI has the potential 
to serve as a sensitive and comprehensive tool in therapeutic clinical trials to evaluate 
longitudinal changes in regional lung function, and further help generate viable thera-
pies that may reduce the bane of pulmonary diseases. 
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1. Significance and Motivation 
 
My thesis work is centered on the development of inhaled hyperpolarized 129Xe 
MRI as a method to detect, characterize, and monitor pulmonary disease and its re-
sponse to therapy. In this chapter I will lay out the case for why the study and treatment 
of pulmonary disease is in urgent need of imaging biomarkers, the current landscape of 
imaging biomarkers in pulmonary disease, and why hyperpolarized 129Xe MRI has spe-
cific advantages over these other approaches. Although we expect hyperpolarized 129Xe 
MRI to have an impact across a broad range of pulmonary conditions, my specific re-
search is focused on applications to chronic obstructive pulmonary disease (COPD) and 
interstitial lung diseases (ILD). Hence, these conditions and their specific imaging needs 
will be highlighted in this introduction.  
Lung diseases are currently a global healthcare concern and in the United States, 
remain the 4th leading cause of death (1). While most other diseases (cancer, stroke, car-
diovascular disease) have experienced decreasing rates of death, that of lung disease has 
continued unabated (2). For example, asthma affects 300 million people worldwide, and 
its prevalence is expected to increase by 50 million per decade (3). Chronic obstructive 
pulmonary disease affects roughly 14 million people in the United States alone, with a 
staggering cost of hospitalization exceeding $29 billion (2). As discussed in (4), the cur-
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rent rise of pulmonary disease is economically unsustainable, and COPD is predicted to 
be the 3rd leading cause of death by 2020 (5).   
A key bottleneck in the diagnosis and treatment of pulmonary disease is the ab-
sence of sensitive and specific biomarkers to measure disease burden and progression. 
The current ‘gold standard’ in the diagnosis and management of COPD is the pulmo-
nary function test (PFT). This test obtains multiple metrics describing pulmonary func-
tion through breathing maneuvers performed using a spirometer. The metrics of pul-
monary function provided by the PFTs have been used to assess response to therapy 
and have also been used to phenotype COPD (4). However, as subjects with COPD pre-
sent varied symptoms and have a combination of multiple disease processes, quantify-
ing these changes with a global PFT metric has been shown to be inadequate (6). Fur-
thermore, current clinical standards require that PFT metrics such as the forced expirato-
ry volume in 1 second (FEV1) change by at least 20% to be considered a significant 
change in disease status (6). Changes in PFT metrics have also shown a poor correlation 
to patient survival (7). As a result, although there have been multiple clinical trials at-
tempting to understand and better treat pulmonary diseases using changes in PFT met-
rics as an endpoint, this insensitivity has resulted in limited progress made in creating 
viable treatment options (6). Hence, the heterogeneous mechanisms of pulmonary dis-
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eases and function create an urgent need to look beyond PFTs for biomarkers that allow 
quantitative evaluation of lung function regionally.  
Early detection of lung diseases will be aided by imaging modalities that are sen-
sitive to subtle changes in lung structure and function. Regional information obtained 
through imaging could help us understand the functioning of the healthy lung and also 
analyze the extent and severity of different disease phenotypes. To this end, a large con-
tribution to the radiologic evaluation of the lung has been made by thin-section comput-
ed tomography (CT) (8-10). The improvement in detector technology afforded CT its ex-
quisite resolution and due to its inherently quantitative nature, CT has provided a 
framework to classify different phenotypes of COPD (11). Despite its current ubiquity, 
the application of CT in the longitudinal evaluation of subjects with lung diseases is lim-
ited by the associated radiation dose (12). Apart from structural changes, the key in un-
derstanding changes with disease is in imaging changes in pulmonary function. In spite 
of its capabilities in imaging perfusion (13), with its associated radiation dose, CT is fur-
ther limited in its capacity primarily as a structural imaging modality.  
While the primary function of the lung is to exchange gases with the alveolar ca-
pillary blood stream, information of this gas-exchange has been inferred primarily 
through ventilation and perfusion imaging. These processes have been studied using 
dual energy CT using xenon and iodine as ventilation and perfusion contrast agents (14), 
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and radionuclide imaging modalities such as positron emission tomography (PET) (15) 
and single photon emission computed tomography (SPECT) (16). These modalities have 
shown that even in the healthy lung, ventilation and perfusion is quite heterogeneous. In 
spite of this heterogeneity, in order to maintain adequate oxygen saturation, perfusion is 
higher in regions that are well ventilated, resulting in a good matching of the two pro-
cesses (15). Thus, in a healthy lung, the ratio of ventilation and perfusion, which is used 
as a metric of gas-exchange, is unity. However with the onset of diseases, the delicate 
interplay between the structure and function of the lung is disrupted. This results in a 
poor transfer of oxygen into the bloodstream and consequently, causes a reduction in 
the ventilation-perfusion ratio (17). However, imaging lung function using these modali-
ties is limited by the associated radiation dose contributed by the radiotracer, and this 
further limits the use of radionuclide imaging modalities in the longitudinal assessment 
of subjects with disease.  
As an alternative to radiation based imaging approaches, magnetic resonance 
imaging (MRI) offers an ionizing radiation free, non-invasive modality to study lung 
structure and function. Although imaging the lung using MRI remains challenging be-
cause of its low proton density and susceptibility losses caused by air-tissue interfaces, 
recent technological advancements have made MRI of the lung feasible. The advent of 
multi-channel receiver coils, and ultra-short echo time (UTE) sequences, have helped 
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overcome the low magnetization and rapid T2* of the parenchyma to image the pulmo-
nary microstructure (18). While these radiation-free images had a lower resolution than 
the CT, the images showed similar information. As for ventilation,1H images acquired 
while the subject inhales 100% O2 can be used to indirectly map specific ventilation in 
the lung (19). While a novel technique, it has a complicated experimental procedure, and 
is plagued with images that have a rather poor contrast-noise-ratio and more important-
ly, to minimize blurring induced by heart motion, is limited to a single slice in the right 
lung. Pulmonary perfusion imaging however, is on a more stable footing, and has been 
well developed with and without the use of external contrast agents (20,21). Among the-
se techniques, dynamic contrast enhanced (DCE) studies use an external bolus of a Gad-
olinium based agent to study the time varying enhancement of the pulmonary vascula-
ture (20) and extract quantitative metrics of perfusion. As an alternative, arterial spin 
labeling (ASL) MRI has enabled imaging lung perfusion without the need for an exoge-
nous contrast agent (22). While capillary perfusion is of prime importance to indirectly 
study gas-exchange in the lung, ASL and DCE MRI are also sensitive to perfusion in the 
larger vasculature (23). Furthermore, to minimize blurring caused by the motion of the 
heart, ASL perfusion images are also limited to a single slice in the right lung (19,21).  
To overcome the shortcomings of traditional 1H based MRI, hyperpolarized (HP) 
noble gases have emerged over the last decade, as an external gaseous contrast agent for 
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ventilation imaging (24,25). Over the formative years, ventilation based imaging studies 
have used HP 3He as its high polarization and high diffusivity lent itself to multiple 
methods of imaging the lung. While typical helium imaging was completed in a single 
breath hold to yield static ventilation images, high helium polarizations afforded the 
ability to map ventilation dynamically (26). These dynamic methods have also been used 
to study fractional ventilation (27). While helium cannot be used to study regional per-
fusion, it has been extensively used to map regional oxygen partial pressure (28). This 
method is an indirect and cumbersome approach to study the matching of regional ven-
tilation and perfusion. Beyond ventilation imaging, HP 3He can also measure the region-
al apparent diffusion coefficient (ADC) (29,30). With the use of 3He ADC in the small 
animal models of emphysema, considerable progress has been made in understanding 
the disease progression, and this led to studies that have used HP 3He to non-invasively 
phenotype the alveolar degradation seen in COPD based diseases (31). 3He ADC has al-
so been shown to be extremely reproducible and has been used to study the impact of 
second-hand smoke on healthy volunteers (32), gradients caused by subject posture (33), 
and age-related changes in alveolar size (34). While helium MRI had a promising future, 
the reallocation of 3He has led to a dwindling of the helium stockpile from about 235,000 
liters in 2001 to 50,000 liters in 2010. Consequently, the price of helium has risen from 
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100 – 200$/liter to as high as 2000$/liter, making pulmonary research with this gas unaf-
fordable (35).  
As a result of the helium shortage, the hyperpolarized community looked toward 
129Xe to serve as a viable replacement. Compared to helium, working with xenon is sig-
nificantly harder as a) xenon has a lower gyromagnetic ratio (11.77 MHz/T vs. 32.4 MHz/T) 
and b) the polarization achievable with xenon is lower (10 – 15% vs. 40%). Both of these fac-
tors result in almost 27-fold lower xenon signal intensity. On the plus side, 129Xe is natu-
rally available in the atmosphere, and as a result, significantly cheaper (~30$/liter, natu-
ral abundance). In spite of these challenges, we have shown the utility of 129Xe in static-
ventilation studies by quantifying the ventilation defects seen in healthy volunteers and 
subjects with COPD (36). Apart from pure ventilation studies, we have also implement-
ed 129Xe diffusion-weighted imaging (37). This is a significant achievement as the lower 
gyromagnetic ratio required longer diffusion weighting gradients to achieve adequate 
diffusion weighting, which increased the minimum achievable echo time. This resulted 
in greater T2* weighting, which lowered the signal intensity further. In spite of these lim-
iting factors, high quality apparent diffusion coefficient maps were generated, which 
were sensitive enough to detect changes in the alveolar microstructure in healthy volun-
teers, age-matched controls and subjects with COPD. The results of this study will be 
discussed in detail in chapter 3.  
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As COPD and asthma largely affect the airways and parenchyma, they can be 
well assessed using ventilation and ADC imaging. On the other hand, interstitial lung 
diseases (ILD) are diseases that impact the alveolar interstitium and primarily affect 
pulmonary gas-exchange. These diseases are particularly deadly, and are in dire need of 
therapeutic attention and sensitive biomarkers. Among these, idiopathic pulmonary fi-
brosis (IPF), which is a common type of ILD, has a prevalence rate for men over the age 
of 75 years, of ~175 per 100,000 (38). In spite of the low prevalence, the problem howev-
er, is that existing treatment options for the disease are merely palliative and result in a 
mean survival from diagnosis of only about 4 years (39). The current gold standards in 
the diagnosis of IPF involve ionizing radiation as a part of a CT scan, or worse, an inva-
sive open lung biopsy (40). Additionally, the current endpoints for therapeutic clinical 
trials use rather insensitive PFT metrics such as the Forced Vital Capacity (FVC), and the 
6-min walk test, both of which have been shown to be only reasonable predictors of pa-
tient mortality (41). These insensitive endpoints require at least a 20% change in FVC, or 
a 10% change in DLCO to warrant significant change in disease status. Furthermore, sub-
jects with IPF have extensive interstitial inflammation and fibrosis that limits the diffu-
sion of gases across the capillary blood-gas barrier. As this disease primarily impacts 
gas-exchange, traditional ventilation imaging showed qualitatively normal lungs, and 
hence had limited use in quantifying the extent of fibrosis. As a result, while there are 
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multiple clinical trials underway to test potential therapies for IPF (42), what is truly 
lacking are sensitive tools to test the effectiveness of these therapies, and predict early 
changes in lung function. Interestingly, it is possible to get such gas-exchange bi-
omarkers using properties that are unique to hyperpolarized 129Xe.  
In addition to its presence in the alveolar air spaces which yields ventilation and 
diffusion weighted images, the appeal in using 129Xe truly stems from its moderate solu-
bility in the pulmonary tissues, and the capillary blood stream (Ostwald solubility in 
blood at 37°C = 0.0939, and barrier tissue = 0.271 (43)). When in either of these compart-
ments, 129Xe experiences large distinct chemical shifts – barrier tissue/plasma (~3.5kHz, 
198 ppm) and red blood cells (RBC, 3.83kHz, 217 ppm). These two additional resonances 
are together termed as the ‘dissolved-phase’ of 129Xe and the characteristics of these res-
onances (width, frequency, amplitude) are sensitive to the structural and functional fea-
tures of the lung. As the pathway taken by xenon to reach the RBCs is identical to that of 
oxygen, in addition to studying ventilation and microstructural changes, xenon can be 
used as an ideal surrogate for the study of the diffusive gas-exchange. A representative 
dissolved-phase spectrum is shown in figure 1.  
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Figure 1: Spectrum showing the different resonances of xenon in the lung. 
129Xe in the barrier is separated from the gas-phase xenon by ~3.5 kHz (198 ppm), and 
the RBC resonance is further removed at 3.8 kHz (217 ppm). 
My thesis is centered on exploiting this dissolved-phase to obtain global and re-
gional information about gas-exchange in the lung. Given the low magnetization of the 
xenon in the dissolved-phase compartments (~2% of the gas-phase) and rapid relaxation 
rate (~2ms (44)), initial efforts to image this dissolved-phase distribution employed indi-
rect approaches. As the xenon resonances are in dynamic exchange with one another, 
pulsing on the dissolved-phase would partially depolarize the gas-phase resonance. This 
phenomenon was used to indirectly map the dissolved-phase distribution. However, 
this xenon transfer contrast, or XTC, was extremely limited because of the restrictions 
imposed on the RF pulses, and the need for multiple images to correct for the T1 decay of 
the gas-phase (45). Most importantly, this method lacked the ability to separate the con-
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tributions of xenon in the barrier and the RBCs. With improvements in polarization, and 
using rapid pulse sequences, our group and others have shown the ability to directly 
image the dissolved-phase (43,46).  
Reliable imaging of this dissolved-phase poses a unique set of challenges. a) The 
RF pulse needed to excite the dissolved-phase must be selective enough to avoid exciting the sig-
nificantly larger gas-phase magnetization b) Given the rapid T2* of the dissolved-phase, this RF 
pulse also needs to be sufficiently short c) Quantifying the dissolved-phase signal distribution 
requires an image of the gas-phase ‘source’ distribution in the same breath d) The flip-angle used 
for the sequence must be large enough to obtain a sizeable dissolved signal, but small enough to 
reduce the time needed to replenish this signal. This can be complemented with a short repetition 
time (TR) such that we adequately sample k-space in a short 15 second breath hold. While the 
first two factors may seem trivial, it required overcoming the non-linearity of the RF 
amplifier, which made the choice of RF pulse length or power non trivial. Chapter 4 de-
tails the steps taken to overcome these challenges, and the development and clinical 
translation of a 3D radial pulse sequence used to acquire both the gas and the dissolved-
phase images in a single breath. This pulse sequence was used quantify the impact of 
posture on the distribution of gas-exchange, which has been a long standing debate in 
the pulmonary community. These results are discussed in detail in chapter 5.  
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The dissolved-phase of 129Xe is an extremely sensitive tool to study the structural 
changes noticed in IPF. In fact, the spectra acquired in an IPF subject showed a reduction 
in the RBC signal amplitude. This reduction is indicative of reduced gas-exchange, and 
as a result, extensive diffusion impairment. This gas-exchange impairment was first 
quantified using global gas-exchange spectroscopy, which is discussed in chapter 6 and 
the rationale behind the method is also discussed in chapter 2. While this provided a 
global biomarker of gas-exchange, extending this to regional information would require 
creating separate images of 129Xe in the RBCs and 129Xe in the barrier tissue. However, as 
the dissolved-phase signal intensity is only 2% of the gas-phase, and has a very rapid T2* 
of ~2 ms (44), separating the components of the dissolved-phase would require unique 
acquisition strategies. Driehuys et al. (47), used a variant of the Dixon acquisition scheme 
in rats, to create 2D images of 129Xe in the barrier and the RBC, which we extended to 3D 
(48). In translating this to the clinic, Qing et al. employed an alternate strategy, and im-
plemented the Hierarchical IDEAL algorithm to create images of all three resonances of 
xenon in a single-breath (49). The downside of this method however, is that it requires 
two additional echoes to decompose the 129Xe in barrier and the RBCs. While the short 
T2* was overcome using higher 129Xe polarization (~40%), the requirement of additional 
echoes makes this method rather undesirable. Hence, the focus of chapter 7 is in detail-
ing the acquisition and processing methods needed for the clinical realization of the 1-
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point Dixon approach to acquire 3D, co-registered images of all three resonances of 129Xe 
in a single breath. This technique has enabled us to separately quantify the perfusion-
dependent RBC 129Xe image and interstitial tissue-dependent barrier 129Xe image, and 
compare the changes in healthy subjects and patients with IPF. The 129Xe-RBC image 
thus gives us a non-invasive method to study diffusive gas-exchange right at the alveo-
lar capillary regions of the lung.  
  
The focus of my research can be broken down into these specific aims:  
 
I) Demonstrate feasibility of diffusion-weighted imaging using HP 129Xe to visualize 
pulmonary microstructural changes 
As a replacement for the established hyperpolarized 3He, we studied the viability of 129Xe 
diffusion-weighted imaging in obtaining its apparent diffusion coefficient (ADC). Imaging was 
carried out in healthy volunteers, age-matched controls and subjects with chronic obstructive 
pulmonary disease. We hypothesized that 129Xe ADC would be lower in the healthy volunteers 
and will show an age-related increase in the ADC. Also, age-matched healthy volunteers were 
expected to have a lower ADC than the subjects with emphysema. The details of this study are 
presented in chapter 3.  
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II) Enable semi-quantitative dissolved-phase imaging by acquiring both the gas and 
dissolved-phase images in a single-breath 
The moderate solubility of 129Xe yields chemically shifted resonances in the barrier tissue 
and red blood cells, collectively termed as the dissolved-phase. The dissolved-phase to first order 
depicts gas-exchange in the lung. While this dissolved-phase can be imaged separately from the 
xenon in the gas-phase, it requires the simultaneous acquisition of the gas-phase image for its 
quantitation. As a result, we developed a 3D radial pulse sequence to acquire both images in a 
single breath. The details behind the radial pulse sequence are presented in chapter 2, and chap-
ter 4 details the modifications to the sequence and its clinical translation. As an application of the 
technique we studied the impact of posture on the regional distribution of the dissolved-phase 
(chapter 5). We hypothesized that the dissolved-phase signal after correcting for the gas-phase 
signal contribution would be higher in the dependent lung in both the supine and prone postures.     
 
III) Use HP 129Xe gas-transfer spectroscopy to establish a global biomarker for gas-
transfer impairment 
Most interstitial lung diseases cause inflammation of the interstitial tissue, which results 
in diffusion limitation and consequently, impaired gas-exchange. This chapter uses global dis-
solved-phase spectra to show that ‘perfusion-limited’ xenon can be used to measure diffusion limi-
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tation in subjects with idiopathic pulmonary fibrosis. Additionally, this chapter lays the ground-
work needed to enable independent imaging of xenon in the barrier and the RBCs.  
 
IV) Generate regional biomarkers of gas-transfer by creating separate images of HP 
129Xe in the barrier tissue and red blood cells 
While the previous aim focused on obtaining global information using gas-transfer spec-
tra to quantify diffusion impairment, by imaging the uptake of 129Xe directly into the alveolar ca-
pillary blood stream, we would be truly imaging gas-exchange in the lung, and will be ideally 
poised to study regional changes induced by pulmonary diseases. This goal has been achieved us-
ing a 3D 1-point Dixon acquisition. The theory behind these techniques is presented in chapter 
2. Chapter 7 details the acquisition methods, phase processing, and results obtained using these 
techniques in a water-cyclohexane phantom, and the preliminary results in healthy volunteers 
and subjects with idiopathic pulmonary fibrosis. 
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2. Relevant Theory 
 
2.1. Pulmonary Physiology 
The topics covered here present an overview of the functions of the lung that are 
relevant to my thesis. This sub-section has been adapted from the book ‘Respiratory 
Physiology: The Essentials’ by John West.  
 
2.1.1. Structure of the Lung 
While the lung participates in the metabolism of certain compounds, and aids in 
the body’s defense as a filter for airborne particulate matter, the primary function of the 
lung is in exchanging gases with the capillary blood stream. The structure of the lung is 
primed to make this process extremely efficient.  
The flow of gases begins at the trachea, which branches out at the carina to form 
the bronchi that feed into the right and left lung. These main-stem bronchi continue to 
branch out in a fractal manner and get progressively narrower, to yield a total of 23 gen-
eration of airways. The first 16 generations (‘conducting zone’) do not participate in gas-
exchange, and in an adult human, contribute only ~150 ml to the total volume of the 
lung. However, diseases such as asthma and chronic obstructive pulmonary disease 
(COPD) can affect these conducting airways, thus affecting the transfer of gases to these 
gas-exchanging regions. The later generations of airways however (‘terminal bronchi-
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oles’), have tiny air-sacs or alveoli that participate in gas-exchange. These alveoli, while 
only about 300 microns in diameter, contribute as total of ~3 L to the total lung volume 
in a healthy adult, and are rightfully termed the ‘respiratory zone’ of the lung. These al-
veoli are separated from the capillary network by the blood-gas barrier. This barrier is 
composed of three layers – the alveolar epithelium, the interstitium (extra cellular ma-
trix), and the capillary endothelium. In certain regions, the overall thickness of the 
blood-gas barrier is only about third of a micron. As there are ~500 million alveoli in the 
lung, with an extremely thin blood-gas barrier (<1 μm), this provides the enormous sur-
face area (50 – 100m2) needed for efficient gas-exchange. However, this efficiency can be 
disrupted, as the delicate structure of the alveoli can be impacted by the onset of certain 
diseases. For example, emphysema, a phenotype of COPD, may cause alveolar degrada-
tion which results in a loss in the surface area, thus minimizing gas-transfer. Interstitial 
lung diseases on the other hand, cause a thickening of the alveolar interstitium, limiting 
the diffusion of gases across the blood-gas barrier.  
The blood flow to the lung begins at the right atrium of the heart which pumps 
the deoxygenated blood through the pulmonary arteries. The pulmonary arteries track 
the bronchi and have a branching pattern that mirrors that of the bronchi. These arteries 
continue to branch and reduce in size until they form a dense network of capillaries. 
These capillaries have a diameter of about 10 microns which is just large enough to fit 
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one red blood cell. The capillary network forms a fine mesh around walls of the alveoli 
resulting in an enormous surface area for gas-exchange. This process is so efficient, that 
in healthy adults at rest, the capillary blood spends only about 0.75 s in the capillary 
network. However, this gives it sufficient time for it to be fully oxygenated. This net-
work terminates in the pulmonary veins which feed the oxygenated blood back to the 
left atrium, and then this oxygenated blood gets pumped to the rest of the body by the 
systemic circulation. 
  
Figure 2: A simplified block diagram showing the three main processes gov-
erning gas-exchange in the lung. 
 
2.1.2. Gas-exchange 
As shown in figure 2 above, there are three processes that determine the efficien-
cy of pulmonary gas-exchange: ventilation, perfusion, and diffusive gas-transfer. Failure 
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of any one of these processes will result in improper gas-exchange and ultimately hy-
poxemia – low oxygen saturation of the blood in the pulmonary arteries.  
 
2.1.2.1. Ventilation & Perfusion 
Ventilation (V) and perfusion (Q) are two processes that need to be well 
‘matched’ to ensure an adequate transfer of oxygen to the blood stream. In the field of 
pulmonary medicine, the ratio of ventilation and perfusion is used as a surrogate marker 
of regional oxygenation and gas-exchange. Interestingly, this ratio is not homogenous, 
and speaks to the heterogeneity of both ventilation and perfusion. This is graphically 
illustrated in figure 3 below (adapted from (50)). In a healthy lung, both ventilation and 
perfusion have shown a preferential enhancement in the gravitationally dependent por-
tion of the lung (51,52). This heterogeneity informs us that the lung possesses a large re-
serve capacity for gas-exchange.   
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Figure 3: Ventilation and perfusion is heterogeneous, and increases in the 
gravitationally dependent lung.  With the subject upright, we would see greater sig-
nal in the bottom of the lung. The V/Q as a result, is also heterogeneous.   
 
The value of V/Q indicates the changes in regional pulmonary function. When 
perfusion is active in an alveolar unit that is unventilated, this results in a ‘shunt’ and 
would give a V/Q of 0. Consequently, within this alveolar unit, this may result in an in-
crease in the partial pressure of CO2 in the blood, and a decrease in its oxygenation. In 
contrast, a region that is ventilated, and not perfused, will have a V/Q of infinity. This 
would also result in decreased arterial oxygen saturation. Thus, ensuring efficient gas-
exchange will require a well matched ventilation and perfusion, resulting in a mean V/Q 
of 1. This delicate interplay is disrupted with the onset of diseases that largely affect ei-
ther of these processes, or the diffusive transfer of gases between them and the mean 
V/Q is shifted from unity.  
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2.1.2.2. Diffusion 
While ventilation and perfusion have been heavily studied using imaging modal-
ities, diffusion across the blood-gas barrier has not received tremendous attention and is 
of most relevance to my thesis. In regions that are ventilated and perfused, efficient oxy-
genation of the blood will require that these processes are connected by diffusive gas-
transfer. This means that the alveolar gases pass through the blood-gas barrier through 
passive diffusion. This process is governed by Fick’s first law of diffusion, and the vol-
ume of gas taken up by the blood stream (V) can be written as 
 1 2
. .( )A D P PV
T
α
−
  (2.1) 
where A is the surface area, D is the diffusion coefficient, P1-P2 represents the alveolar-
capillary partial pressure difference and T is the thickness of the medium. Thus, with 
their large surface area (50 – 100m2) and extremely thin barrier, the alveoli promote effi-
cient diffusion of gases.  As this gas-exchange is very efficient, the blood spends a short 
time within the capillary network. In a healthy adult, the heart pumps about 6 L of blood 
per minute, or about 100 ml per second. The volume of the blood within the capillary 
network is about 75 ml. Hence, through this back of the envelope calculation, the blood 
is estimated to spend only about 0.75 sec within the capillary network. Given such a 
short time frame, the transfer of gases to the capillary blood stream must be almost in-
stantaneous. For example, in a healthy lung, oxygen saturates the capillary blood stream 
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within ~200 ms. However, if the interstitial barrier becomes inflamed, this diffusive 
transfer of oxygen is impeded, and gets progressively worse with increased thickening.  
A number of tracer gases (CO, NO) have been used as surrogates to study the 
transfer of oxygen in the lung. While oxygen is impacted by both diffusion and perfu-
sion, the bulk transfer of these tracer gases may be primarily controlled by either diffu-
sion or perfusion. For example, the diffusion capacity of the lung for carbon monoxide, 
or DLCO, is used as a surrogate marker to study global gas-exchange in the lung. Carbon 
monoxide (CO), has a high affinity for hemoglobin. It quickly interacts with it to form 
carboxy-hemoglobin. As a result, the alveolar-capillary partial pressure gradient (equa-
tion 2.1) for carbon monoxide is always maintained, and as shown in figure 4A (red 
curve), CO never fully saturates the capillary blood stream. The uptake of carbon mon-
oxide, while influenced by perfusion, is dictated by its diffusion across the blood-gas 
barrier, making it a diffusion-limited gas. On the other hand, nitrous oxide has no affini-
ty for hemoglobin, and when inhaled, its concentration in the capillary blood stream in-
creases very quickly. Consequently, as the blood gets more saturated, the alveolar capil-
lary partial pressure gradient (equation 2.1) is slowly nullified, and the bulk transfer of 
N2O stops. Hence the transfer of nitrous oxide is not determined by the diffusion prop-
erties of the lung, and further increasing the transfer of N2O across the barrier into the 
blood stream would require increasing the perfusion. As a result, nitrous oxide is a per-
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fusion-limited gas (figure 4A; adapted from (50)). Figure 4B shows that oxygen, depend-
ing on the interstitial thickness, can transition from being a perfusion-limited gas, to a 
diffusion-limited gas. Interestingly, while 129Xe is classically defined as a perfusion-
limited gas, chapter 6 shows that this gas can be used to measure diffusion limitation. 
 
Figure 4: (A) Shows the uptake of CO and N2O in the lung. The transfer of N2O 
is not limited by the diffusion properties of the lung, and is hence perfusion limited. 
CO on the other hand is limited by the diffusion properties, and never saturates the 
intersitium. (B) Depending on the interstitial thickness, the uptake of oxygen can ei-
ther be perfusion or diffusion limited.   
 
As a global metric of gas-exchange, single breath measurements of DLCO have 
been well established and this is the current clinically accepted gold standard to test for 
pulmonary diffusion limitation. The measurement is carried out with the subject in an 
enclosed chamber. Before the measurement begins, the subject is coached to perform a 
forced exhalation to functional residual capacity. Subsequently, the subject inhales the 
contents of a gas mixture which consists of 0.3% of CO and a tracer gas (CH4, Ne, He), 
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and holds their breath for about 10 seconds (53). The additional tracer gases are used to 
measure the dilution of CO and calculate the alveolar volume (53). After the breath hold, 
the subjects are instructed to exhale the gases completely and the CO concentration in 
this exhaled gas is used to determine the DLCO. In order to ensure reproducibility, the 
measurements are repeated to get an accurate reading. The amount of CO taken up by 
the blood stream can be estimated using Fick’s first law shown in equation 1. In healthy 
lungs, as the partial pressure for CO in the alveolar blood is infinitesimally small, the 
partial pressure gradient is primarily determined by the alveolar partial pressure for 
CO. By rewriting AD/T as DL in equation 2.1, it can be written as:  
 COL
CO
VD
Pa
=   (2.2) 
The DLCO depends not only on the diffusion across the blood-gas barrier, but also 
on the reaction rate of the gas with the capillary blood stream. Therefore, the net DLCO 
can be treated as a series of resistances – resistance to cross the blood-gas barrier (DM) 
and the rate of reaction with the hemoglobin (θ). The final equation for DLCO can be 
written as: 
 
1 1 1
CO M CDL D Vθ
= +   (2.3) 
where VC is the capillary blood volume. 
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Even though DLCO is the current gold standard, it does have a few drawbacks 
(53). First, gas-exchange is measured using the bulk transfer of CO in the blood stream. 
This requires good subject cooperation, and an accurate breath hold set between 9 and 
11 seconds. Second, even though DLCO is a measure of gas diffusion at the capillary level, 
the measurement is made using the exhaled gas-mixture at the mouth. Hence, an accu-
rate measurement of bulk transfer of CO also requires that the exhalation be completed 
within a fixed time. Third, these measurements are sensitive to the changes in the exter-
nal temperature, and the associated variability in DLCO can be as high as 7%.  Lastly, and 
most importantly, the measurement of DLCO shows a large variation from site to site, 
and for a given subject, has been reported to be as much as 50% (54). Hence, there is a 
need to study gas-exchange using methods that are less restrictive. Moreover, the study 
of diseases such as idiopathic pulmonary fibrosis would be greatly aided by creating 
images of diffusive gas-exchange. This regional information would greatly help assess 
lung function, and additional help longitudinally monitor response to therapy.   
 
2.2. Relevant MR Theory 
As the goal of my thesis is extract information about pulmonary function using 
hyperpolarized gas MRI, this section aims to establish some of the basic theory behind 
MRI and hyperpolarized gases.   
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2.2.1. Magnetization 
All elementary particles possess an angular momentum or ‘spin’ and in nuclear 
magnetic resonance, we are primarily concerned with the proton spin. This angular 
momentum gives rise to a magnetic moment. This is given by equation 2.4, where J is the 
angular momentum. 
 jµ γ= r   (2.4) 
For spin-1/2 systems, such as hydrogen (1H), when in the presence of an external 
magnetic field, these spins align parallel (spin up) or anti-parallel (spin down), with the 
direction of this magnetic field. The relative abundance of the number of spins in the 
spin-up (↑) or spin-down (↓) state is dependent on the strength of the magnetic field (B0), 
and the temperature of the system (T). This relative abundance leads to a spin excess 
and hence, thermal polarization, which imparts a net magnetic moment of the spins. At 
thermal equilibrium, this thermal polarization given by 
 0 
2thermal
hBP
kT
γ
=   (2.5) 
where γ is the gyromagnetic ratio, h is Planck’s constant and k is Boltzmann’s 
constant. 
At body temperatures (37° C) and field strengths of 1.5 T, this polarization, is 
dominated by the thermal component (kT) shown in equation 2.5 and for protons, re-
sults in a low thermal polarization of only about 5 ppm. Although the polarization of a 
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single nucleus is minimal, as there are 110 moles per liter of protons in a gram of tissue, 
this large ‘spin-density’ leads to a significantly larger signal source. The sum of the net 
magnetic moments of all the spins in a given sample, gives rise to the overall thermal 
magnetization in the sample shown in equation 2.6. 
 
2 2
0 0
0 4
h BM
kT
γ ρ
=   (2.6) 
where ρ0 is the spin density of protons in the sample.  
In the lung however, this magnetization is greatly reduced due to the lower spin 
density of protons. Imaging the lung is further complicated by the air-tissue interfaces 
that cause the weak signal to decay faster (T2* between 0.3 – 5ms (18)). This short T2* can 
be overcome by using short echo times made available by UTE sequences (18). While 
these sequences also use rapid repetition times (TR), this is limited by the longer T1 (~1.2 
s) of the parenchyma (18). As an alternative, hyperpolarized (HP) noble gases were in-
troduced as external contrast agents to probe the structure and function of the lung. 
However, the thermal signal that can be obtained using noble gases is much smaller 
than that of protons owing to its lower gyromagnetic ratio, lower polarization (~1 ppm 
at 1.5T), and primarily because of its lower spin density (55 moles per liter). As a result, 
these isotopes are subjected to ‘hyperpolarization’ to externally induce a much higher 
magnetic moment to overcome the lower thermal polarization and spin density, by in-
creasing their signal by 5 orders of magnitude.  
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2.2.2. Spin-Exchange Optical Pumping 
Spin exchange optical pumping (SEOP) is the most effective method for polariz-
ing xenon in terms of throughput and absolute polarization. In SEOP, the angular mo-
mentum of a photon is imparted unto the lone valence electron of an alkali metal which 
causes this electron spin to become aligned, and this electron spin is then transferred to 
the nucleus of the noble gas of interest (55).  
The first step in this process imparts a quantum of angular momentum to the va-
lence electron of an alkali metal vapor – optical pumping. The alkali metal (in our case, 1 g 
of rubidium) is contained in a glass cell housed in an oven. Rubidium (Rb) melts at 40° 
C, and when heated to 150° C provides enough vapor pressure (5ppm of an atmosphere) 
to absorb ~50% of our broadband (2 nm FWHM) photons at 795 nm. 100 W of this 795-
nm light is circularly polarized and illuminates the cell parallel to a uniform magnetic 
field of 20 G. This wavelength is tuned to the absorption energy of the D1 resonance of 
the Rb valence electron. Once absorbed, the electron is excited into a higher energy state, 
and its subsequent collisions with nitrogen quenches it, and it almost instantaneously 
decays back to ground state. When it does, however, it may fall into either the spin up or 
the spin down state. But because only the spin down state selectively absorbs our 795 
nm photons to conserve angular momentum, the Rb electrons reach high polarizations 
through a "depopulation" of the spin down state. The cell temperature is set to achieve a 
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balance between an even distribution of absorbed photons and mitigation of deleterious 
spin-destruction effects. Once the cell is at an adequate temperature, a mix of 1% Xe, 
10% N2 and 89% 4He is flowed through the cell at a rate of ~1.6 SLM. The additional 
buffer gases (4He, N2) serve to increase the absorption cross-section of the Rb D1 transi-
tion which ensures efficient absorption of the laser light by the rubidium vapor, and to 
quench the excited state Rb. The nitrogen gas further serves to prevent unwanted, depo-
larizing fluorescence of excited Rb within the cell by absorbing the excess energy into its 
rotational and vibrational modes (heat).  
The second step in the polarization process is the exchange of angular momen-
tum between the rubidium valence electron and the 129Xe nucleus – spin exchange. In the 
cell, the polarized rubidium interacts with the nuclei of 129Xe atoms through two pro-
cesses: binary collisions and molecular interactions (van der Waals molecules). During 
these processes, there is a transfer of angular momentum from the Rb electron to the nu-
cleus of the 129Xe atom, also known as Fermi contact hyperfine interactions. Once polar-
ized, 129Xe travels along with the buffer gases into a pyrex coldfinger immersed in liquid 
nitrogen (77 K). As xenon freezes at 165 K, it is frozen into the coldfinger, while other 
gases flow over it. Once frozen, the solid mix is kept in a constant magnetic field (2000 
G), to minimize dipole couplings with the quadrupolar 131Xe (55), thereby increasing the 
T1 of 129Xe to levels that allow extended accumulation times up to an hour. Once the 
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cryogenic accumulation is complete, the xenon is thawed using warm water and evacu-
ated into a perfluoro polymer bag (Tedlar or ALTEF) and sealed, then placed into a 20 
gauss magnetic field for storage until use, now polarized to ~10%. Figure 5 shows a sim-
plified diagram explaining the polarization process. 
 
Figure 5: Simplified diagram showing hyperpolarization of 129Xe using spin 
exchange optical pumping. The optical cell is maintained at a temperature of about 
150° C to increase the vapor pressure of rubidium. Circularly polarized laser light 
tuned to a wavelength of 795 nm is illuminated into the cell to polarize the rubidium 
vapor. A mix of helium, xenon and nitrogen is then flowed into the optical cell. Colli-
sion between the polarized rubidium and 129Xe results in a transfer of the angular 
momentum from the rubidium valence electron to the 129Xe nucleus, which thus polar-
izes the 129Xe nucleus.  
 
The polarization is measured using a calibrated polarization measurement sta-
tion (Model 2881, Polarean Inc, Durham NC). In this station, a 20 G magnetic field is cre-
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ated by two Helmholtz coils and a low flip-angle RF pulse is applied on the polarized 
129Xe using a surface coil tuned to the xenon frequency (~24 kHz). Broadly, the polariza-
tion of the sample is measured by comparing the signal obtained from the HP gas sam-
ple, to its own thermal polarization. A small RF pulse ( Xeα ) is used to obtain an FID 
(free induction decay) from the bag of polarized 129Xe. Once the bag has decayed down 
to its thermal signal, a larger RF pulse ( Tα ) is used obtained a reference FID.  The polar-
ization of the bag of xenon (PXe) is thus given by 
 
sin
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α
=   (2.7) 
Where PT is the thermal polarization, SXe and ST are the amplitudes of the FIDs obtained 
from the polarized and the thermally polarized xenon respectively.  
 
 2.2.3. Pulse sequence considerations for HP Gas imaging 
HP gas MRI, unlike traditional 1H MRI, is limited by its non-renewable thermal 
magnetization, and hence requires unique acquisition strategies. Apart from the non-
renewable thermal signal, HP gases and more specifically 129Xe have certain characteris-
tics that impose a few restrictions on pulse sequence design (56). First, HP gases have a 
non-equilibrium magnetization which has a finite lifetime in the lung (T1). Furthermore, 
this finite lifetime is lowered by dipole interactions between paramagnetic oxygen and 
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xenon. The 129Xe T1 is proportional to the regional oxygen concentration in the lung, and 
for an oxygen concentration range of 9 – 33 amagat, the T1 was shown to vary between 
0.3 s to 0.07 s (57). Also, the application of RF pulses chips away at this magnetization 
and lowers it by the cosine of the flip angle applied. Second, being a gaseous contrast 
agent, the diffusivity of the gas is much higher than that of 1H (~1×10-5 cm2/s versus 0.14 
cm2/s for 129Xe at infinite dilution (58)), which is also dependent on the regional concen-
tration of the HP gas (58). Lighter alveolar gases such as N2 and O2, increase the diffusiv-
ity of the heavier 129Xe. Third, clinical imaging sequences require the acquisition to be 
completed in a single short breath-hold of about 15 seconds.  
As a result of these restrictions, pulse sequences for HP gases are limited to fast 
sequences that can adequately sample k-space in a single breath hold and low flip-
angles that effectively use the magnetization, and yet minimize blurring of the image. As 
RF refocused sequences such as the fast spin-echo require a much larger echo time, and 
also a large flip-angle, most of HP gas imaging has been done using the fast gradient re-
called echo (FGRE) pulse sequence (59). To further minimize the TE, these sequences 
have also exploited the Hermitian symmetry property, which describes the relationship 
between k-space – ( ),k x y  and its complex conjugate – ( )* ,k x y . This is shown in equa-
tion 2.8.  
 ( ) ( )*, ,k x y k x y= − −   (2.8) 
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This allows us to acquire only part of k-space, which minimizes the echo-time, 
diffusion-based attenuation and overall scan time.  
The ideal flip-angle for HP gas MRI is significantly lower than 90°, and can be es-
timated by maximizing the amplitude of the center of k-space after the nth RF pulse ( nS ) 
has been applied. This can be derived as shown below.  
 10 (cos ) sinnnS S α α−=   (2.9) 
where S is the signal at the center of k-space and the subscripts indicate the RF 
pulse number, α is the flip-angle. In order to ensure minimal decay of k0, we would like 
to maximize Sn with respect to α. Hence,  
 0ndS
dα
=   (2.10) 
 ( ) ( )2 21 (cos ) (sin ) (cos )n nn α α α−− =   (2.11) 
Solving for α, we get  
 
( )
1 1
 tan
1n
α −=
−
  (2.12) 
For Cartesian sequences that use sequential encoding of k-space, the ‘n’ in equa-
tion 2.12 will refer to the number of phase-encodes needed to get to the center of k-
space. Hence for 128 phase-encodes, the flip-angle that maximizes the center of k-space 
is 7.2 degrees.  
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2.2.4. Diffusion-weighted Imaging 
As seen in equation 2.1, efficient transfer of gases to the blood stream requires a 
large surface area, and a thin intersitium. While a good portion of my thesis is dedicated 
to the diffusion of gases across this intersitium, it is also important to probe the changes 
in the alveolar surface area. Interestingly, this can be achieved by probing the diffusion 
of gases within an alveolus. In the healthy lung, while the diffusion of hyperpolarized 
gases is heavily restricted by the alveolus, with the onset of diseases like emphysema, 
which induces extensive alveolar destruction, the gases are now freer to diffuse. This 
change in the diffusion of a gas can be used to indirectly probe the underlying change in 
the alveolar microstructure. The information of gas diffusion can be indirectly measured 
using ventilation images. However, the pulse sequences that are used to acquire ventila-
tion images must be modified to include additional gradients that can sensitize the im-
ages for this diffusion. Based on the underlying pulse sequence (spin-echo or gradient 
echo) these diffusion sensitizing gradients can be either unipolar or bipolar. For a GRE 
sequence, bipolar diffusion sensitization is applied, and is done before the readout gra-
dient. An example of bipolar gradients is shown in the figure below (adapted from (60)).   
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Figure 6: The bipolar gradients shown here (Stejskal-Tanner gradients) are 
used to sensitize for diffusion. The strength of the diffusion weighting (b-value) is 
determined by the gradient strength, and the timing parameters (τ, Δ, δ). 
 
The application of such gradients will induce an additional phase to spins that 
experience a displacement, which cannot be re-phased. The extent of phase accumula-
tion will vary as a function of the ramps, and the duration and amplitude of the gradi-
ents. Consider that during the application of the positive half of the diffusion gradient, a 
set of spins diffuse by a root mean squared distance r(t) ( 2Dt , where D is the diffusion 
coefficient and t is the time) then they will experience a change in their resonance fre-
quency ( ω∆ ). Consequently, this motion will cause the spins to accumulate some 
phaseϕ , which depends on the amplitude of the gradients (G), and is given by 
 
0
( ) ( ) r(t)tt G t dtϕ = ∫   (2.13) 
As long as spins remain stationary during the application of both diffusion gra-
dients, the phase imparted to the stationary spins during the positive half of the diffu-
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sion weighting gradient will be refocused by the application of the negative rephasing 
gradient lobe. However, the phase accumulated by the motion of spins, cannot be refo-
cused by the negative gradient lobe. This results in an exponential loss in the measured 
signal, which depends on the ‘b-value’ or the strength of the diffusion weighting gradi-
ent, and mainly, the degree of molecular diffusion (D). Hence, by acquiring images with 
and without the diffusion-weighting gradients, the signal intensities of the resulting im-
ages ( WeightedS , non weightedS − ) can be used to calculate the ‘apparent diffusion coefficient’ 
(ADC) on a pixel-by-pixel basis. 
 .b ADCweighted non weightedS S e
−
−=   (2.14) 
Depending on the extent of molecular diffusion, the amount of diffusion-
weighting can be controlled by adjusting the ‘b-value’ of the gradients. For example, 
compared to gases, water molecules experience lower diffusion, which is on the order of 
1x10-5 cm2/s, and hence typical b-values used for 1H diffusion studies are on the order of 
1000 s/cm2. However, HP gases, especially 3He (ADC ~ 2 cm2/s at free diffusion), diffuse 
rapidly, and imparting significant diffusion attenuation requires lower b-values (<10 
s/cm2). This b-value depends on the shape of the gradient used and can be calculated by 
integrating the following equation (61) 
 2
0
(2 ) ( ). ( )TEb k t k t dtπ= ∫
r r
  (2.15) 
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Where 
0
( ) ( )
2
t
k t G t dtγ
π
= ∫
ur
, and is the net phase imparted by the gradient lobe. 
The resulting b-value for the bipolar trapezoidal gradients shown in figure 6 can be 
written as (60): 
 ( )2 2 2 27 82
3 6 15M
b G δγ δ τ δ δ τ δτ τ    = ∆ − + − ∆ + ∆ − +    
    
  (2.16) 
While the diffusivity for HP 129Xe (0.14 cm2/s at infinite dilution) is higher than 
water, the challenges in implementing diffusion weighted imaging with xenon, arise 
from its lower gyromagnetic ratio. Thus obtaining adequate diffusion weighting (b-
value of ~12 s/cm2) with the highest clinical gradient strength (3.2 G/cm), would need 
longer diffusion gradients (~2.5 ms). This increases the minimum achievable echo time, 
increasing the T2* attenuation. In spite of this challenge, high quality diffusion weighted 
images were acquired, and this will be discussed in chapter 3.  
 
2.2.5. Radial Acquisition for HP Gases 
HP gases, and more specifically 129Xe, exhibit large diffusion coefficients, have a 
short T2*, and require short scan durations (~15 seconds). These properties favor imaging 
their distribution using radial acquisition strategies. Unlike Cartesian sequences that ras-
ter through k-space, radial sequences as the name suggests, sample k-space radially. The 
radial acquisition offers the following advantages. 1) By using a center-out acquisition 
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strategy, the ‘echo-times’ that can be generated with this sequence are well below a mil-
lisecond. This enables imaging chemical species that have a very short T2* and hence can 
generate images with a reasonable SNR. This property is especially useful for imaging 
the dissolved-phase of 129Xe, as discussed in chapters 4 and 5.  2) This acquisition strate-
gy densely over-samples the lower frequencies of k-space which helps minimize artifacts 
introduced by motion. This is helpful while imaging the lung, as this helps negate any 
artifacts introduced by the motion of the heart. 3) As the gases have a larger diffusion 
coefficient, the attenuation introduced by diffusion-based accumulation of phase will be 
pushed to the edge of k-space. 4) As shown by Scheffler et al. (62), radial acquisitions are 
also robust against the under-sampling of k-space. Thus radial acquisitions can be lim-
ited to a single breath-hold by acquiring fewer rays, or views of k-space, well below the 
Nyquist limit.  
While the 2D radial acquisition samples a circular path in k-space, the goal with 
any 3D radial acquisition is to follow a trajectory that uniformly samples the surface of a 
sphere (63). In order to ensure uniform sampling of the surface of a sphere and thus 
minimize aliasing, the equations used for the 3D radial acquisition describe an Archi-
medean spiral through k-space (63). In addition to ensuring uniform k-space sampling, 
this acquisition strategy also reduced the number of views needed to satisfy the Nyquist 
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condition by 50%. The Archimedean spiral trajectory indicated by the equations below, 
will sample the surface of a sphere, when scaled by the maximum gradient amplitude. 
( )
22
cos 1 1
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 ( ) ( )2 21 (Z X YG n G G= − +   (2.17) 
where N is the number of views of k-space, n is the view number, n=1,2 … N, 
and P is an empirically chosen prime sampling factor used to randomize samples along 
the X-Y plane. This empirically chosen prime-sampling factor ensures the uniform sam-
pling of the edge of the sphere, even when tremendously under sampled. This is illus-
trated in figure 7.  
 
Figure 7: 3D radial acquisition of k-space, which uniformly samples the edge 
of a sphere. (A) shows an Archimedean spiral trajectory with just 400 views. This 
clearly shows non-uniform sampling of the edge of a sphere. (B) shows the Archime-
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dean spiral with the same number of views, but with an empirically chosen prime 
sampling factor of 101. This ensures the uniform sampling of k-space, even when 
tremendously under-sampled.    
 
The number of views required to adequately sample the edge of k-space is dictat-
ed by the area of subtended between each view at the surface of the k-space sphere (61) 
as described by figure 8.  
 2Ω  ∆k
maxk ≤∆   (2.18) 
where Ω sin ∆ ∆θ θ ϕ∆ =  is the solid angle subtended by the views at the edge of a 
sphere. As we ensure equiangular sampling of k-space,  can be described as  
 
1
∆
maxk L
θ =   (2.19) 
where L is the field of view (FOV). Similarly,  
 
Figure 8: The calculation of Nyquist limits for the 3D radial sequence, adapted 
from (61). 
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1
∆
sin
maxk L
ϕ
θ
=   (2.20) 
As there are 4π spherical radians in a sphere, to satisfy the Nyquist condition, 
this solid angle can be obtained by acquiring SN number of views of k-space, 
4
∆Ω
SN
π
= . 
Using equations 2.19 and 2.20, SN can be written as 
 ( )24S maxN k Lπ=   (2.21) 
As 
1
2max
k
x
=
∆
and
L
x
npts
∆ = , for a center-out radial acquisition, equation 21 is 
written as 
 ( )2SN nptsπ=   (2.22) 
Hence for a 64×64×64 acquisition, the number of views of k-space required is 
~12900 views. 
 
2.2.6. Non-Cartesian Image Reconstruction 
Although non-Cartesian acquisitions are preferred for imaging HP gases, they 
have yet to be widely adopted as their reconstruction remains moderately challenging. 
While Cartesian data acquired on an equally spaced rectilinear grid can be reconstructed 
rather simply using the FFT, non-Cartesian image reconstruction is impacted by the non-
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uniform sampling density of the data. As the FFT requires uniformly spaced data, this 
requires that non-Cartesian k-space data be re-sampled onto a uniform Cartesian grid, 
before the data can be Fourier transformed.  
A commonly used approach to reconstruct non-Cartesian data is convolution 
gridding (64). Fundamentally, each point in k-space is convolved with a kernel (C), 
compensated for the density of samples (W), and then recast onto a cartesian matrix (R), 
and then finally Fourier transformed to yield the final image. This can be described 
mathematically as [Pipe] 
 ( ){ }( )1( , ) ( , )* ( , ) * ( , )m x y FFT M u v W u v C R u v C−′ ′= ⊗ ⊗     (2.23) 
 where, M(u,v) is the radially acquired frequency domain data, and m(x,y) is the 
regridded Cartesian k-space data.  
While non-Cartesian reconstruction was not the focus of my thesis, our group 
has made significant advances with radial reconstruction that has improved the quality 
of dissolved-phase images. Specifically, the following aspects of reconstruction were op-
timized. First, the choice of the convolution kernel, and the associated width, has an im-
pact on the blurriness seen in the images. The optimal kernel, has been established in the 
literature to be the Kaiser Bessel (65). Second, while densely sampling the lower frequen-
cies of k-space has its advantages for lung imaging, as it minimizes motion artifacts in-
duced by the beating heart, it introduces an additional step in the reconstruction process 
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– density compensation (W). After the convolution gridding operation, each point in k-
space was weighted in accordance with density, with heavier weighting applied to the 
higher frequencies of k-space. While this is still an area of active research and multiple 
methods that have been developed – Voronoi, hit-plane, the iterative density compensa-
tion method was chosen to be the optimal (66). After the density compensation opera-
tion, the resulting data is then cast onto a twice oversampled Cartesian grid. As we use 
non-slice selective pulses, this works to excite any and all xenon magnetization outside 
the FOV, which may fold in and cause aliasing artifacts. This oversampled grid ensures 
that the aliasing artifacts are pushed to the outer edges of k-space, and are minimized 
within the field of view. The re-gridded k-space data is Fourier transformed and 
cropped appropriately to give the reconstructed image. The final step, which had histori-
cally been neglected, is dividing the reconstructed image by the Fourier transform of the 
convolution kernel – deapodization. The optimized convolution kernel, deapodization, 
and density compensation algorithm have had a significant impact on the quality of hy-
perpolarized images, and the SNR has improved by 50%. This boost in SNR, in addition 
to providing higher quality images, has enabled the phase sensitive reconstruction of the 
dissolved-phase images to be discussed in chapter 7.  
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2.2.7. The Dissolved-Phase of hyperpolarized 129Xe 
2.2.7.1. Diffusive replenishment of HP 129Xe in the alveolar septum 
The signal from the xenon dissolved in the alveolar septum is derived entirely 
from diffusive transfer of magnetization from the airspaces. To understand the source of 
this signal, we must understand the mathematics of this diffusion transfer and its inter-
play with the RF pulses. The RF pulses used to detect xenon in the dissolved-phase also 
deplete its signal. But unlike the gas-phase of xenon, the dissolved-phase signal is re-
plenished by the fresh gas-phase xenon magnetization that diffuses into these compart-
ments. Much like the diffusion of carbon monoxide into the capillary blood, this diffu-
sion of xenon is also governed by Fick’s law. To understand and simulate the signal dy-
namics of the dissolved phase and understand the impact of barrier thickness on signal 
replenishment, Driehuys et al. postulated a 1D model of gas-transfer.  
To model the signal dynamics of xenon in the dissolved-phase, the diffusion of 
xenon across the blood-gas barrier can be modelled as diffusion across the plane surface 
with a constant diffusion coefficient D. The entire gas-exchanging region is modeled to 
extend from –L<x<L, and the capillary extends from –LC<x< LC and L> LC. The thickness 
of the diffusion barrier is Ldb = L-Lc. This is graphically illustrated in the figure below.  
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Figure 9: Graphical representation of the diffusion of xenon across a plain 
sheet.  
 
To get an expression for the concentration (or magnetization) of xenon as a func-
tion of time, one needs a solution for the equation: 
 
2
2.
C CD
t x
∂ ∂
=
∂ ∂
  (2.24) 
which is Fick’s second law. C is the concentration of the tracer, t is time, x is the 
distance, and D is the diffusion coefficient. The magnetization of 129Xe in the dissolved-
phase after the application of a 90 degree pulse can be obtained by solving equation 24. 
The solution for this equation is provided in (67) and the 129Xe magnetization in the dis-
solved-phase Mdiss can be written as  
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∑   (2.25) 
where λ is the fraction of the 129Xe magnetization in the airspaces (Mair) that is in 
the dissolved-phase, erfc is the complement of the error function where erfc = 1- erf. 
While equation 25 gives the magnetization of the dissolved-phase at time t, the RBC sig-
nal (SRBC) can be obtained by integrating this dissolved-phase signal from – LC to LC. 
Consequently, the barrier signal (SBarr) can be obtained by subtracting the RBC signal 
from the integral of the dissolved signal obtained over -L to L.  
( , )LcRBC dissLcS Hct M x t dx−= ∫ , where Hct is the hematocrit 
 ( , ) ( )LBarr diss RBCLS M x t dx S t−= −∫    (2.26) 
In modeling the dissolved-phase signal, we are making a few assumptions (47). 
First, the solubility and the diffusion coefficient are considered to be constant through-
out the lung. Second, the T1 of the 129Xe in the dissolved-phase (T1 of 129Xe in deoxygenat-
ed blood is 2.2s, and 7.7s in oxygenated blood (68)) is longer compared the rate of signal 
replenishment and hence can be ignored. Lastly, the capillary blood spends about 750 
ms in diffusive contact with the 129Xe in the alveolus. As the signal replenishment is 
much shorter than this capillary transit time, perfusion has not been included in the 
model.  The solutions to the equations 2.26 can be normalized by the signal in the air-
spaces and written as follows (47) 
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where S0 is MAirLA where LA is the dimension of an alveolus. Similarly, the equation for 
the barrier can be written as 
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∑   (2.28) 
The normalized SRBC and SBarr signals have been plotted as a function of replenishment 
time for a range of interstitial thicknesses in figure 10 below.  
 
 
Figure 10: Barrier and RBC replenishment after the application of a 90 RF 
pulse. With minimal interstitial thickening, while the barrier signal increases in sig-
nal, the RBC signal shows a significantly delayed replenishment. This delay can be 
used as a sensitive probe of interstitial thickening.  
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As the barrier is immediately adjacent to the alveolar space, compared to the 
RBC signal, this signal replenishment begins earlier. Furthermore, it should be noted 
that minimal interstitial thickening of this barrier tissue delays the replenishment of the 
RBC signal. As seen in figure 10, with a nominally normal interstitial thickness of 1 μm, 
the RBC replenishment time begins almost immediately and is nearly complete by 100 
ms. In contrast, with an interstitial thickness of 2.5 μm the RBC replenishment time al-
most doubles to about 66 ms. This RBC replenishment also lags the barrier signal, as the 
xenon diffuses into it first. The barrier signal replenishment is unaffected by this in-
crease in thickness, and in fact shows an increase in signal intensity. Hence with a prop-
er choice of acquisition parameters, one can weight for the delayed RBC signal replen-
ishment. This delayed replenishment can be used as a marker of diffusion limitation, 
and as discussed in chapter 6, will form the basis for a global biomarker of gas-
exchange.  
 
2.2.7.2. Phase sensitive imaging of the 129Xe in the barrier and RBCs 
The low dissolved 129Xe magnetization and the rapid T2* makes dissolved-phase 
imaging challenging. By taking advantage of the dynamic replenishment of the dis-
solved-phase signal, which was highlighted in the previous section, improvement in 
xenon polarization, and by using rapid pulse sequences, direct imaging of the dissolved-
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phase was made possible. This first attempt at imaging the dissolved-phase imaging 
captured both the resonances in the images. One of the goals of my thesis is to create 
separate images of xenon in the barrier, and transiently bound to the RBCs, to get a fun-
damental view of gas-exchange in the lung.   
The techniques I have used in phase-sensitive imaging of the dissolved-phase de-
rive their concepts from fat-water 1H imaging. This similarity arises as protons that are a 
part of the fat resonance are chemically shifted from the main water resonance by -3.5 
ppm, and hence have a similar frequency difference as the resonances of the dissolved-
phase of xenon (~225 Hz for fat-water, ~340 Hz for the barrier and RBC). The fat reso-
nance is the source of chemical shift artifacts in conventional 1H MR. As a result, the 
separation of fat and water has been the topic of research for multiple decades, which 
has yielded highly refined techniques and algorithms for fat-water separation and sup-
pression. Some of these techniques rid the fat signal by selectively exciting only the wa-
ter resonance using long RF pulses. Other approaches exploit the differences in the T1 
between fat and water, and use inversion recovery sequences to suppress the fat reso-
nance. Long RF pulses and 180 degree flip-angles needed for these approaches are not 
applicable for the dissolved-phase because of its low gyromagnetic ratio (11.77 MHz/T), 
and short T2* (~2 ms).  
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As an alternative to RF based fat suppression, T. Dixon introduced a novel tech-
nique to create images of both fat and water (69). As the fat signal resonates 225 Hz be-
low the water resonance, when the transmit and receive frequency are tuned to the wa-
ter resonance, this frequency separation, causes the fat signal to accumulate phase with 
respect to the receiver. This technique introduced by T. Dixon (69) took advantage of this 
phase accumulation between the two resonances to separate the fat and water contribu-
tions. Two images using two different echo times, were generated using a spin-echo 
pulse sequence; the first image was acquired with both resonances in phase (fat + water 
image) and for the second image, the timing of the 180° RF pulse was adjusted to ensure 
the two resonances were 180° out of phase (water – fat image). Using a combination of 
the two images, a pure water or pure fat image could be generated. As this method used 
two TEs, this was the 2-point Dixon technique for fat-water separation. However, as this 
approach uses a spin-echo sequence, the issues that affect RF or T1 based approaches, 
also plague the 2-point Dixon technique. Thus the 2-point Dixon cannot be implemented 
to separate the components of the dissolved-phase in a single breath. 
However, it is possible to use the principles of Dixon imaging to create separate 
images of the components of the dissolved-phase of 129Xe, using just a single echo time 
(70). This is appropriate given its short T2*. Using the radial pulse sequence, the echo-
time is set such that the phase separation between the two resonances was 90° (Figure 
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11).  At that echo time, once the phase offset with respect to the receiver has been cor-
rected for, each receive channel will have information about one of the resonances. 
Hence by starting the data acquisition at that echo time, and employing a phase sensi-
tive reconstruction, the two resonances can be separately imaged with at least the center 
of k-space with a 90° phase separation between the RBC and barrier. As this employs 
just one echo time, this is the 1-point Dixon technique. This strategy has been used in 
rats with the radial sequence to generate 2D images of 129Xe in the barrier and RBCs (47). 
The echo time for a 90° phase separation (TE90), can be derived as shown below. 
 
Figure 11: The variation in the amplitude of the center of k-space for the xenon 
in the red blood cells (on resonance; red) and the barrier tissue (blue). Data acquisi-
tion is initiated at TE90, where the two resonances are 90° out of phase with each other.  
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The general equation for the phase difference accumulated by an ensemble of 
spins with a frequency difference f∆ over time t in a magnetic field can be written as 
 ( )   2t ftϕ π∆ = ∆   (2.29) 
where ( )tϕ∆  is the phase difference, γ is the gyromagnetic ratio. If the transmit and re-
ceive frequency were on resonance with the xenon in the RBCs, and the barrier was 
would resonate at Δf Hz lower in frequency, after a time t, the barrier being at a lower 
frequency will lag the RBCs by ϕ∆  degrees.  At a time 90t TE= , the two resonances will 
be 90° out of phase 
2
π
ϕ ∆ = 
 
. Using this information in equation 2.29, we get 
 9022
fTEπ π= ∆   (2.30) 
Hence, the echo time needed for a 90 phase separation can be calculated using just the 
frequency difference between the RBC and barrier resonances, and can be written as 
shown below. 
 90
1
  
4
TE f= ∆   (2.31) 
While the 1-point Dixon technique provides a simpler approach to creating sepa-
rate images of xenon in the RBC and barrier, it does require overcoming a few challeng-
es. First, the 1-point Dixon acquisition is inherently sensitive to the inhomogeneity of the 
B0 field. Moreover, any technique that uses phase to decompose chemical components 
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will be sensitive to phase variations introduced by RF pulse imperfections, and local 
magnetic field inhomogeneity (71). The phase changes caused due to this inhomogeneity 
can be corrected for with the calculation of a B0 map. Second, the Dixon technique also 
does not account for the continuous evolution of phase between the two resonances after 
the first few k-space points have been acquired. As a result, the Dixon condition is valid 
only near the origin of k-space (k0). Lastly, while the two resonances may be 90° out of 
phase, they may still be at an arbitrary phase with respect to the receiver. Calculating 
this receiver phase offset requires developing calibration procedures, or as we will see in 
chapter 7, can be calculated using the acquired data. Hence, in spite of its shortcomings, 
the 1-point Dixon acquisition helps overcome the short T2* of the dissolved-phase and 
create separate images of its components in a single-breath.  
As illustrated by the theory outlined in this chapter, my work combines the 
unique properties of hyperpolarized 129Xe, optimized MR acquisition strategies, signal 
processing, and the mathematics of diffusion to provide a fundamentally new approach 
to studying alveolar microstructural changes, and more importantly, providing a new 
approach to imaging diffusive gas-exchange in the lung.  
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3. Imaging Lung Microstructure using Diffusion-
Weighted 129Xe MRI 
 
In addition to ventilation and perfusion, the efficiency with which the lungs ex-
change gases depends on two structural parameters – the alveolar surface area, and the 
interstitial thickness. This chapter probes the changes in the alveolar surface area 
brought on by COPD, using diffusion weighted imaging. The results discussed in this 
chapter were previously published as a journal article: S.S. Kaushik et al., ‘Diffusion-
Weighted Hyperpolarized 129Xe MRI in Healthy Volunteers and Subjects with Chronic Obstruc-
tive Pulmonary Disease’, Magnetic Resonance in Medicine, 2011; 65(4):1155-1165.    
 
3.1. Motivation 
3.1.1. Chronic Obstructive Pulmonary Disease (COPD) 
Chronic obstructive pulmonary disease (COPD) is characterized by slowly pro-
gressing irreversible airflow limitation (72). COPD affects roughly 12 million patients in 
the United States, is the 3rd leading cause of death in the United States and Europe (73), 
and is one of the common causes of death that continues to increase in incidence. COPD 
describes a group of diseases (phenotypes) that include emphysema, bronchitis, and 
bronchiectasis. Moreover, multiple phenotypes can exist within a single individual. To 
treat and monitor COPD patients effectively, it will be necessary to assess the regional 
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extent and severity of each phenotype, and to determine the predominance of one over 
the others (73).  
To this end, thin-section computed tomography (CT) has been extensively inves-
tigated for the radiologic evaluation of COPD (8). CT can identify regions of airspace 
tissue destruction (emphysema) by their low x-ray attenuation, often defined as less 
than –950 Houndsfield units, and has shown good correlation to histology (9). CT imag-
es acquired at end-expiration can be used to visualize air trapping, and airway wall 
thickening can be measured in the first 6 generations (10). However, despite the power 
and high resolution achievable with CT, the associated radiation dose constrains its use 
in asymptomatic patients and in longitudinal follow-up studies (74), limiting its use for 
investigational purposes.  
3.1.2. Hyperpolarized 3He Diffusion-weighted MRI 
Hyperpolarized (HP) 3He MRI has established itself as a powerful, noninvasive 
imaging modality for diagnosis and evaluation of COPD (24). HP 3He MRI provides rel-
atively high-resolution images of ventilation, which permits areas of regional obstruc-
tion to be visualized. Beyond static ventilation imaging, 3He MRI has been used to 
measure the apparent diffusion coefficient (ADC), which is arguably the most developed 
and straight forward to interpret. The principle of ADC MRI is that diffusion of 3He at-
oms in the lung is constrained by the size of the alveolar space. Hence, the 3He ADC 
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measured in healthy lung is small [∼0.25 cm2/s in humans for typical protocols, (29)] 
compared to a large self-diffusion coefficient of ~2 cm2/s. However, in regions of appre-
ciable emphysematous tissue destruction, the ADC becomes elevated, eventually reach-
ing a maximum value consistent with the free diffusion of 3He in air (~0.8 cm2/s). By con-
trast, ADC would not be expected to increase if airflow limitation was caused by an air-
way-predominant disease such as bronchitis.  
Since the introduction of 3He ADC (58,75) in small animal models of emphysema, 
considerable progress has been reported. In addition to revealing emphysema in pa-
tients with known COPD, 3He ADC shows early emphysema-like changes in asympto-
matic smokers (76) and in individuals exposed to second-hand smoke (32). The relation 
of ADC to alveolar size has been demonstrated by its sensitivity to postural gradients 
(33) and age-related changes in alveolar size (34). 3He ADC MRI has proven highly re-
producible in repeated studies (77) and has shown hints of disease progression in indi-
vidual subjects (78). Recently, 3He ADC was put on a firm theoretical footing by 
Yablonskiyi et al., who demonstrated the ability to extract precise airspace dimensions 
from the ADC measurement (79). 3He ADC has been compared clinically to CT, and the-
se studies suggest that it correlates more strongly with DLCO (Diffusing capacity of car-
bon monoxide in the lung) than the CT based metrics (80). Unfortunately, the scarcity of 
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3He and its rapidly increasing cost have severely limited the broader dissemination of 
HP 3He MRI. 
3.1.3. Transitioning to Hyperpolarized 129Xe MRI 
 The limitations of 3He have made clear the need to transition to HP 129Xe MRI, 
the supply of which is unconstrained. 129Xe MRI has improved considerably (81)] since 
the first human ventilation imaging was demonstrated (25). 129Xe MRI has also been im-
plemented with diffusion weighting (58), and Mugler et al. first demonstrated 129Xe ADC 
in healthy human volunteers (82), which was followed up by Sindile et al. (83). While 
Mata et al. demonstrated that 129Xe ADC becomes elevated in an elastase-model of em-
physema in rabbits (84), there have been no reports of 129Xe ADC measurements in pa-
tients with COPD. Therefore, the aim of this study was to assess the clinical feasibility of 
129Xe ADC MRI and apply it in a population of healthy volunteers, COPD subjects, and 
age-matched control subjects.  We report a detailed analysis of ADC trends with disease, 
age, and posture, and correlate the ADC values with conventional pulmonary function 
testing.  
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3.2. Methods 
3.2.1. Subject Inclusion/Exclusion Criteria 
Studies were conducted under the GE Healthcare Investigational New Drug 
(IND) as part of a Phase I clinical trial for hyperpolarized 129Xe MRI, and studies were 
approved by the Duke University Medical Center (DUMC) Institutional Review Board 
(IRB). Written informed consent was obtained from the volunteers and subjects prior to 
enrollment. Subjects were excluded if they were pregnant or lactating; had a history of 
asthma, allergy, or hypersensitivity that affects the pulmonary function; had a history of 
cardiac arrhythmias; or had a respiratory illness (or exacerbation for COPD subjects) 
within 30 days of imaging.  
The study consisted of a technical run-in phase for pulse-sequence development 
followed by an efficacy phase using a fixed version of each sequence. During the run-in 
phase, a group of healthy volunteers (HV) (3 men, 4 women, mean age = 32.9 ± 11.3 
years) underwent the same version of the 129Xe ADC MRI protocol that was used during 
the efficacy phase (with minor differences in b-values), and hence, these subjects are in-
cluded as part of this report. These subjects met the same inclusion/exclusion criteria as 
the age-matched control subjects (see below), except they did not undergo pulmonary 
function testing. 
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For the efficacy phase, 1 subject with GOLD Stage I, 8 subjects with GOLD Stage 
II, and 1 subject with GOLD Stage III COPD were recruited from a population of pa-
tients who had a smoking history of at least 20 pack-years (7 men, 3 women; mean age = 
65.9 ± 7.1 years). Given the relatively small population, Stage II patients were primarily 
selected to ensure observing a reasonable, but not overly variable, degree of pathology. 
The Stage II COPD subjects had a forced expiratory volume in 1 second (FEV1) between 
50 and 80%, FEV1/FVC (forced vital capacity) of less than 70%. They had a single-breath 
carbon monoxide diffusing capacity (DLCO) of less than 70% of the predicted value. The 
Stage I subject had an FEV1 that was 81% of predicted and the Stage III subject had an 
FEV1 that was 35% of predicted, as seen in Table 1. This GOLD classification is also de-
fined in the appendix of this thesis. All COPD subjects had a chest x-ray or CT scan on 
file, with 8 out of 10 exhibiting evidence of emphysema, as determined by a board certi-
fied radiologist (HPM).  
In addition, 10 age-matched healthy controls (AMC) were enrolled (4 men, 6 
women, mean age = 62.9 ± 7.6 years). These subjects each had a smoking history of less 
than 5 pack-years and had not smoked for at least 5 years prior to participating in the 
study. Volunteers typically had an FEV1 and DLCO that were both greater than 80% of 
the predicted value and an FEV1/FVC that was greater than 70%. All pulmonary func-
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tion testing was conducted within one week of 129Xe MRI. Table 1 provides a complete 
list of all the PFT data for all subjects. 
 
3.2.2. 129Xe Polarization and Delivery 
Isotopically enriched 129Xe (85%) was polarized in an hour as detailed in chapter 
3, to generate 1-L doses. With the subjects lying supine, HP 129Xe was then administered 
from a Tedlar bag through 0.95-cm inner diameter Tygon tubing (Saint-Gobain Perfor-
mance Plastics, Akron, OH). Each subject received a 1-L 129Xe dose regardless of their 
lung volume, with inspiration commencing after exhaling to a volume estimated to be 
between residual volume (RV) and functional residual capacity (FRC). Imaging started 
within 1-2 seconds of the subject inhaling the contents of the bag. For each 129Xe dose, the 
subject’s subjects’ blood pressure, heart rate, and oxygen saturation level were continu-
ously measured using a Datex-Ohmeda monitoring system (GE Healthcare, Helsinki, 
Finland). 
 
3.2.3. Hyperpolarized 129Xe Imaging 
Imaging was performed using a 1.5 T Excite 14M5 MRI scanner (GE Healthcare, 
Milwaukee WI) and a quadrature vest coil (Clinical MR Solutions, Brookfield, WI) tuned 
to the 17.66 MHz 129Xe resonance frequency and proton blocked to enable localizing and 
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shimming using the body coil of the scanner. Diffusion-weighted HP 129Xe images were 
acquired in the coronal plane using a multi-slice spoiled gradient recalled echo (SPGR) 
sequence (field of view = 40 cm, slice thickness = 15 mm, matrix = 64× 64, bandwidth = 
15.6 kHz, TE/TR = 9.3/12 ms and flip angle = 5.1°). Diffusion weighting was achieved us-
ing bipolar gradients (amplitude = 3.2 G/cm, ramp time = 500 μs, and pulse width = 2.4 
ms), having a b-value (60) of 12 s/cm2. This b-value was used for all subjects except for 5 
healthy volunteers, who received a slightly longer sensitizing gradient pulse width of 
2.9 ms, resulting in a b-value of 18.76 s/cm2. For each diffusion-weighted image, an ac-
companying unweighted image was acquired in an interleaved fashion to enable pixel-
wise ADC values to be calculated from the two images. The total acquisition time was 
limited by the protocol to 16 seconds, thus restricting the number of slices to 10. As a re-
sult, the most anterior and most posterior slices of the lung were generally not scanned. 
 
3.2.4. Source Image Processing 
The images were interpolated by the reconstruction algorithm of the scanner 
from a 64× 64 to a 256× 256 matrix and saved in DICOM format. These images were then 
imported into MATLAB™ (The MathWorks, Inc., Natick, MA) to generate the ADC 
maps. To ensure that ADC calculations were made only on pixels corresponding to ven-
tilated lung, several processing steps were applied to the source images. First, the non-
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diffusion weighted (b = 0) images were used to generate binary masks of each slice, us-
ing a threshold derived from the mean of the background noise plus twice its standard 
deviation. The background noise was determined from a 200× 50-pixel region outside 
the lungs, which provided reproducible noise measurements regardless of its placement.   
The relatively low threshold caused numerous islands of background noise to be 
retained in the mask. These islands were removed by an ‘erosion’ operation, which was 
followed by a ‘dilation’ operation to restore mask features belonging to ventilated lung, 
but lost during erosion. Erosion (Θ ) of a binary image, A, by a smaller structuring ele-
ment, B, is mathematically defined as (85) 
 { | (B) }ZA B z AΘ = ⊆   (3.1) 
where ( )21 , zzz =  is the coordinate within the image space and BZ represents a translation 
of a symmetric structuring element across the image by one pixel at a time. B is chosen 
to be small compared to the primary image features, but large compared to the spatial 
scale of the image noise. Erosion of A by B thus retains the subset of points in A upon 
which the center of B can be placed such that all the pixels in B overlap only with pixels 
of value 1. Thus, regions of noise, which are smaller than the structuring element B, are 
removed. Following erosion, dilation (⊕ ) is subsequently used to restore the size of im-
age A using the same structuring element B according to (85)     
 { | [( ) ] }ZA B z B A A⊕ = ⊆I   (3.2) 
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If the center of the structuring element falls on top of a pixel with value = 1, the pixel is 
dilated, meaning that all the neighboring pixels encompassed by the structuring element 
are replaced by 1.  
 
3.2.5. ADC Calculation 
The ADC value of each pixel was calculated from the segmented source images 
according to 
 0
1 ln SADC
b S
 
=  
 
  (3.3) 
where S is the signal intensity of the diffusion weighted image pixel, and S0  is the inten-
sity of the pixel without weighting. The resulting ADC maps were further processed by 
rejecting any pixels with a value outside the interval 0 ≤ ADC ≤ 0.14 cm2/s. The 0.14 cm2/s 
cutoff was chosen because it corresponds to the expected free diffusion coefficient of 
xenon in nitrogen at infinite dilution and 37 °C (86). Finally, since 129Xe diffusion in the 
visible airways is largely unrestricted (58), the airways were manually segmented out of 
the maps, such that ADC values for the airways and the distal lung parenchyma were 
calculated separately.  
ADC maps were further analyzed for spatial gradients in the anterior-posterior 
and superior-inferior direction. ADC gradients in the anterior-posterior direction were 
calculated by plotting the average ADC for each of the ten slices and calculating the 
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slope. ADC gradients in the superior-inferior direction were calculated by dividing each 
lung into 3 strips of equal height and using the mean ADC of each region to derive a 
corresponding slope. 
 
3.2.6. Statistical Analysis 
Linear regression analysis was used to test for correlations between ADC and 
pulmonary function tests, as well as ADC and age, and these were reported using Pear-
son’s correlation coefficient. The mean ADCs of each subject group were tested for sta-
tistical significance using the Wilcoxon Rank Sum test. This test was chosen rather than 
the Student’s t-test, because a Bartlett test of our data showed unequal variances be-
tween groups. The Wilcoxon test was also used to establish statistical significance of the 
anterior-posterior and superior-inferior ADC gradients observed in the maps.  
 
3.3. Study Results 
3.3.1. Effects of Image Processing 
The signal-to-noise ratio (SNR) in 129Xe MRI is generally lower than that achieved 
for 3He MRI. In this work, the unweighted images had a mean SNR of 15.21 ± 4.74 versus 
9.41 ± 2.98 for the weighted images. Therefore, several imaging processing steps were 
employed to eliminate noise in regions of the image outside the lungs.  
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Figure 12: Erosion and dilation of binary masks. (A) Non diffusion-weighted 
(b=0) gas-phase image of a COPD subject with emphysema. (B) The corresponding 
binary mask. The mask was generated using a threshold obtained using the mean 
background intensity mean plus twice its standard deviation. (C) Mask from A after 
erosion using a circular structuring element (radius = 3 pixels), showing that the ma-
jority of the background noise has been removed (D) Mask from B after dilation with 
the same structuring element showing the restoration of subtle image features.  
 
Figure 12A shows a non-diffusion weighted (b=0) image slice, and Figure 12B 
shows the mask obtained using a simple thresholding procedure that retains much of 
the background noise, which, if propagated, would contribute meaningless values to the 
ADC maps. When this mask was eroded with a circular structuring element of 3-pixel 
radius (Figure 12C), most of the discontinuous noise was eliminated, but some structur-
al features in the mask were also lost, particularly the major airways. However, as is 
seen in Figure 12D, subsequent dilation restores most of these structural features. 
To assist in choosing an appropriately sized structuring element for ero-
sion/dilation, the source images from several representative subjects in the HV, AMC, 
and COPD groups were also manually segmented to delineate the ventilated lung from 
the background. The resulting masks were applied to the source images and their ADC 
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maps were calculated, along with the mean ADC and its standard deviation. These 
maps were then compared with those obtained by automatic segmentation using ero-
sion/dilation with different sized structuring elements. These comparisons showed a cir-
cular structuring element with a 3-pixel radius to provide results identical to manual 
segmentation and, therefore, this element was used to erode/dilate the masks for all sub-
jects. This is illustrated in Figure 13. For this example, the mean parenchymal ADC of a 
healthy subject obtained using a threshold mask without erosion/dilation or further 
manual segmentation was 0.041±0.026 cm2/s. By contrast, manual segmentation reduced 
the mean parenchymal ADC to 0.037 ± 0.021 cm2/s while erosion/dilation using a 3-pixel 
radius structuring element generated the same result (ADC = 0.037 ± 0.021 cm2/s). 
 
Figure 13: Effect of masking on the ADC map generation. Separate masks were 
generated for a healthy volunteer using only a threshold, a threshold followed by ero-
sion/dilation, and manual segmentation. The top row shows the masks and the bot-
tom row shows the corresponding ADC map obtained after application of the mask. 
With a threshold mask, the mean ADC of the healthy subject was 0.041 ± 0.026 cm2/s. 
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This mean ADC reduced to 0.037 ± 0.021 cm2/s with a mask that underwent ero-
sion/dilation with a circular structuring element with a radius of 3-pixels. With a 
manually segmented mask, the mean ADC was the same as that obtained using ero-
sion/dilation.   
 
3.3.2. 129Xe ADC in the Three Subject Groups 
Figure 14 displays representative ADC maps from individuals in each of the 
three subject groups. Figure 14A shows the ADC map from a HV (age = 28 years) with a 
mean parenchymal ADC of 0.037 ± 0.021 cm2/s, which is significantly smaller than the 
self-diffusion coefficient of pure xenon (0.06 cm2/s) (58), indicating that confinement by 
the lung microstructure restricts the diffusion of xenon. In this healthy volunteer, the 
mean ADC in the airways, where 129Xe experiences nearly free diffusion (58), was 
0.083 ± 0.029 cm2/s. This value actually exceeds the self-diffusion coefficient of pure xen-
on, indicating some degree of dilution with the lighter pulmonary gases such as nitrogen 
and oxygen occurred. The ADC values in this subject exhibit a narrow distribution, as 
seen in the corresponding histogram. Figure 14B shows the ADC map of an older AMC 
subject (age = 69 years), with a slightly higher, but still relatively low, mean parenchy-
mal ADC (0.042 ± 0.025 cm2/s) and a narrow ADC distribution in the histogram. By con-
trast, Figure 14C shows the ADC map of a Stage II COPD subject (age = 59 years) with a 
substantially higher mean (0.068 ± 0.028 cm2/s), reflecting enlarged airspaces. The ADC 
measurements for all subjects in this study are summarized in table 1. 
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Figure 14: Representative slices from 129Xe ADC maps and corresponding 
whole-lung ADC histograms. (A) Healthy volunteer (age = 28 years) with a low mean 
ADC of 0.037 ± 0.021 cm2/s indicating normal alveolar microstructure. The ADC values 
in the airways are higher (0.083 ± 0.029 cm2/s) and reflect nearly free diffusion. (B) Age 
matched healthy control displaying similarly low parenchymal ADC values 
(0.042 ± 0.025 cm2/s). (C) COPD subject with emphysema shows high ADC values 
(0.068 ± 0.028 cm2/s) in the parenchyma, indicating alveolar destruction. (D) Whole-
lung histogram for the healthy volunteer in panel A showing narrow ADC distribu-
tion. (E) Whole-lung histogram for the age-matched control in panel B, exhibits a sim-
ilarly homogenous distribution. (F) Whole-lung histogram corresponding to the 
COPD subject with emphysema in panel C, exhibiting a moderately broader distribu-
tion. 
 
The mean parenchymal ADC from each of the three subject groups is summa-
rized in table 2 and graphed in Figure 15. As a group, the HVs had a mean ADC of 
0.036 ± 0.003 cm2/s, which is significantly lower than that of the AMC (0.043 ± 0.006 cm2/s; 
p = 0.0046), which in turn was significantly lower than that of the COPD subjects 
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(0.056 ± 0.008 cm2/s, p = 0.0021). Additionally, the mean ADC of the COPD subjects with 
emphysema was significantly elevated compared to that of the HV (p = 0.0003). Note 
that this mean for the COPD group excludes the two COPD patients who had no evi-
dence of emphysema on their CT scans. Indeed, these two subjects showed mean paren-
chymal ADCs of 0.036 ± 0.021 cm2/s and 0.039 ± 0.022 cm2/s, which are below the mean 
ADC for the AMC and the subjects with emphysema. For all three groups, the mean 
airway ADC was ~0.08 cm2/s, and as expected for a gases experiencing nearly free diffu-
sion, there was no significant difference in airway ADC between the three groups. 
 
Figure 15: Mean parenchyma ADC values for each subject group. The mean 
ADC of the COPD subjects with emphysema (0.056 ± 0.008 cm2/s) was significantly 
higher than that of the age-matched controls (0.043 ±  0.006 cm2/s, p = 0.0021), which in 
turn was significantly higher than that of the healthy volunteers (0.036 ± 0.003 cm2/s, p 
= 0.0046). 
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Table 1: Demographics and experimental values for all subjects. 
* b = 18.76 s/cm2 rather than b = 12 s/cm2 used for all other subjects. 
 
 
Sub 
   Age 
Years 
Sex 
Parenchyma 
ADC cm2/s 
Airway ADC               
cm2/s     FEV1 
%Pred 
FEV1/FVC 
% Pred 
DLCO/VA 
% Pred 
Mean SD Mean SD 
Healthy Volunteers 
5* 38 M .035 0.025 0.069 0.032    
7* 32 M .037 0.019 0.084 0.029    
8* 27 F 0.041 0.021 0.081 0.027    
9* 56 M 0.037 0.019 0.086 0.030    
10* 25 F 0.032 0.020 0.078 0.032    
12 28 F 0.037 0.021 0.083 0.029    
24 24 F 0.032 0.020 0.082 0.031    
Age-matched Controls 
31 64 M 0.053 0.031 0.079 0.032 91 75 62 
33 65 F 0.037 0.020 0.074 0.030 107 72 74 
36 55 M 0.045 0.029 0.093 0.034 96 79 86 
37 66 F 0.033 0.018 0.085 0.030 113 84 96 
38 67 M 0.048 0.022 0.087 0.031 83 75 86 
43 52 F 0.043 0.025 0.078 0.031 87 79 82 
44 69 F 0.042 0.025 0.085 0.030 117 76 75 
45 66 F 0.043 0.023 0.083 0.033 99 67 98 
46 51 F 0.044 0.027 0.075 0.030 118 74 71 
COPD Subjects with Emphysema 
47 74 M 0.044 0.027 0.094 0.031 73 78 100 
26 59 M 0.068 0.028 0.078 0.036 57 41 40 
29 71 M 0.050 0.024 0.085 0.029 72 65 55 
30 73 M 0.065 0.026 0.073 0.025 35 39 37 
32 66 M 0.060 0.027 0.078 0.030 64 63 67 
39 63 M 0.057 0.028 0.089 0.029 57 49 62 
40 53 F 0.049 0.025 0.079 0.033 81 64 45 
41 70 M 0.053 0.026 0.073 0.029 54 46 63 
42 72 F 0.044 0.025 0.073 0.028 54 52 83 
25 63 F 0.036 0.021 0.075 0.028 78 69 76 
28 68    M 0.039 0.022 0.093 0.033 79 66 55 
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Table 2: 129Xe ADC distribution within the lungs 
 
 
Parenchymal 
ADC (cm2/s) 
Airway 
ADC 
(cm2/s) 
Superior- Inferi-
or Gradient b 
(cm2/s/cm) 
Anterior- Poste-
rior  
Gradient b 
(cm2/s/cm) 
Healthy 
Volunteers 
0.036 ± 0.003 0.080 ± 0.005 0.00038 ± 0.00013 0.00072 ± 0.00017 
Age-
Matched 
Controls 
0.043 ± 0.006 0.083 ± 0.006 0.00049 ± 0.00022 0.00065 ± 0.00038 
COPD Sub-
jects with 
Emphysema 
0.056 ± 0.008 0.078 ± 0.006 0.00074 ± 0.00033 0.00003 ± 0.00047 
a
 Values are population mean ±  standard deviation. 
b Major airways were excluded when determining ADC gradients. 
 
3.3.3. ADC Gradients and Correlations 
Each of the subjects depicted in Figure 14 exhibit noticeable gradients in the 
ADC values with higher ADC observed in the apex relative to the base of the lungs. 
These superior-inferior gradients are well illustrated in the full ADC maps of a healthy 
volunteer depicted in Figure 16.  These gradients, which produced a ~24% higher ADC 
in the apex relative to the base for the two healthy groups (p = 0.00018, HV; p = 3.45x10-5, 
AMC), are consistent with those observed for all the groups as shown in Figure 17A. 
The superior-inferior gradient was larger (p = 0.024) for the COPD subjects with emphy-
sema (0.00074 ± 0.00033 cm2/s/cm) than for the AMCs (0.00049 ± 0.00022 cm2/s/cm), which 
in turn was larger, though not significantly larger (p = 0.09), than the HVs 
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(0.00038 ± 0.00013 cm2/s/cm). The strong superior-inferior ADC gradient in the COPD 
subjects is indicative of greater smoking-induced tissue destruction in the upper lobes of 
the lung, which has also been reported in the CT (87), pathology (88), and 3He MRI liter-
ature (29). 
 
 
Figure 16: A complete ADC map for a healthy volunteer. The map shows clear ADC 
gradients in both the superior-inferior and anterior-posterior directions. 
 
Figure 16 also shows a clear trend towards higher ADC values in the more ante-
rior image slices.  Such anterior-posterior ADC gradients are clearly present in both of 
the healthy groups, but this gradient was negligible in the COPD subjects with emphy-
sema. As illustrated in Figure 17B, the average anterior-posterior ADC gradients for the 
HVs were 0.00072 ± 0.00017 cm2/s/cm and 0.00065 ± 0.00038 cm2/s/cm for the AMCs, but 
were nearly absent (0.00003 ± 0.00047 cm2/s/cm) for the COPD subjects with emphysema. 
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This difference was statistically significant relative to both the HV group (p = 0.014) and 
the AMC group (p = 0.0085). 
 
 
Figure 17: ADC gradients. (A) Mean ADC gradients in the superior-inferior di-
rection. This gradient was significantly larger in the COPD subjects with emphysema 
(0.00074 cm2/s/cm) than in the age matched healthy controls (0.00049 cm2/s/cm, p = 
0.024), and was also larger than that of the healthy volunteers (0.00038 cm2/s/cm, p = 
0.0017). There was no significant difference between the superior-inferior gradients 
observed in the two groups of healthy subjects (p = 0.09). (B) Mean ADC gradients in 
the anterior-posterior direction. The mean ADC gradient from the COPD subjects 
with emphysema (3.05× 10-5 cm2/s/cm) is significantly smaller than that of either the 
healthy volunteers (0.00072 cm2/s/cm, p = 0.014) or the age matched healthy controls 
(0.00065 cm2/s/cm, p = 0.0085). The ADC gradients from the two groups of two healthy 
subjects were not significantly different (p = 0.81) from one another. 
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For the COPD and AMC subjects, the mean parenchymal ADC was correlated 
with three pulmonary function metrics — DLCO/VA, FEV1, and FEV1/FVC. As illustrated 
in Figure 18A-C, the mean parenchyma ADC was moderately, yet significantly, corre-
lated with all three metrics (FEV1 and DLCO/VA expressed as percent predicted values). 
The mean parenchyma ADC also significantly correlated with the absolute DLCO/VA 
(mL/mHg/min/L) values (r = -0.77, p = 0.0002) but not with the absolute FEV1. As shown 
in Figure 18D, the mean ADC for the HVs and AMCs also increased with age (r = 0.56, p 
= 0.02), with a slope of 0.0002 cm2/s per year.  
 
3.4. Inferences about 129Xe ADC MRI 
Diffusion-weighted MRI using HP 129Xe poses numerous challenges compared to 
using 3He. The nearly three-fold lower gyromagnetic ratio (γ) of 129Xe and lower polari-
zation achieved in our setting contributed to the low image SNR. Moreover, the lower 
diffusivity of 129Xe relative to 3He requires that a larger b-value be applied to achieve suf-
ficient weighting to derive meaningful ADC calculations. Because the b-value also scales 
with γ2 (60)], sufficiently large b-values could only be attained using relatively long dif-
fusion weighting pulses. For this study, the 2.4 ms pulse durations required, resulted in 
minimum echo times of 8.3 ms, which contributes unwanted T2*-weighting. These fac-
tors combined to create a significant SNR challenge and led us to introduce several pro-
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cessing steps to calculate 129Xe ADC values only for pixels belonging to ventilated lung. 
This involved first creating a rough lung mask by applying a relatively low threshold, 
and refining the mask using erosion/dilation to remove residual background noise. This 
approach gave similar ADC results as when masks were generated by manual segmen-
tation and have the advantage of being objective and fast. However, a disadvantage of 
the erosion/dilation technique is that it could erroneously remove isolated areas of venti-
lation smaller than the structuring element. Of course, the need for image processing 
would be substantially reduced by improving the relatively modest 129Xe polarization (5-
10%) available in this study. Considering that liter-quantities of HP 129Xe with polariza-
tions approaching 50% have recently been demonstrated (89), achieving better ADC 
map fidelity through improved image SNR appears promising. 
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Figure 18: Correlation of mean parenchymal ADC with pulmonary function 
metrics and age. (A) Correlation with percentage of predicted FEV1. r = –0.77, p = 
0.0002. (B) Correlation with percentage of predicted FEV1/FVC. r = -0.78, p = 0.0002. (C) 
Correlation with percentage of predicted DLCO/VA. r = –0.77, p = 0.0002. (D) Correlation 
with age (healthy subjects only). r = 0.56, p = 0.02. 
 
Besides lower SNR, 129Xe differs from 3He in that xenon diffuses into the capillary 
blood-stream (43)], which could decrease 129Xe concentration during imaging. Assuming 
an initial alveolar xenon concentration of 20% after inhalation, its solubility of ∼15% in 
the blood, combined with a cardiac output of ∼80 ml/sec would reduce the alveolar con-
centration to about 19.2% during a 16 second breath-hold. This change in concentration 
is expected to increase the xenon self-diffusion coefficient by only 0.9%. Given that any 
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difference in diffusion will be further reduced by confinement, the influence of xenon 
solubility on the ADC is expected to be negligible.  
The mean parenchymal 129Xe ADC values of 0.036 cm2/s for HVs agrees well with 
the preliminary values of 0.039 and 0.036 cm2/s reported by Mugler et al. (82) and 0.04 
cm2/s reported by Sindile et al. (83). Even with this relatively small sample of 17 healthy 
subjects (7 HVs and 10 AMCs), 129Xe ADC shows an increase with age. The age-related 
change can be compared to the annual 3He ADC change of 0.0015 cm2/s/yr reported by 
Fain et al. (34) by considering the predicted ADC for a single subject age. The predicted 
3He ADC at for a healthy subject at age 25 is 0.1875 cm2/s, which gives a 3He ADC slope 
of 0.8% per year. From our data, the predicted 129Xe ADC at age 25 is 0.0363 cm2/s, giv-
ing a 129Xe ADC slope of 0.6% per year. Moreover, the mean 129Xe ADC correlates rela-
tively well with pulmonary function testing, which is again similar to the trend seen for 
the 3He ADC (29). The correlation of 129Xe ADC with FEV1/FVC (r = -0.78) is slightly 
weaker than that reported for 3He ADC [r = -0.97, (29)]. Additionally, the standard devi-
ation of the 129Xe ADC did not correlate well with pulmonary function metrics, whereas 
such correlations have been reported for 3He ADC (30). This difference may be attribut-
able to the substantial superior-inferior ADC gradients seen with 129Xe, which broadens 
the ADC distribution even in the absence of disease.  
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Although the mean ADC metric was effective in separating the three subject 
groups in aggregate, there was some overlap between the subjects with emphysema and 
the healthy volunteers. These deviations could result from different degrees of 129Xe di-
lution into lung volumes (discussed below). However, similarly overlapping mean ADC 
data have been reported in asymptomatic smokers (76) and emphysema patients (29,90) 
in the 3He MRI literature, suggesting that natural individual-to-individual variations in 
lung microstructure could also play a role. 
The ADC gradients seen in the anterior-posterior direction in healthy subjects are 
attributable to gravity-dependent compression of the lung airspaces (91).  Compression 
in the dependent lung is caused by the weight of the lung itself (91), with additional con-
tributions from the weight of the heart (92). Thus, in the healthy lung smaller ADC val-
ues (smaller alveolar size) are expected in the dependent lung compared to the non-
dependent lung. This observed trend is similar to that reported by Fichele et al. using 
3He ADC (51). However, the near absence of anterior-posterior ADC gradients in the 
COPD subjects with emphysema may suggest that the heterogeneity of emphysematous 
tissue destruction could negate the influence of gravity. The reduction of the anterior-
posterior gradient has also been attributed to a decrease in the compressibility of the 
lung tissue due to COPD (33). A similarly small anterior-posterior gradient was seen by 
Diaz et al., using 3He ADC (80). The superior-inferior gradient we observed in the HVs 
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and AMCs corresponded to an average ADC reduction of 23.5%, which is significantly 
smaller (p = 0.00018, HV; p=3.45× 10-5, AMC) than the 28.1% observed in the COPD sub-
jects with emphysema, but still quite substantial.  
The higher 129Xe ADC observed in the superior lung may result from 129Xe dilu-
tion effects. This conclusion is driven by reports suggesting that supine subjects exhibit a 
larger functional residual capacity (FRC) in the superior lung relative to the inferior lung 
(93). This greater residual volume will more fully dilute the inhaled 129Xe in the superior 
lung, thereby producing larger xenon diffusion constants in this region. This superior-
inferior gradient, which we note is the opposite of that reported by Sindile et al. (83), 
cautions that 129Xe ADC, while sensitive to microstructure, is also affected by 129Xe dilu-
tion in lighter alveolar gases. 129Xe dilution could lead to erroneously high ADC values 
in regions of air trapping, which would admit very little xenon per breath. Such regions 
of high dilution could potentially be identified as those with very low SNR on the b = 0 
images. Alternatively, the effect of 129Xe dilution on 129Xe ADC could provide a novel 
means to quantify regional fractional ventilation.  
This study did have several limitations that could affect the precision of the re-
sults. First, the need for simplified logistics in this first clinical trial required that the in-
haled 129Xe volume remain fixed at 1 liter for all subjects regardless of their total lung 
capacity. Hence, subjects with smaller resting lung volumes would experience more al-
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veolar expansion, perhaps slightly elevating the resulting 129Xe ADC (90). However, 
smaller residual volumes of alveolar gas will result in less dilution of the inhaled 129Xe, 
which will have the opposite effect on the ADC. Further work, in which inhaled volume 
is adjusted to the subject total lung capacity (TLC) (92), will be required to fully eluci-
date the interplay of these two effects. Also, the starting lung volume for subjects was 
only loosely controlled to lie between RV and FRC. Better control of initial lung volume, 
would likely improve reproducibility, particularly of the ADC gradients, which may be 
eliminated when lung volumes reach closer to TLC (94). Similarly future 129Xe studies 
will use a consistent b-value for all subjects, rather than the two that were used here. 
Hence, while this small trial had certain limitations, and does not definitively cement the 
diagnostic utility of 129Xe ADC, the preliminary results are encouraging.  
This work showed that despite the lower gyromagnetic ratio, polarization, and 
free-diffusion of 129Xe relative to 3He, hyperpolarized 129Xe ADC maps can be obtained in 
human subjects in a clinically feasible manner. The associated lower SNR of 129Xe images 
requires careful segmentation of the lung from background noise, which we have ac-
complished using a thresholded mask in conjunction with erosion/dilation operations. 
The resulting 129Xe ADC maps exhibit sufficient dynamic range to distinguish subjects 
with emphysema from age-matched control subjects, and younger healthy subjects. The 
mean ADC exhibits a moderate, yet significant corre
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tests, similar to what has been reported for 3He ADC. Moreover, the 129Xe ADC is suffi-
ciently sensitive to reveal its dependence on changes in pulmonary microstructure due 
to subject age. 
 
3.5. Summary 
Taken together, the results reported in this work indicate that 129Xe holds prom-
ise for replacing the scarcely available 3He for generating pulmonary ADC measure-
ments. 129Xe ADC holds promise for the detection and characterization of early emphy-
sematous changes in the lung. In conjunction with ventilation analysis (31) and the dis-
solved-phase images to be discussed in the next chapter, diffusion-weighted imaging 
could serve as a means to non-invasively phenotype and monitor the treatment of sub-
jects with COPD.  
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4. Development of Simultaneous Gas and Dissolved-
phase 129Xe MRI  
 
4.1. Motivation 
HP 129Xe exhibits physical and MR properties that make it almost ideally suited 
for probing gas-exchange. Inhaled 129Xe is moderately soluble in the pulmonary tissues 
and capillary blood, and when 129Xe is in either compartment, its magnetic-resonance 
detection frequency exhibits a dramatic chemical-shift, which allows for its discrete and 
separate detection from gaseous 129Xe in the air spaces. These two resonances constitute 
the “dissolved-phase” of 129Xe. This is graphically depicted in figure 19A, and figure 19B 
shows a typical gas-transfer spectrum in a healthy volunteer. As the pathway taken by 
129Xe to reach the capillary blood stream is identical to that of oxygen, imaging this dis-
solved-phase as a single entity, to first order, depicts the regional distribution of gas-
exchange and is crucial to understanding the functioning of the lung. 
  
83 
 
Figure 19: (A) Schematic showing the presence of 129Xe in the air-spaces, plas-
ma and the red-blood cells. The arrows indicate that 129Xe is in constant exchange with 
the different compartments. (B) A typical 129Xe spectrum in the lung, showing the 
three resonances corresponding to 129Xe in the air-spaces (0 ppm), barrier and plasma 
tissue (197 ppm) and the red-blood cells (217 ppm). 
 
Given the low signal-intensity of the dissolved-phase (~2% of the gas-phase), the 
initial efforts to image this dissolved-phase used an indirect approach. One such ap-
proach was the xenon transfer contrast (XTC), which took advantage of the exchange 
dynamics between the dissolved and gas-phase xenon resonances (95). As the resonanc-
es of xenon are in continuous exchange, pulsing on the dissolved-phase will cause a 
mild depolarization of the gas-phase magnetization, and this depolarization was used to 
map the dissolved-phase distribution. This technique was a good first step to mapping 
this dissolved distribution, and was also extended to 3D (45). However, this technique is 
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complicated by the need for large saturation pulses and a multi-breath acquisition to 
correct for T1 decay, both of which limit its widespread acceptance as a clinical tool to 
study gas-exchange (45). The most important shortcoming of this approach is its inabil-
ity to create separate images of the components of the dissolved-phase – 129Xe in the bar-
rier, and 129Xe in the RBCs. As mentioned in chapter 1, creating an independent image of 
129Xe in the RBCs will provide a truly fundamental image of gas-exchange in the lung. 
Attempting to create such an image using XTC would require a highly selective excita-
tion of the either the RBC or the barrier resonance, which is not feasible, and hence this 
technique is limited to studying the dissolved-phase as a single entity. These drawbacks 
led our group to drive the transition to imaging the dissolved-phase directly, the feasi-
bility of which was first demonstrated in the preclinical arena (47), and more recently, 
direct dissolved-phase imaging was translated to the clinic (43). The direct approach to 
imaging the dissolved-phase takes us a step closer towards creating independent images 
of 129Xe in the barrier and the RBCs.  
At the start of this thesis work, our group had just shown the ability to image the 
dissolved-phase directly, in a single breath-hold (43). Importantly, we observed that the-
se initial dissolved-phase 129Xe images exhibited a strong gravitational gradient that re-
versed when subjects were imaged prone vs. supine (96). Moreover, these images also 
hinted at significant heterogeneity within a given gravitational plane. However, con-
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firming and quantifying these observations required overcoming a several shortcom-
ings. a) The imaging approach was not yet proven to be reliable and reproducible. b) As the gas-
phase is the source magnetization for the dissolved-phase distribution, quantifying the dissolved-
phase distribution will require also acquiring an image of the gas-phase in the same breath-hold. 
Single-breath gas and dissolved-phase images were first acquired by Mugler et al. (46) 
who exploited the chemical shift artifact using a Cartesian GRE sequence to acquire both 
the gas and dissolved-phase images within the same field of view. However, because of 
the longer TEs needed with the GRE sequence, overcoming the short dissolved-phase 
T2* (~2ms) and acquiring good images using this approach required very high polariza-
tions of 129Xe (~40%). Again, the fundamental flaw in this approach is the inability to cre-
ate separate images of the xenon in the barrier and the RBCs. Nonetheless, this work 
provided important initial confirmation of our observation that dissolved 129Xe images 
exhibit significant gravitational gradients, and further provided a valuable framework 
for quantifying the gas-exchange distribution.  
Alternatively, we hypothesized that a 3D radial pulse sequence is more ideally 
suited to image both the gas and dissolved-phase in a single breath. By sampling the free 
induction decay (FID), this sequence can generate sub-millisecond ‘echo’ times that 
helps us overcome the short dissolved-phase T2*. More importantly, this sequence, in 
conjunction with a number of algorithms from the proton literature, was felt to lend it-
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self best to create separate images of the 129Xe in the barrier and the RBCs. However, the 
clinical implementation of this sequence to image the gas and dissolved-phase in a sin-
gle-breath would require overcoming a few challenges – a) Unlike the approach of Mugler 
et al., which pulsed on both gas and the dissolved-phase distributions, this radial acquisition 
would require the selective excitation of the dissolved-phase. b) To image both the gas and dis-
solved-phase, we need twice the number of RF pulses. As the HP signal is depleted with the appli-
cation of an RF pulse, the flip-angles should be carefully chosen to minimize the decay of the lon-
gitudinal magnetization. This chapter will focus on overcoming these challenges that hin-
dered the development and subsequent clinical translation of a single-breath gas and 
dissolved-phase imaging approach using a 3D radial pulse sequence.  
 
4.2. Improving the reliability of dissolved-phase imaging 
While the initial demonstration that dissolved-phase imaging could be achieved 
in a single breath-hold was important, there were technical hurdles to overcome to en-
sure the technique is established on a reliable and reproducible footing. The quality of 
dissolved-phase images was unpredictable and seemed to vary drastically with each 
subject scanned. One such example is seen in figure 20, which shows the dissolved-
phase images acquired with similar parameters in two subjects, but one severely con-
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taminated with artifacts. Hence, it was really important to understand the underlying 
factors that control dissolved-phase image quality.  
 
Figure 20: Dissolved-phase images acquired in two subjects with the same im-
aging parameters. The subject shown in (A) exhibited severely compromised image 
quality, while for the subject in (B), the dissolved-phase image was normal.  
 
While the image quality is impacted by the choice in imaging parameters (flip-
angle, TE, TR, receiver bandwidth), polarization, or subtle changes in the reconstruction 
parameters, one issue was suspected to be primarily responsible for good image quality 
– selective excitation of the dissolved-phase resonances. Dissolved-phase imaging re-
quires a sufficiently short, yet highly selective RF pulse to avoid exciting the 50-fold 
larger gas-phase resonance to avoid generating significant artifacts in the images. To 
provide some background, figure 21 shows the expected pulse profile of a Hamming-
apodized 3-lobed sinc pulse, which is currently being used for RF excitation of the dis-
solved-phase of xenon. The bandwidth (BW) of the resulting rect-like frequency profile 
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is dictated by the length of the RF pulse, 
0
1BW
t
= where t0 is time to the first zero cross-
ing of the sinc pulse.  
 
Figure 21: Idealized RF frequency profiles. An infinitely long sinc pulse would 
give an ideal, rect frequency profile. The RF pulses used clinically, are truncated and 
apodized. A three-lobe, apodized sinc pulse would give a slightly broadened, 
smoother frequency profile.   
 
Traditionally, dissolved-phase imaging has employed a 1200-μs 3-lobed sinc 
pulse. The resulting RF frequency profile would have a bandwidth of ~3400 Hz. This 
bandwidth is sufficiently narrow to avoid exciting the gas-phase resonance, which on a 
1.5T system, is ~3800 Hz from the dissolved-phase. However, as the dissolved-phase is 
only 2% of that in the gas-phase, even if 2% of the RF power intended for the dissolved-
phase were to be applied on the gas-phase, this would lead to equal contributions to the 
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free induction decay (FID) from both gas and dissolved-phases. Even such a minimal, 
unintentional excitation would lead to significant artifacts in the dissolved-phase image, 
as seen in figure 20A.  
To investigate this theory further, we undertook a careful review of prior dis-
solved-phase spectra that were acquired with the same RF pulse used for imaging. 
While these spectra should reveal only the RBC and barrier resonance, they instead con-
tained varying amounts of gas-phase signal. It was noticed that this off-resonance excita-
tion of the gas-phase varied based on the amount of applied RF power. This RF power is 
controlled using the amplitude of the RF pulse set using the pulse sequence, or the 
transmit gain (TG, in dB). As an example, figure 22 shows two dissolved-phase spectra 
acquired in different subjects, but with the same pulse length and the same effective RF 
power. The spectrum seen in figure 22A was acquired with low RF amplitude, and a 
high TG, and we see minimal excitation of the gas-phase resonance. In contrast, figure 
22B was acquired with a larger RF amplitude, and a lower TG, and shows a significantly 
larger gas-phase excitation. 
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Figure 22: Variable off-resonance gas-phase excitation. (A) Shows a magnitude 
dissolved-phase spectrum acquired with a low RF amplitude and high TG, resulting 
in minimal off-resonance gas-phase excitation (B) A similar spectrum was acquired 
with the same pulse length, with a higher RF amplitude and lower TG, which yielded 
significantly larger gas-phase excitation.  
 
These results show that the off-resonance excitation is variable and depends on 
the amplitude of the RF pulse, and the transmit gain – both of which decide the applied 
flip-angle. Gaining further insight into this off-resonance excitation and studying the 
impact of these parameters will require measuring the actual frequency profile of the RF 
pulse.  
 
4.2.1. RF Frequency Profile Mapping 
It was hypothesized that the main reason for the off-resonance excitation of the 
gas-phase could be a distortion of the frequency profile of the RF pulse. Also, with the 
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results seen in figure 22, the choice of flip-angle and transmit gain could distort the fre-
quency profile differently. If distorted, this profile could retain RF power at much higher 
frequencies than theoretically estimated, which will result in unintentional excitation of 
the gas-phase resonance.  
In order to confirm this hypothesis, a pulse sequence was developed to map the 
frequency profile of the RF pulse. Because of its higher thermal signal, as a surrogate for 
xenon, the experiments were carried out using a sodium phantom and a surface coil. 
With the gradients turned off, both transmit and receive frequencies in the sequence 
were dynamically changed to cover a specified bandwidth (BW) about the main sodium 
resonance (fs). At each frequency, a sodium spectrum was acquired. The amplitude of 
these spectra would then be an indicator of the power deposited at that frequency. By 
then plotting the peaks of the individual sodium spectra as a function of the transmit 
and receive frequency, we can measure the frequency profile of the RF pulse. This pro-
cess is graphically explained in figure 23A-B. Figure 23C shows the frequency profile of 
the 1200-μs sinc pulse, which shows a dip in the pass-band and the prominent side lobes 
in the profile as indicated by the arrows. At a field strength of 1.5T, these prominent 
side-lobes appear at a frequency that is ~200 Hz from the gas-phase resonance, and 
hence will cause its significant off-resonance excitation. Surprisingly, similar results 
have been reported by Chan et al. (97), who also noticed a warping of the RF frequency 
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profile used for slice selection and this was attributed to the non-linearity of the RF am-
plifier. Hence, one can conclude that this RF distortion induced by the non-linear ampli-
fier causes the off-resonance excitation of the gas-phase, and understanding its behavior 
will have a significant impact on dissolved-phase imaging.  
 
Figure 23: (A) graphically illustrates the method used to map the frequency 
profile of an RF pulse. Multiple spectra of the sodium phantom were acquired using a 
sinc pulse while sweeping across a range of frequencies (BW) around the main reso-
nance. The peaks of the resulting spectra shown in (B) were used to plot the frequen-
cy profile of the pulse (C).  
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With this tool to map the frequency profile, we were ideally poised to under-
stand the impact that RF amplitude and TG have on the frequency profile. Frequency 
profiles using a sodium phantom were first acquired with a constant RF amplitude 
(scaled to the maximum) and with a varying TG. As shown in figure 24A, the frequency 
profile was warped irrespective of the TG, and as the RF amplitude was increased, the 
frequency profile became progressively worse. Figure 24B shows the frequency profiles 
acquired with a constant TG (150 dB) while the RF amplitude was increased (11 – 100% 
of maximum). Surprisingly, the frequency profile acquired with low RF amplitude (11%, 
blue profile) at this high TG, was free of any distortion. However, an increase in RF 
power brought on by the higher RF amplitudes warped the frequency profile. Hence, 
based on these results, an increase in RF power brought on by RF amplitude or TG, are 
not equivalent. Also, it would be preferable to operate at high TGs and a low RF ampli-
tude as the warping introduced in this regime was lower. Based on these results, one can 
speculate that the distortion is introduced by two stages. The first may be introduced by 
the mixer that feeds into the exciter board to generate a modulated RF waveform. The 
second stage of distortion would be introduced by the RF amplifier, which is known to 
have a non-linear gain response (97). Furthermore, these results seem to explain the pat-
tern of off-resonance excitation seen in figure 22. 
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Figure 24: B-spline smoothed RF frequency profiles for an apodized 3-lobed 
1200-μs sinc pulse. The frequency profiles have been measured as a function of 
transmit gains (A) and RF amplitudes (B).  As shown in (A), low gains and high RF 
amplitudes seem to introduce prominent side lobes, whereas high gains and a low RF 
amplitude shown in (B) produce a cleaner RF frequency profile.  
 
4.2.2. Characterizing Off-resonance Gas-phase Excitation 
The previous section showed that the off-resonance excitation was caused by 
warped RF pulse which was potentially caused by the mixer and the non-linear RF am-
plifier. Based on the warping introduced by these two stages, it was expected that higher 
RF powers would cause larger off-resonance excitation of the gas-phase of 129Xe. Con-
versely, in the dissolved-phase spectra acquired at higher RF powers (RF amplitude was 
increased at a constant TG), it was noticed that the amplitude of the off-resonance gas-
phase signal dropped.  
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The off-resonance excitation pattern as a function of RF power was empirically 
characterized. The goal of this experiment was to determine a pulse-length that would 
be short enough to overcome the short dissolved-phase T2*, and the associated transmit 
power that would minimize off-resonance gas-phase excitation, thus giving us a pulse 
that is ideal for dissolved-phase imaging. This characterization was performed on a 1.5T 
GE clinical scanner, using the 129Xe vest coil, which was wrapped around a loading shell 
that contained and an ALTEF bag with 1-L of HP 129Xe (natural abundance). Transmit 
and receive frequencies were placed +3.832 Hz above the gas-phase resonance frequen-
cy, to simulate dissolved-phase excitation. As the bag of gas would not have a dissolved-
phase resonance, any signal seen would be a measure of off-resonance gas-phase excita-
tion, and hence, RF pulse imperfection. Sinc pulses of pulse lengths 1–1.5 ms were used 
to acquire multiple spectra over a specified range of applied flip-angles (1-35°) which 
corresponded to RF powers of 7.5-264 W. This is illustrated in figure 25A. As shown in 
figure 25B, for pulse lengths shorter than 1.2 ms, the off-resonance excitation increased 
with an increase in power, and dropped minimally at higher powers. However, for the 
1.2-ms sinc pulse, there exists a narrow band of powers where the off-resonance excita-
tion was greatly minimized. The minima for this narrow band occurred at a power of 
106 W. At higher pulse-lengths, this narrow band shifted to a lower power. Although 
the off-resonance excitation was lower for the 1.4-ms pulse, 1.2-ms was considered ideal, 
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as it provided the perfect balance between the high-selectivity needed to excite just the 
dissolved-phase and was short enough to overcome the short T2* of the dissolved-phase 
(~2 ms). With this information in hand, it is now clear that the dissolved-phase image 
with significant artifacts shown in figure 20A was acquired at an RF power that corre-
sponded to a flip-angle of 10°, which as shown in figure 25B, would have extensive exci-
tation of the gas-phase. This empirically characterized pulse length and power was used 
for all subsequent dissolved-phase imaging. 
 
Figure 25: (A) Schematic showing the characterization of off-resonance excita-
tion. To model dissolved-phase excitation using a bag of polarized xenon, 3-lobed 
sinc pulses of varying amplitudes were used to pulse 3.8 kHz above the gas-phase 
resonance. (B) Gas-phase signal intensities for various pulse lengths as a function of 
RF power. The 1.2-ms sinc pulse reduced the gas-phase excitation for a narrow band 
of RF powers.  
 
To test the validity of this finding in-vivo, this experiment was repeated in 3 
healthy volunteers, and the results matched the phantom experiments by showing a re-
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duced gas-phase excitation at a flip-angle of 22°. Figure 26A shows just the gas-phase 
signal (off-resonance) of a dissolved-phase spectrum as a function of flip-angle for a 1.2-
ms sinc pulse. As shown, there was reduced off-resonance excitation at an RF power of 
106 W, which corresponded to a flip-angle of 22° (figure 26B). Based on these results, 
dissolved-phase imaging was carried out with a 1.2-ms sinc pulse and an RF power of 
106 W. 
 
Figure 26: In-vivo confirmation of the variable off-resonance excitation pat-
tern. (A) Spectra acquired in a human subject shown as a waterfall plot of only the 
gas-phase off-resonance signal for a 1.2-ms sinc pulse, as a function of flip-angle. This 
off-resonance excitation reached a minimum at a flip-angle of 22°, which is also 
shown in (B). 
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4.3. Radial Pulse Sequence 
An interleaved radial sequence was written to acquire single-breath images of 
the gas and dissolved-phase (figure 27). The acquisition began with both transmit and 
receive frequencies centered on the gas-phase resonance. Once a ray of k-space was ac-
quired, transmit and receive frequencies were changed to that of the dissolved-phase 
resonance (+217 ppm), and after increasing the flip-angle to an appropriately higher val-
ue, the same ray of k-space was acquired again. This process was repeated until all of k-
space was sampled using an Archimedean spiral sampling strategy.  
 
Figure 27: (A) The interleaved 3D radial pulse sequence. The sequence began 
by pulsing on the gas-phase resonance with a small flip-angle, acquiring a ray of k-
space. Transmit and receive frequencies were then changed to pulse on the dissolved-
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phase with a larger flip-angle and the same ray of k-space was acquired. This was re-
peated to isotropically sample k-space as shown in (B). 
 
4.3.1. In-Vitro Experiments  
The feasibility of this approach was first demonstrated in vitro, on a 2T pre-
clinical MR scanner. To create a dissolved-phase signal, hydrophobic gas-exchange 
membranes were used to continuously infuse 129Xe into distilled water. Distilled water 
and gas flowed at 20 ml/min and 5 ml/min respectively, through a hydrophobic hollow 
fiber membrane module (MicroModule, Membrana, Charlotte, NC), where 129Xe was in-
fused into the water (98). The HP 129Xe infused water passed from the modules through 
the center of the RF coil. The 129Xe exhaust from the membrane outlet was also routed 
into the RF coil and wrapped around the liquid line to create a reference gas-phase sig-
nal (figure 28). Imaging began on the ‘dissolved’ 129Xe resonance, and images were ac-
quired using the modified radial sequence and the following imaging parameters: pulse 
duration (sinc)=1200 μs, views=2500 for each frequency, TE/TR=2/250 ms, BW=8 kHz, 
FOV=10 cm, resolution=32× 32× 32, flip angles (gas/dissolved)=20/30°. The k-space data 
was then split, and the dissolved and gas phase components, were reconstructed sepa-
rately, using NUFFT reconstruction (99). The images shown in figure 29, showed that 
the sequence was capable of dynamically changing transmit and receive frequencies and 
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the applied flip-angle, while sampling k-space identically for both the gas and dis-
solved-phase resonances.  
 
Figure 28: Imaging schematic. The exhaust gas line is wrapped around the wa-
ter outlet line to provide the additional gas-phase signal. 
 
Figure 29: Maximum intensity projections of the 3D images of 129Xe in the gas 
and dissolved-phases. 
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4.3.2. Clinical Imaging 
With the successful in-vitro experiments, and properly characterized RF pulses, 
the new radial pulse sequence was ready for clinical imaging. As the clinical images 
need to be completed in a 16-second breath-hold, the number of rays of k-space was 
chosen to under-sample k-space by a factor of ~3. To prevent gradient-infidelities, the 
ramp time of the gradients was kept at a higher value (~500 μs). To minimize off-
resonance gas-phase excitation, the RF length was chosen to be 1200 μs, and the flip-
angle for the dissolved-phase was dialed in to be 22. The acquisition began at the gas-
phase with a 0.5 flip-angle. Once all the rays of k-space were acquired, the data were 
split and reconstructed using the NUFFT algorithm (99) to yield separate images of the 
gas and dissolved-phase. Thus, the modified radial pulse sequence could be used to reli-
ably obtain isotropic, co-registered single breath gas and dissolved-phase images. An 
example of these images is shown in figure 30. 
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Figure 30: Example single-breath gas and dissolved-phase images acquired in a 
healthy volunteer. 
 
4.4. Summary 
This chapter focused on the key technical developments that enabled the reliable 
acquisition of 3D isotropic gas and dissolved-phase 129Xe images using an interleaved 3D 
radial pulse sequence. This reliability was achieved by improving the selective excitation 
of the dissolved-phase of 129Xe. With the acquisition strategy established on a reliable 
footing, we are ideally poised to quantify the distribution of the dissolved-phase signal, 
which will the focus of chapter 5.   
 
 
 
  
103 
5. Probing the Effect of Posture on the Distribution of 
Dissolved-Phase Images 
 
The results presented in this chapter were published as a journal article: S.S. 
Kaushik et al., ‘Probing the regional distribution of pulmonary gas-exchange through single-
breath gas and dissolved-phase imaging’, Journal of Applied Physiology, 2013; 115 (6), 850-
860.  
 
5.1. Motivation 
With a robust 129Xe gas-transfer acquisition in hand, our second goal was to de-
velop a fundamental understanding of the physiologically relevant information provid-
ed by these images. This was done by performing 129Xe MRI of the lungs under a set of 
conditions that are known to alter the underlying pattern of physiological gas exchange. 
Thus, 129Xe gas-transfer was imaged in both the supine and prone position for all sub-
jects. Such postural changes are known to alter the resting perfusion distribution (52) 
and diffusing capacity for oxygen (100). Moreover, our preliminary efforts in imaging 
the dissolved 129Xe distribution showed the images were characterized by a strong pos-
tural gradient, which favored the dependent lung. We thus hypothesized that, upon de-
veloping a single-breath method of imaging 129Xe gas-transfer, a postural gradient would 
be detectable in both the individual 129Xe gas- and dissolved-phase distributions and that 
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gravitational gradients would still be retained in the normalized 129Xe gas-transfer maps. 
Furthermore, we hypothesized that gradients in the gas- and dissolved-phases, as well 
as in 129Xe gas-transfer would reverse when subjects were repositioned from the supine 
to the prone position. Such imaging of the underlying variability of 129Xe gas-transfer in 
healthy subjects provides a necessary platform to probe basic lung physiology and even-
tually understand the pathophysiological changes that arise with the onset of pulmo-
nary diseases.  
 
5.2. Methods 
5.2.1. Subject Inclusion/Exclusion Criteria 
Studies were approved by the Duke Institutional Review Board and conducted 
under FDA IND 109,490. Written, informed consent was obtained from all the subjects 
prior to the scan. All subjects were at least 18 years of age (8 men, 1 woman, average age 
= 45.6 ± 18.7 years) and had less than a 5 pack-year smoking history, had not smoked in 
the last 5 years, and had no diagnosed pulmonary disorders. The body mass index (BMI) 
for the subjects ranged from 19-29.6 (average BMI = 24.3 ± 3.6). Subjects were excluded if 
they were unable to hold their breath for 16 seconds, had a history of cardiac arrhythmi-
as, were pregnant or lactating, or had a respiratory illness within 30 days of MRI. One 
hour prior to MR studies, subjects underwent pulmonary function testing, including 
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measures of total lung capacity (TLC) that were used to interpret aspects of the MR im-
ages. 
 
5.2.2. Xenon Polarization and Delivery 
Each subject received two 1-L doses of HP 129Xe (isotopically enriched to 86% 
129Xe, Linde Gases, Stewartsville, NJ). The polarization process is described in chapter 2. 
Prior to gas inhalation, subjects were instructed to inhale to TLC and exhale to function-
al residual capacity (FRC) twice. They then inhaled the gas through 0.95-cm ID Tygon 
tubing (Saint Gobain Performance Plastics, Akron, OH) and held their breath for a max-
imum of 16 seconds while the images were acquired. Throughout the imaging session, 
blood oxygenation and heart-rate were monitored using an MR-compatible monitoring 
system (GE Healthcare, Helsinki, Finland).  
 
5.2.3. MR Acquisition and Workflow 
Studies were conducted on a 1.5-T scanner (GE Healthcare EXCITE 15M4, 
Waukesha, WI) equipped with a 2-kW broadband (8–70 MHz) amplifier for the multinu-
clear RF chain (CPC, Hauppauge, NY). Subjects were fitted in a quadrature 129Xe vest 
coil (Clinical MR Solutions, Brookfield, WI) tuned to 17.66 MHz and proton-blocked to 
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permit 1H MRI of the thoracic cavity to be performed with the scanner’s body coil, with-
out repositioning the subject.  
Single breath gas and dissolved-phase were acquired with the following parame-
ters: sinc pulse duration = 1.2 ms, TE/TR = 0.932/7.5 ms, matrix = 32×32×32, 1001 rays for 
each frequency, gas flip-angle = 0.5°, dissolved flip-angle = 22°, bandwidth = 15.625 kHz, 
FOV = 40 cm. the k-space data was then reconstructed using the NUFFT algorithm. In 
order to constrain the image analysis to the thoracic cavity, radial 1H images were ac-
quired with the following parameters: hard pulse duration = 274 μs, TE/TR = 0.336/2.4 
ms, matrix = 64×64×64, 5647 rays, 512 dummy pulses, flip-angle = 5°, bandwidth = 15.625 
kHz, and FOV = 40 cm. 
The imaging workflow was as follows: after the acquisition of a free breathing 
localizer in the supine position, 1H radial thoracic-cavity images were acquired after the 
subject had inhaled 1-L of air from a polyethylene bag from functional residual capacity. 
This was followed by administering 1-L of 129Xe for single-breath acquisition of the gas- 
and dissolved-phase distributions in the supine position. The subject was then trans-
ferred to the prone position without changing the coil orientation, and a second,  
1-L single-breath scan of the dissolved and gas-phase distribution was acquired. This 
was followed by another radial breath-hold 1H thoracic cavity scan in the prone position. 
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The 1-L air bag was used to make sure that the lung was expanded to roughly the same 
volume as during the 129Xe scan.  
 
5.2.4. Quantitative Analysis of Images 
To match the resolution of the anatomical images, the 129Xe gas-phase images 
were up-sampled from their native 32×32×32 matrix to 64×64×64, using bilinear interpo-
lation. The 1H and gaseous 129Xe images were then registered using a multi-resolution, 
affine transformation, with joint entropy as the cost function and a cubic-spline interpo-
lation using the Image Registration Toolkit (101). This is illustrated in figure 31A and 
31B. The thoracic-cavity 1H image was then segmented using the region-growing algo-
rithm in 3DSlicer (36) to create a binary thoracic-cavity mask (figure 31C). This mask 
was then manually segmented to remove airways, morphologically closed using a 
spherical structuring element (diameter = 7 voxels), and was followed by an additional 
filling operation, in MATLAB™ R2011a (MathWorks, Inc., Natick, MA) to create the fi-
nal mask shown in figure 31D. Figure 31E shows multiple slices of the thoracic cavity 
image and the corresponding, processed thoracic cavity mask.  
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Figure 31: Image processing to limit analysis to the thoracic cavity. In spite of 
volume-controlling the acquisitions, (A) shows a significant mis-registration of the 
gas-phase image (green) and the thoracic  cavity image (gray), which is reduced post 
registration in (B). Registered thoracic cavity image used to create a “mask” as shown 
in (C), which is manually segmented and morphologically closed to create the mask in 
(D). (E) shows the thoracic cavity image and  the corresponding processed mask.   
 
Both gas- and dissolved-phase images were normalized by the sum of their re-
spective voxel intensities within the thoracic cavity mask (16), and the resulting dis-
solved-phase images were divided on a voxel-by-voxel basis by the corresponding gas-
phase images to create the gas-transfer maps. Figure 32 shows an example of these gas-
transfer maps in a supine healthy subject.  
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The axial gas and dissolved-phase images in figure 32 exhibit a gravitational 
gradient. However, when these images are normalized and divided, this gradient is re-
tained in the gas-transfer maps. The gas-transfer is higher in the dependent lung and 
diminishes in the anterior, non-dependent lung. Hence, the gas-transfer itself exhibits a 
gravitational gradient beyond what is attributable to the gas-phase 129Xe distribution. 
 
Figure 32: Representative single breath, isotropic gas- and dissolved-phase im-
ages and the corresponding gas-transfer map, defined as the normalized dissolved-
phase image to gas-phase image ratio. 
 
5.3. Study Results 
5.3.1. Postural gradients 
An example showing the impact of posture on the gas-transfer map is shown in 
figure 33. When supine, as seen in figure 33A, this subject showed decreasing gas-
transfer from the posterior to anterior lung. However, when the subject was prone (fig-
ure 33B), this gas-transfer gradient reversed, and showed higher values in the anterior 
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lung that decreased towards the posterior lung. This is made clearer in figure 33C, 
where the gas-transfer distributions are plotted as a function of slice position. This plot 
shows quantitatively, the visual reversal seen in figures 33A and 33B. Furthermore, it 
also speaks to the extent of gas-transfer variability in this subject, who showed a 43% 
change in gas-transfer when supine, and 27% when prone. Also, in both postures, gas-
transfer was non-monotonic and showed a marked increase in slices iso-gravitational 
with the main pulmonary arteries. The results for this subject are representative of most 
subjects scanned. To quantify this posterior-anterior signal intensity gradient, the images 
were subjected to a linear-regression (weighted by voxel count) of the mean signal in-
tensity of each slice as a function of slice position. These results are summarized in table 
3.  
 
Figure 33: Representative gas-transfer map from a healthy volunteer (subject 2) 
in the supine (A) and prone (B) positions. (C) Mean gas-transfer as a function of lung 
position, showing higher gas-transfer in the dependent lung for both postures. 
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Table 3: Subject demographics and postural gradients 
Sub Age 
(yrs) 
TLC 
(L) 
Gradients (% of mean cm-1) Mean  
Gas-Transfer Supine Prone 
Gas Dissolved 
Gas-
Transfer 
Gas Dissolved 
Gas-
Transfer 
Supine Prone 
1 29 9.16 -3.51 -5.30 -2.28 -1.16 2.34 3.24 0.997 1.017 
2 60 8.05 -2.43 -4.85 -2.56 3.37 5.55 2.45 1.003 1.001 
3 68 7.00 -2.19 -4.15 -2.32 1.13 2.69 1.94 1.001 0.999 
4 23 7.84 -3.28 -4.84 -2.08 -3.88 -0.93 2.95 0.991 1.011 
5 59 7.56 -2.54 -3.57 -1.36 2.07 4.49 2.78 0.988 0.997 
6 65 7.17 2.40 0.54 -1.98 -0.21 0.10 0.46 1.008 1.008 
7 51 5.74 -2.17 -3.42 -1.34 1.90 3.96 2.32 0.996 1.003 
8 22 6.71 -1.71 -2.13 -0.80 -1.66 -0.74 1.42 0.998 1.005 
9 33 7.96 -1.81 -5.30 -3.24 0.95 2.34 -0.08 1.026 1.010 
 
Changes in the posterior-anterior gradients (slope of the regression line) and 
mean gas-transfer difference between postures were evaluated for significance using a 
matched pair T-test. The significance level was set at 5% (p < 0.05) for all comparisons. 
Gas-phase images exhibited a modest population-mean posterior-anterior gradient of -
1.92 ± 1.73% cm-1 for supine subjects that reversed and diminished significantly to 0.28 ± 
2.23% cm-1 (p = 0.042) when the subjects were prone. Dissolved-phase 129Xe images ex-
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hibited a larger posterior-anterior gradient of -3.46 ± 1.91% cm-1 for supine subjects that 
did reverse significantly (p = 0.0034) to 2.18 ± 2.47% cm-1 when subjects were prone. The-
se gradients persisted in the gas-transfer maps, and these also reversed significantly  
(p < 0.001) when subjects changed from the supine (-1.99 ± 0.74% cm-1) to prone (1.94 ± 
1.14% cm-1) position. These results are shown in figure 34 and summarized in table 4.   
 
Figure 34: Signal intensity and gas-transfer gradients for all subjects. Gas-
phase gradients were significantly impacted by posture (p = 0.042). Dissolved-phase 
images also showed a significant gradient reversal when subjects were repositioned 
from the supine to the prone position (p = 0.0034). The gradient in gas-transfer also 
reversed significantly when subjects were repositioned from supine to prone (p < 
0.0001). 
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Table 4: Mean gas-transfer gradients and coefficients of variation 
 
 
 
 
 
 
 
 
 
5.3.2. Gas-Transfer Heterogeneity 
Gas-transfer maps and source images were further analyzed for heterogeneity by 
calculating the coefficient of variation (CV) for the whole lung. The CV for all the sub-
jects has been summarized in table 4 and is graphically shown in figure 35. The popula-
tion-mean CV of the gas- and dissolved-phase 129Xe images were similar and not signifi-
cantly impacted by posture (gas, p = 0.21; dissolved, p = 0.22; gas-transfer, p = 0.45). 
However, for both postures, the whole-lung CVs of the dissolved-phase image were 
modestly higher than those of the gas-phase images (supine, p = 0.0001; prone, p = 
0.0028). Interestingly, the CV of the normalized gas-transfer maps relative to either the 
Posture Gas Dissolved Gas-Transfer 
Gradients 
Supine -1.92 ± 1.73 -3.46 ± 1.91 -2.00 ± 0.74 
Prone 0.28 ± 2.23 2.18 ± 2.47 1.94 ± 1.14 
Coefficient of Variation 
Supine 0.34 ± 0.05 0.38 ± 0.05 0.19 ± 0.04 
Prone 0.32 ± 0.04 0.36 ± 0.05 0.20 ± 0.04 
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gas- or dissolved-phase images alone was roughly 45% lower in both positions. In spite 
of the pronounced spatial variation in the gas-transfer maps, the gas-transfer value aver-
aged over the entire lung remained near unity for all subjects and displayed no signifi-
cant posture-dependence (supine mean gas-transfer: 1.00 ± 0.01; prone mean gas-
transfer: 1.01 ± 0.01; p  = 0.25). 
 
Figure 35: Population means for whole lung CVs. Mean gas-transfer CV was 
almost half that of the gas- and dissolved-phase images. Dissolved-phase images had 
significantly higher CVs than the gas-phase images for both postures (p = 0.0001, su-
pine; p = 0.003, prone). No significant posture-dependent change in CV was observed 
in gas- (p = 0.22) and dissolved-phase (p = 0.21) images or gas transfer maps (p = 0.34).  
 
5.3.3. Impact of Lung Inflation 
The distribution of gas-transfer was also impacted by lung inflation. In the su-
pine position, subjects with larger total lung capacities tended to exhibit greater gas-
transfer heterogeneity than those subjects with smaller TLC. Because all subjects in this 
study received the same 1-L dose of HP 129Xe, this meant imaging was done at lung infla-
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tion levels ranging from FRC + 10.9% of TLC to FRC + 17.4% of TLC. Hence, subjects 
with larger lung volumes underwent imaging at a lower degree of lung inflation. As 
shown in figure 36, for supine subjects, gas-transfer CV correlated significantly with 
TLC (r = 0.77, p = 0.015). However, when prone these same subjects exhibited no correla-
tion between CV and TLC (r = 0.18, p = 0.64). Also, no significant posture-dependent dif-
ference in polarization-corrected SNR (SNR/polarization) was observed (p = 0.55, gas-
phase; p = 0.42, dissolved-phase). Thus, TLC-dependent heterogeneity observed in the 
supine position does not appear to be explained by lower image SNR resulting from 
greater 129Xe dilution, but instead reflects fundamental aspects of gas-transfer distribu-
tion. Similarly, CT studies have shown that tissue-density gradients are almost com-
pletely eliminated when the lung is fully expanded (102). Lower lung inflation may lead 
to alveolar de-recruitment and small airway closure (103), which could contribute to the 
increased CV seen in subjects with higher TLC. By contrast, no correlation was seen be-
tween CV and lung volume (r = 0.2) for prone subjects, which may be due to the more 
uniform lung expansion in that position (104).  
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Figure 36: Whole-lung gas-transfer CV as a function total lung capacity. (A) 
Gas-transfer CVs in supine subjects. A significant (p = 0.015) increase in CV with in-
creasing TLC is observed in supine subjects. (B) Gas-transfer CVs in prone subjects. 
CV in prone subjects showed no significant correlation with the TLC (p = 0.64). 
 
5.4. Inferences about Gas-Transfer 
5.4.1. Gravitational gradients 
The acquisition and analysis method described accounts for the contribution of 
the gas-phase 129Xe distribution to the dissolved-phase 129Xe image, permitting quantita-
tive regional mapping of 129Xe gas-transfer. These maps corroborate our hypothesis that 
129Xe gas-transfer itself is heterogeneous in normal subjects and is subject to gravitational 
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gradients that reverse with subject posture. Indeed, 129Xe gas-transfer varies by 30-40% 
across the lung field. These single-breath 129Xe gas-transfer images show trends that are 
consistent with observations from other imaging modalities and experimental tech-
niques that image tissue density (105) and perfusion (15,16,52), while providing a unique 
window on the regional variability of lung function in healthy subjects.  
It is important to note that 129Xe gas-transfer imaging signal arises from funda-
mentally different physical origins than established physiologic measures of respiratory 
gas transfer. Firstly, since 129Xe gas-transfer images are acquired in a single breath, they 
will report primarily on well-ventilated regions of the lung. Secondly, 129Xe gas-transfer 
signal arises almost exclusively from the alveolar septa where diffusion from the alveo-
lar spaces continuously replenishes the dissolved 129Xe magnetization. Given that the 
harmonic mean thickness of the barrier L=1 micron, and the diffusion coefficient of 129Xe 
in the barrier D=0.33 × 10-5 cm2/s, 129Xe takes only ~1.5 ms ( )2 2t L D= to diffuse across 
the interstitial barrier and into the RBCs, and only ~150 ms more to saturate the septum 
(106). Furthermore, 40–50% of the dissolved 129Xe signal originates from the capillary 
blood, which transits through the capillary network in 0.75 seconds. Since local blood 
volume tracks with perfusion (107), 129Xe transfer imaging may be thought of as approx-
imating local VQ matching. Hence, in this regard, 129Xe transfer MRI is a closer surrogate 
  
118 
for studying the oxygen transfer pathway than other imaging modalities that infer this 
information indirectly through ventilation and perfusion metrics.  
The postural gradients in 129Xe gas-transfer we observed are consistent with tis-
sue density, ventilation, and perfusion gradients reported by other imaging modalities, 
which are summarized in table 3. For supine subjects, lung tissue density has been re-
ported to exhibit a posterior-anterior gradient of -4.33% cm-1 by CT (105) and -4.9 ± 1.9% 
cm-1 by MRI (22). By comparison, the mean 129Xe gas-transfer gradient of -2.00 ± 0.74% 
cm-1 for supine subjects was of the same sign, but roughly half as large. This is because 
129Xe transfer is affected by tissue density gradients, which in turn cause a gradient in the 
intra pleural pressure that similarly increases ventilation in the dependent lung. Since 
129Xe gas transfer is ‘ventilation-normalized,’ this explains why 129Xe gas-transfer exhibits 
a smaller gradient than the dissolved signal or tissues density alone. Comparing 129Xe 
gas-transfer distribution to perfusion distributions measured by other modalities, re-
vealed a gravitational gradient that was of the same sign, but somewhat smaller than the 
perfusion gradient of -3.10 ± 1.50% cm-1 observed for supine subjects by SPECT (16) and 
roughly half the -4.40 ± 3.20% cm-1 gradient reported by PET (15). However, the supine 
129Xe gas-transfer gradient was very similar to the perfusion gradient reported by ASL (-
2.10 ± 4.32% cm-1), albeit with reduced inter-subject variability. For prone subjects the 
129Xe gas-transfer gradient was reversed and exhibited a positive slope of 1.94 ± 1.14% 
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cm-1, which is comparable to the density gradient of 2.72% cm-1 measured by CT (105), as 
well as perfusion gradients of 2.70 ± 1.50% cm-1 measured by SPECT (16) and 1.11 ± 
1.68% cm-1 by ASL MRI (52). However, it was less than half the perfusion gradient of 
5.20 ± 4.30% cm-1 reported by PET (15). While perfusion and tissue density contribute 
significantly to the gas-transfer distribution, the differences noticed in the gravitational 
gradients can be attributed to the sensitivity of the dissolved-phase signal to the capil-
lary blood volume (not flow), and the tissue density primarily in the acinar region of the 
lung.  
Although all subjects demonstrated a consistent trend of increasing 129Xe gas-
transfer from non-dependent to dependent lung in both positions, this behavior was dis-
tinctly non-monotonic and unique to each subject scanned (see Figure 37). For example, 
when scanned prone, subjects 6, 8, and 9, exhibited prominently increased 129Xe gas-
transfer in the central image slices that decreased towards the anterior lung. In fact, even 
for supine subjects, a subtle increase in 129Xe gas-transfer was seen in the central lung at 
the plane of the main pulmonary arteries. This was evident for 7 out of the 9 subjects, 
with 2 other subjects displaying a 129Xe gas-transfer plateau in the central regions of the 
lungs. Such non-monotonic behavior has also been reported in tissue-density (105) and 
perfusion (108) distributions, but their origins have not been probed extensively. As a 
result of the non-monotonic increase in the 129Xe gas-transfer in the more central slices of 
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the lung, the full degree of 129Xe gas-transfer variability in this population was poorly 
reflected by a simple linear gradient metric.  
 
Figure 37: 129Xe gas-transfer pattern for all subjects (subject number indicated 
in upper right-hand corner of each panel).  
 
The general gravitational trend observed in our study is consistent with the clas-
sic West model, which predicts a larger fraction of capillary blood volume to reside in 
the gravitationally dependent lung (109), and hence provides a larger sink for 129Xe gas-
transfer. Of course, as shown by Hopkins, et al., the remaining tissues of the lung also 
follow a gravitational “slinky”-like density pattern that favors the dependent lung (22).  
 
  
121 
5.4.2. Additional sources of heterogeneity 
Beyond gravity induced changes in distribution, additional factors contribute 
significantly to 129Xe gas-transfer heterogeneity in resting healthy subjects (110,111). One 
consideration may be the shape of an individual’s chest cavity, which impacts regional 
lung expansion and alveolar recruitment (105). To this end some regions may exhibit 
slower ventilatory filling, which gives rise to lower gas-phase signal intensity, and con-
sequently, lower dissolved-phase intensity.  
Additionally, the effect of the heart must also be considered, because its weight 
compresses the pulmonary tissue beneath it, increasing tissue density in this region 
(112). As a greater portion of the heart rests over the left lung, we might expect differ-
ences in the 129Xe gas-transfer gradient between the right and left lung. However, no 
such differences were observed in our study, which may suggest that ventilation is 
equally increased in these areas of high tissue density. Finally, the observation of in-
creased 129Xe-transfer in regions iso-gravitational with the main pulmonary arteries sug-
gests that those capillary beds may be filled preferentially, even relative to regions expe-
riencing greater gravitational compression.  
For supine subjects, 129Xe gas-transfer was also affected by the extent of lung ex-
pansion. Specifically, 129Xe gas-transfer heterogeneity as measured by whole-lung coeffi-
cient of variation (CV) was found to be highest for supine subjects with larger TLC, who 
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were therefore imaged at a lower level of lung inflation after inhaling 1-L of 129Xe. This is 
consistent with CT studies that have shown that tissue-density gradients are almost 
completely eliminated when the lung is fully expanded to TLC (102). By contrast, lower 
lung inflation may lead to alveolar de-recruitment and small airway closure (113), which 
could contribute to the increased CV seen in subjects with higher TLC. However, for 
prone subjects, 129Xe transfer CV did not correlate with lung volume (r = 0.2), which may 
reflect more uniform lung expansion in that position (114).  
 
5.4.3. Gas-transfer matching 
Although 129Xe gas-transfer images exhibited significant heterogeneity and vary-
ing gradient patterns, the mean 129Xe gas-transfer ratio for all the subjects, regardless of 
posture, was ~1. This finding is noteworthy considering that 129Xe gas-transfer values in 
a given gravitational plane ranged from as low as 0.6 to as high as 1.4, and exhibited 
even greater range at the voxel level. Much like the well-established ventilation-
perfusion ratio, the 129Xe gas-transfer ratio appears to exhibit a wide range of values in 
healthy subjects, and yet retain nearly perfect ‘matching’ when averaged over the entire 
lung. The substantial regional variability observed in 129Xe gas-transfer suggests that the 
healthy lung at rest possesses significant “reserve capacity”, a notion that has also been 
put forth to explain why stereology-based estimates of pulmonary diffusing capacity 
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consistently predict diffusing capacities that exceed the experimentally measured values 
(115,116). In fact DLCO is known to increase with cardiac output (117). Thus, it could be 
intriguing to conduct 129Xe gas-transfer MRI in subjects undergoing either exercise-
induced or physiological stress, because these conditions should make the perfusion-
dependent capillary bed filling more uniform, and would be expected to result in corre-
spondingly uniform 129Xe gas transfer maps, and exhibiting a narrower range. 
 
5.4.4. Gas-Transfer Gradients in Subjects with Disease 
In addition to the healthy subjects, single-breath gas and dissolved-phase images 
were acquired in the supine position, in two subjects with disease – one with idiopathic 
pulmonary fibrosis (IPF) and the other was described by a physician to have a combina-
tion of emphysema and asthma. Shown in figure 38A and 38B, are the gas-transfer maps 
obtained in the two subjects.  
The first feature that stands out in both subjects is the reduction of the gradient 
in gas-transfer values from the posterior dependent lung to the anterior, non-dependent 
lung. This gradient reduction is made obvious in figure 38C, which shows the gradient 
calculated from the images of the two disease subjects and for comparison, also shows 
the gradient in a healthy volunteer. As reported earlier, the mean gas-transfer gradient 
in the supine healthy volunteers is -2.00 ± 0.74% cm-1, and in the subject with IPF, this 
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gradient was -0.6% cm-1 and for the subject with emphysema and asthma, -0.82% cm-1. 
Mugler et al. similarly noted that the posterior-anterior gas-transfer gradients reduced in 
subjects with disease (46).  
 
Figure 38: Gas-transfer maps in subjects with emphysema/asthma (A) and idi-
opathic pulmonary fibrosis (B). (C) shows gas-transfer gradients in these two subjects 
and a healthy subject for comparison. 
 
This reduction in the gas-transfer gradient could once again, point to the notion 
of reserve capacity. The extensive alveolar damage induced by both disorders could re-
quire the subjects to use their remaining gas-exchange capacity to maintain oxygen satu-
ration, thus minimizing the gradient in gas-transfer. Interestingly, in spite of this re-
duced gradient, the mean gas-transfer for the whole lung for both subjects was unity. 
Hence, acquiring the dissolved-phase images as a single entity may provide a good es-
timate of gas-transfer in the lung, but for subjects with IPF, this example suggests that 
there could be subtle changes in the distribution of xenon in the barrier and the RBCs, 
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and points to the need to create separate images of the components of the dissolved-
phase of xenon.  
 
5.5. Summary 
This work discussed in this chapter has demonstrated the feasibility of acquiring 
3D, isotropic images of gas-phase and dissolved-phase HP 129Xe in a single breath. This 
acquisition, coupled with appropriate normalization, enables mapping of regional gas-
transfer from airspace to pulmonary blood and tissues. The study conducted to study 
the impact of posture on gas-transfer, has confirmed our primary hypothesis that gas-
transfer in the healthy lung at rest is heterogeneous, and favors the dependent lung. 
Although the distribution of gas-transfer can be characterized by a linear gravitational 
gradient reverses when subjects are imaged prone rather than supine, this analysis does 
not capture the full extent of the heterogeneity. The healthy subjects studied exhibit a 
distinctly non-monotonic posterior-anterior variation of gas-transfer with particularly 
increased values in the plane of the main pulmonary arteries. In aggregate, this study 
suggests that healthy individuals possess a significant reserve capacity for gas-transfer, 
which results in a heterogeneous distribution under basal conditions. However, while 
that distribution has some similarities among subjects, it also appears to follow patterns 
specific to individual body habitus. Furthermore, in the two subjects with disease, in 
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spite of the whole lung gas-transfer being unity, we noticed that the gas-transfer gradi-
ent was significantly reduced which indicates a loss in the reserve capacity of the lung.  
Given that capillary blood contributes significantly to the gas-transfer intensity 
in a given voxel, the study of the impact of posture and the data from the subjects with 
disease point to the value of further separating the dissolved 129Xe signal into its paren-
chymal tissue and red blood cell (RBC) components (118).  
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6. Gas-Transfer Spectroscopy as a Biomarker for Diffu-
sion-limitation 
 
The results presented in this chapter were published as a journal article: S.S. 
Kaushik et al., ‘Measuring Diffusion-limitation with a Perfusion-Limited Gas – Hyperpolarized 
129Xe Gas-transfer Spectroscopy in Patients with Idiopathic Pulmonary Fibrosis’, Journal of 
Applied Physiology, 2014; 117(6), 577-585.  
 
6.1. Motivation 
As shown in chapter 5, the reliability of dissolved-phase imaging was significant-
ly improved by minimizing the off-resonance excitation of the gas-phase. Additionally, 
acquiring an image of the gas-phase in conjunction with the dissolved-phase enabled 
quantification of the gas-transfer distribution, and further confirmed that this distribu-
tion varied with subject posture (119). However this work was limited in that both the 
barrier and RBC resonances were imaged together as a single entity.  This makes it diffi-
cult to untangle the competing effects of regional changes in perfusion, interstitial thick-
ness and alveolar-capillary surface area available for gas exchange. Hence, harnessing 
the properties of 129Xe to more fully evaluate regional gas exchange requires the ability 
to detect 129Xe transfer to the RBCs separately from transfer to the barrier.  
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Working on separating the dissolved-phase components requires understanding 
the physical mechanisms controlling the dissolved-phase components. The radio fre-
quency pulses applied to excite the 129Xe magnetization in the barrier and RBC, also con-
sume it. As the xenon in either of these compartments is in dynamic exchange with the 
xenon in the gas-phase, this depleted magnetization is replenished when 129Xe atoms 
and their associated magnetization diffuse back into these compartments from the air-
spaces. This was illustrated using a mathematical model (47) as shown in chapter 2, and 
again, in figure 39. For a typical mean harmonic barrier thickness of 1 micron, after the 
depletion caused by an RF pulse, the RBC signal is replenished within 50 ms. However, 
if the interstitium becomes thickened even by a few microns, we see that this replenish-
ment time is drastically increased.  
 
Figure 39: Signal replenishment of the dissolved-phase resonances as a func-
tion of barrier thickness. Even minimal interstitial thickening causes an increase in 
the replenishment time for the RBC signal. 
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Because these xenon atoms must first diffuse through the barrier before reaching 
the RBCs, it was hypothesized that the ratio of 129Xe signal in RBCs versus barrier would 
be reduced in patients with interstitial lung disease. We sought to first test this hypothe-
sis by employing simple 129Xe gas-transfer spectroscopy to evaluate the global gas-
transfer impairment averaged over the entire lung. Given the relative simplicity of im-
plementing and executing 129Xe transfer spectroscopy, and the small volumes of gas re-
quired, this measurement could be easily added to the calibration sequence of the 
broader 129Xe MRI protocol.  
An appropriate population to study this approach is in patients with idiopathic 
pulmonary fibrosis (IPF), a rare but particularly devastating form of interstitial lung dis-
ease, with an estimated incidence of 10.7/100000 people (120). IPF is characterized by 
decreased fibroblast death, which results in excessive collagen deposition that thickens 
the interstitial barrier tissue in the lungs causing diffusion limitation (121). IPF has a 
poor prognosis, with a mean survival of approximately 3 years from diagnosis (40). This 
is largely attributable to a lack of viable therapeutic options that can reverse or halt dis-
ease progression (120). However, numerous therapies are now under investigation for 
the treatment of IPF (41,122), and these clinical trials are in need of sensitive biomarkers 
to monitor their potential benefits and efficacy. Given the continuing need to develop 
non-invasive biomarkers of gas-transfer impairment, and that this patient population 
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has known diffusion limitation (123), this group is well suited for initial evaluation of 
129Xe gas-transfer spectroscopy. 
This chapter is going to focus on a proof of concept study which was done to es-
tablish a preliminary range of normal values for the RBC:barrier signal ratio in healthy 
subjects, understand the short- and intermediate-term reproducibility, and establish the 
degree to which 129Xe gas-transfer spectroscopy correlates with conventional metrics of 
gas exchange such as DLCO.  Moreover, we tested the hypothesis that 129Xe gas-transfer 
spectroscopy can detect impaired gas-transfer was tested in patients with IPF compared 
to healthy volunteers. 
 
6.2. Methods 
6.2.1. Subject Recruitment 
The study was approved by the Duke Institutional Review Board and written in-
formed consent was obtained from all subjects prior to recruitment to the protocol. 129Xe 
spectra were acquired in 6 subjects with idiopathic pulmonary fibrosis (mean age = 66.8 
± 12.3 years, all men) and 11 healthy volunteers (mean age = 41.3 ± 17.8 years, 10 men, 1 
woman). One hour prior to MR studies, all subjects underwent baseline pulmonary 
function testing and body plethysmography to obtain functional residual capacity (FRC) 
and total lung capacity (TLC) measurements by methods previously described (119), 
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and DLCO by the single breath method (124), in order to characterize lung function and 
lung diffusing capacity of the subject cohorts and to aid in interpreting the 129Xe transfer 
spectra.  
 
6.2.2. Xenon Polarization and Delivery 
As detailed in Chapter 2, isotopically-enriched 129Xe (85%, Linde Gases, Stew-
artsville, NJ) was polarized using Rb-vapor spin-exchange optical pumping in a com-
mercially available polarizer (Model 9800, Polarean Inc., Durham NC). 129Xe transfer 
spectra were acquired using a 200-mL dose of 129Xe, which was cryogenically accumulat-
ed and subsequently dispensed into a Tedlar bag (Jensen Inert Products, Coral Springs, 
FL), typically polarized between 10–14%. This dose was then mixed with 800 mL of ul-
tra-high purity nitrogen, and administered to the subject. Prior to inhalation, subjects 
were coached to inhale to total lung capacity (TLC) and exhale to functional residual ca-
pacity (FRC) twice. Following this, the subjects inhaled the contents of the bag through a 
6 mm ID Tygon tube, and held their breath for 4–8 seconds during which time 129Xe 
spectra were acquired (see below). The subject’s heart rate and oxygen saturation were 
monitored using an MR-compatible monitoring system (GE Healthcare, Helsinki, Fin-
land).  
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6.2.3. Dissolved-phase Spectroscopy 
6.2.3.1. Acquisition 
Studies were conducted on a 1.5-T MRI scanner (GE Healthcare, 15M4 EXCITE). 
Subjects were fitted with a quadrature 129Xe vest coil tuned to the gas-phase xenon 
Larmor frequency of 17.660445 MHz (Clinical MR Solutions, Brookfield, WI). Spectra 
were acquired in a single breath-hold with the following parameters: dissolved-phase 
129Xe was selectively excited by applying a 3-lobe sinc pulse of 1200 μs duration to the 
129Xe-RBC resonance, 3832 Hz above the gas phase. Spectra were collected with TE = 
0.932 ms, TR = 20/40 ms, receiver bandwidth = 8.06/15.63 kHz, flip-angle = 15–19°, and 
number of FIDs = 200. Subsequently, in the same breath-hold, the transmit/receive fre-
quency were switched to the gas-phase resonance, and with otherwise identical pulse 
parameters, a single gas-phase reference spectrum was acquired. The acquisition is 
graphically illustrated in Figure 40.  
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Figure 40: Acquisition scheme for the dissolved and gas-phase 129Xe spectra. 
First, 200 dissolved-phase 129Xe spectra were acquired by pulsing and acquiring on the 
RBC resonance, +3832 Hz above the gas-phase resonance. Then, with identical acqui-
sition parameters, transmit and receive frequencies were lowered to match the gas-
phase 129Xe resonance, and a single reference spectrum was acquired. 
 
For a subset of healthy subjects (n = 7), spectra were acquired again using the 
same protocol ~30 minutes later to study the short-term reproducibility. To analyze the 
inter-scan variability over a longer time period (t = 2.2 ± 1.8 months), 9 healthy volun-
teers participated in a follow-up scan, and 129Xe transfer spectra were again acquired as 
described above. 
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6.2.3.2. Processing and Analysis 
129Xe spectra were processed in MATLAB™ (MathWorks, Natick, MA) as fol-
lows. Because the first 129Xe spectra in the series occurred an arbitrary time after starting 
inhalation, they were expected to contain 129Xe signal that had accumulated “down-
stream” of the pulmonary capillary beds in the larger vasculature. Therefore, the first 
100 free induction decays of the series were discarded. However, their associated 100 RF 
pulses ensured that any 129Xe signal from the larger vasculature should be depleted to 
~1% of its starting value. Thus, signal in the remaining spectra originated entirely from 
129Xe within the capillary beds and represented a diffusive steady-state. The remaining 
100 FIDs were averaged together and processed as follows. The averaged FID under-
went 50-Hz line-broadening using an exponential apodizing function. Such techniques 
are commonly used in NMR spectroscopy to improve the SNR of spectra (125). The FID 
was then Fourier transformed to yield a 129Xe spectrum consisting primarily of dissolved 
phase 129Xe signal, with only a small amount of gas-phase 129Xe signal to provide a refer-
ence frequency. As recently shown by Chang et al. (126), the complex spectrum was 
curve fit using a nonlinear least squares optimization algorithm to a sum of complex 
frequency-dependent Lorentzian functions for the three resonances (RBC, barrier and 
gas), allowing each to have its own amplitude, central frequency, line width, and phase, 
according to  
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and f is frequency, Aj is the amplitude of a given resonance, fj its resonant frequency, ∆fj 
its full width at half maximum (FWHM), and jφ its phase. 
Typical fits of the real and imaginary channels of a 129Xe transfer spectrum are 
shown in Figure 41 along with the three fitted resonances with phase differences re-
moved. The same fitting procedure was applied to the single gas-phase reference spec-
trum. The resulting fit parameters were used to compute the area under the curve 
(AUC) of each resonance, which for Lorentzian functions is simply the product of peak 
amplitude and FWHM. From these AUCs the ratio of the RBC to barrier (RBC:barrier) 
was calculated and used as the primary metric of gas-transfer. To further investigate 
whether changes in RBC:barrier ratio were caused by changing RBC or barrier signals, 
the ratios of each resonance to the dedicated gas-phase reference spectrum, RBC:gas and 
barrier:gas, were also computed. 
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Figure 41: Curve fitting the dissolved-phase 129Xe spectra. The real (blue) and 
imaginary (red) spectra were fit separately. The imaginary fit was re-phased by 90° 
and averaged with the real spectrum to generate the final fit parameters, including 
amplitude, frequency and spectral width for each peak. 
 
A Wilcoxon Rank-sum test was used to test whether the various ratios, frequen-
cies, and peak widths were significantly different between the two groups. Reproduci-
bility was assessed using Bland-Altman plots and a pair-wise, two-tailed t-test was used 
to check for significant differences between the scans. Potential associations between the 
subject's RBC:barrier ratio and lung volume, age and DLCO were also evaluated. To ex-
amine the impact of the fixed dose volume on our measurements, a metric to estimate 
lung inflation during 129Xe signal acquisition was defined as ( 1 ) /FRC L TLC+ , and cor-
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related against the spectroscopic ratios for the healthy volunteers. The significance of the 
correlations was examined using a two tailed t-test. 
 
6.3. Study Results 
129Xe gas-transfer spectra were successfully acquired in all subjects, whose de-
mographics and pulmonary function test data are summarized in table 5. Figure 42A 
shows a 129Xe transfer spectrum from a typical healthy volunteer compared to that of an 
age-matched subject with IPF. For this healthy volunteer, the RBC:barrier ratio was 0.49, 
whereas for the IPF subject, it was 0.17, nearly 3-fold lower.  
 
 
Figure 42: (A) Shows a truncated dissolved-phase spectrum from a representa-
tive healthy volunteer and a subject with IPF. Compared to the healthy volunteer, this 
IPF subject exhibits a 2.9-fold reduction in the RBC:barrier ratio. (B) For all subjects 
the RBC:barrier ratio was 0.55 ± 0.13 in the healthy volunteers, which was reduced by 
3.3-fold in the IPF patients to 0.16 ± 0.03 (p = 0.0002).  
  
138 
The RBC:barrier ratio was consistently diminished in the entire IPF group rela-
tive to the healthy volunteers. As shown in Figure 42B, the mean RBC:barrier ratio for 
all healthy volunteers was 0.55 ± 0.13 compared to a more than 3-fold smaller value of 
0.16 ± 0.03 for IPF subjects (p = 0.0002). Further investigation revealed that the reduced 
RBC:barrier ratio in IPF subjects was attributable to a 2.1-fold reduction in the RBC:gas 
(p = 0.02) and a 1.6-fold increase in barrier:gas (p = 0.01) (Figure 43). These ratios are 
summarized in table 5.  
 
 
Figure 43: Comparison of the RBC:gas ratio and the barrier:gas ratio in healthy 
volunteers and IPF subjects. The RBC:gas ratio was reduced ~2-fold in IPF vs. healthy 
subjects (p = 0.02) and the barrier:gas ratio was increased ~1.6-fold in IPF subjects (p = 
0.01). These two effects together reduced the overall RBC:barrier ratio in the IPF sub-
jects.   
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Table 5: Subject demographics, spectroscopic ratios and pulmonary function 
data 
Suba 
Age 
(years) 
Ratiosb 
TLCc 
(L) 
   DLCOc 
(ml min-1  
mm Hg-1) 
Lung Inflation 
(%) 
RBC:barrier RBC:gas barrier:gas 
1 59 0.47 0.002 0.005 7.6 23.3 59.1 
2 65 0.47 0.003 0.006 7.2 28.1 62.6 
3 51 0.35 0.002 0.007 5.7 21.5 74.9 
4 24 0.79 0.003 0.004 6.7 26.6 66.3 
5 33 0.57 0.003 0.005 8.0 31.8 68.6 
6 29 0.43 0.003 0.007 6.3 27.8 61.7 
7 27 0.65 0.005 0.008 7.2 42.7 54.6 
8 23 0.53 0.007 0.014 7.3 31.9 46.7 
9 22 0.69 0.006 0.009 9.2 29.8 54.9 
10 56 0.52 0.004 0.007 6.6 25.7 70.3 
11 65 0.53 0.004 0.008 7.0 30.1 59.7 
1 74 0.13 0.002 0.012 4.2 10.8 - 
2 83 0.22 0.003 0.013 4.7 12.6 - 
3 54 0.17 0.003 0.016 3.8 11.2 - 
4 51 0.14 0.002 0.011 3.3 7.2 - 
5 72 0.16 0.001 0.008 4.1 9.4 - 
6 67 0.16 0.001 0.009 3.8 9.4 - 
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In addition to their significantly lower RBC:barrier ratios, the IPF subjects also 
exhibited differences in their RBC resonance frequencies and widths. As shown in table 
6, the RBC resonance frequency was 342.2 ± 15.5 Hz above the barrier resonance in 
healthy volunteers, but the RBC frequency was 43.3Hz lower in patients with IPF  (298.9 
± 21.7 Hz, p = 0.003). By contrast, the frequencies of the barrier and gas-phase resonances 
did not differ significantly between the groups. However, the spectral widths of all three 
resonances were significantly different between the two groups. The mean width of the 
RBC resonance was 166.5 ± 16.5 Hz (with line broadening subtracted) in the healthy vol-
unteers, but significantly narrower in the IPF subjects (125.8 ± 16.8 Hz, p = 0.0002). This 
was true for the barrier resonance as well, with the healthy volunteers exhibiting a width 
of 144.4 ± 10.4 Hz, and the IPF subjects exhibiting a barrier width of only 124.7 ± 6.0 Hz 
(p = 0.001). The width of the gas-phase resonance in IPF subjects was ~62% of that in the 
healthy volunteers (18.6 ± 6.0 Hz vs. 30.2 ± 9.6 Hz, p = 0.01).  
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Table 6: Frequencies and widths of resonances in healthy volunteers and IPF subjects 
a Frequencies are referenced to the mean barrier resonance frequency in the healthy 
volunteers. Chemical shift (ppm) referenced to the gas phase frequency of 17.66 MHz. 
 
As shown in Figure 44A, the RBC:barrier ratio obtained in healthy volunteers 
during a given MRI session did not change significantly. The mean difference between 
scans 1 and 2 was 0.036 ± 0.06 or 6.6% (p = 0.15) as seen in table 7.  While RBC:barrier 
was highly reproducible within a given imaging session, it did change significantly over 
scans conducted on different days. On average, the RBC:barrier ratio acquired on the 
second day of scanning was 8.25% lower than on day one, and this was significant (p = 
0.01). As shown in table 8, the bulk of this variability was contributed by 2 subjects 
whose RBC:barrier ratios were reduced by 24.5% and 16.5% (subjects 2 and 7) between 
 
Frequency (Hz)a Width (Hz) 
 
RBC  
(ppm) 
Barrier  
(ppm) 
Gas RBC Barrier Gas 
Healthy 
342.2±15.5 
(217.4) 
0.0±11.0 
(198.0) 
-3497.0±6.5 
 
166.5±16.5 
 
144.4±10.4 
 
30.2±9.6 
 
IPF 
298.9±21.7 
(214.3) 
-5.0±9.7 
(198.2) 
-3500.2±13.8 
 
125.8±16.8 
 
124.7±6.0 
 
18.6±6.0 
 
p-value 0.003 0.18 0.18 0.0002 0.0009 0.01 
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scan and rescan. The RBC:gas and barrier:gas metrics however, showed no significant 
short-term or inter-scan change (p > 0.1). The same was true for the frequencies and 
widths of all three resonances, all of which were highly reproducible (p > 0.1).    
 
 
Figure 44: Bland-Altman plots showing the reproducibility of the RBC:barrier 
ratio. (A) Within a given session, RBC:barrier had a variability of 6.6%, which was not 
significant. (B) Over different scanning sessions, RBC:barrier was significantly re-
duced in the follow-up session (p = 0.01), with a mean variability of 8.25 %.  
 
RBC:barrier across all subjects studied, correlated to a high degree with DLCO (r = 
0.89, p < 0.0001, Figure 45A). There was also evidence that for healthy subjects, total RBC 
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signal depended on lung inflation level during acquisition (table 5). Since the subjects 
received an identical fixed volume of gas, those with larger total lung capacity (TLC), 
were scanned at a lower level of lung expansion. As shown in Figure 45B, we found a 
robust association between the RBC:gas ratio and the lung inflation parameter (r = -0.78, 
p = 0.005). The barrier:gas ratio also correlated with lung inflation (r = -0.67, p = 0.025); 
however, the RBC:barrier ratio did not (r = -0.28, p = 0.40).  
 
Table 7: Intra-scan variability of the spectroscopic ratios 
Subject 
 
Ratios 
RBC:barrier RBC:gas barrier:gas 
Scan 1 Scan 2 Scan 1 Scan 2 Scan 1 Scan 2 
2 0.37 0.42 0.003 0.004 0.006 0.01 
3 0.32 0.33 0.003 0.002 0.007 0.007 
4 0.78 0.68 0.003 0.003 0.004 0.005 
6 0.43 0.40 0.003 0.003 0.007 0.007 
7 0.65 0.55 0.005 0.004 0.008 0.007 
8 0.53 0.52 0.007 0.008 0.014 0.014 
9 0.70 0.62 0.006 0.005 0.009 0.008 
 
  
144 
Table 8: Inter-scan variability of the spectroscopic ratios 
 
Ratios 
Subject RBC:barrier RBC:gas barrier:gas 
 
Scan 1 Scan 2 Scan 1 Scan 2 Scan 1 Scan 2 
       
1 0.47 0.41 0.0024 0.0026 0.0050 0.0065 
2 0.47 0.37 0.0030 0.0026 0.0064 0.0070 
3 0.357 0.32 0.0025 0.0020 0.0070 0.0063 
4 0.797 0.78 0.0029 0.0032 0.0036 0.0041 
6 0.43 0.40 0.0030 0.0034 0.0069 0.0085 
7 0.65 0.63 0.0050 0.0059 0.0077 0.0095 
8 0.537 0.47 0.0072 0.0091 0.0136 0.0194 
9 0.70 0.59 0.0063 0.0035 0.0091 0.0060 
11 0.53 0.54 0.0042 0.0041 0.0080 0.0078 
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Figure 45: Correlations of gas-transfer metrics. (A) RBC:barrier was strongly 
correlated with DLCO (r = 0.89, p < 0.001). (B) In healthy subjects, the RBC:gas metric 
was significantly reduced by greater lung inflation (r = -0.78, p = 0.005).  
 
6.4. Inferences about 129Xe Gas-Transfer 
6.4.1. Measuring diffusion-limitation with a perfusion-limited gas 
The ability to use 129Xe to measure diffusion limitation may appear counter-
intuitive given that xenon, like other inert gases, is traditionally considered to be “perfu-
sion-limited.” This apparent paradox was recently explained by Cleveland et al. (48), 
who pointed out the fundamental differences between MR-based detection of hyperpo-
larized 129Xe magnetization and traditional diffusing capacity measurements. Standard 
physiological measurements of gas-transfer exploit the physical consumption of a tracer 
(V) in accordance with Fick’s law 
( )A CAd P P tV
x
−
= (67), where A is the surface area, d is 
the diffusion constant, PA is the alveolar partial pressure of the tracer, PC is the capillary 
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partial pressure of the tracer, t is the measurement time and x is the thickness of the 
membrane. This consumption is driven by the alveolar-capillary partial pressure gradi-
ent (PA - PC). Since inert gases like xenon quickly saturate the alveolar septum and cause 
this partial pressure gradient to vanish, the only means to remove more xenon from the 
alveolar spaces during a breath hold is to increase perfusion. This is why xenon is con-
sidered to be “perfusion-limited.”  
In order to measure diffusion limitation by traditional means, carbon monoxide 
(CO) is typically used because it binds strongly to hemoglobin such that the pulmonary 
blood acts as an “infinite sink” and the alveolar-capillary partial pressure gradient is 
maintained (127). In this way, the bulk consumption of CO during a breath-hold is pri-
marily limited by its rate of diffusion across the blood-gas barrier. If the blood-gas barri-
er thickness increases, the flux of CO across it is reduced and less CO is taken up by the 
capillary blood before it exits the gas-exchange region.  
However, when HP 129Xe is combined with MR-based detection and destruction 
of magnetization, it can detect diffusion limitation. It should be noted that while the net 
flux of xenon atoms across the barrier is zero, the net flux of 129Xe magnetization into these 
compartments is non-zero. This is because the radio frequency (RF) pulses used to detect 
dissolved 129Xe magnetization, also consume it. This depletion can only be replenished 
by new magnetization from the xenon diffusing in from the alveolar compartment (106). 
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Because the barrier is adjacent to the alveoli, magnetization within this compartment is 
replenished first. By contrast, the RBC compartment cannot be replenished until 129Xe 
magnetization has traversed the barrier. Thus, 129Xe magnetization in the barrier and 
RBCs is “pinned” to a depleted, non-equilibrium value by continuous RF irradiation. 
With a thickened barrier, the magnetization flux to the RBCs will be particularly dimin-
ished, as the time it takes for the magnetization to diffuse across a barrier (τ) scales as 
the square of its thickness (Δx) as 
2
2~
x
Dτ
∆
 (47). Such thickening only impacts the re-
plenishment of the RBC resonance, since only this compartment is separated from the 
airspaces by the barrier tissue. By contrast, the barrier signal is not diminished by thick-
ening, and depending on its chemical composition, this signal can even be increased by 
inflammation or fibrosis. Hence, with the proper choice of acquisition parameters, inter-
rogating HP 129Xe signal in the RBCs relative to the 129Xe signal in the barrier can detect 
diffusion impairment. 
In this small subject population, the global RBC:barrier ratio exhibited a consid-
erable dynamic range. For example, one IPF subject exhibited an RBC:barrier more than 
5-fold lower than the largest ratio seen in a healthy volunteer (0.79). This supports our 
hypothesis that 129Xe transfer spectroscopy can serve as a marker of diffusion impair-
ment. This is further bolstered by a strong correlation between RBC:barrier and the well-
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established measure of pulmonary gas exchange, DLCO. Although these two techniques 
differ substantially in their implementation, they are able to measure similar effects.  
 
6.4.2. Gas-transfer in healthy volunteers 
The mean RBC:barrier ratio in healthy volunteers was 0.55 ± 0.13, but exhibited a 
relatively broad range (0.35–0.79), even in this relatively small subject population. The 
lowest ratio observed was 0.35 or 64% of the population mean, whereas the largest value 
of 0.79 was 144% of the population mean. In healthy volunteers, we assume that the 
blood-gas barrier is of normal thickness, and there exists no diffusive limitation to 129Xe 
reaching the RBCs. Thus, the remaining source of variability appears to be contributed 
by individual differences in the resting capillary blood volume. If a greater fraction of 
the capillary bed is recruited and perfused at rest, this provides a larger pool of RBCs for 
129Xe to enter, and the RBC:barrier ratio will increase accordingly. Additionally, as no-
ticed by Qing et al. (49), our healthy volunteers with the largest lung capacity also exhib-
ited the greatest RBC:barrier ratio. This is likely because for these subjects, inhaling 1 
liter of gas from functional residual capacity (FRC) left them at the lower lung inflation 
during data acquisition, and this resulted in a larger capillary blood volume during MR 
acquisition (128).  
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The potential sensitivity of RBC:barrier to lung inflation was illustrated in one 
healthy volunteer who conducted a series of breathing maneuvers during continuous 
acquisition of 129Xe spectra. With the same acquisition parameters described in the meth-
ods section, 803 spectra were acquired over a 16 second time interval. During this time, 
the subject performed a 4 s breath hold, followed directly by a 4 s Valsalva maneuver 
(positive pulmonary pressure caused by forced exhalation against a closed airway), a 4 s 
Müller maneuver (negative pulmonary pressure caused by forced inhalation against a 
closed airway), and finally an exhale to FRC during the remaining 4 s. This is shown in 
figure 46.  
 
 
Figure 46: Changes in the RBC:gas, RBC:barrier and barrier:gas ratios observed 
during a breath-hold. Spectra were processed using a ‘sliding-window’ processing 
technique to provide a pseudo-temporal depiction. During the breath-hold, RBC:gas 
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and RBC:barrier ratio are initially reduced by depletion of 129Xe magnetization in the 
larger vasculature (downstream signal). During the Valsalva maneuver RBC:gas di-
minishes while barrier:gas remains stable, resulting in diminishing RBC:barrier ratio. 
This is attributable to a reduction in capillary blood volume during the maneuver. 
Conversely, the Müller maneuver increases capillary blood volume, and hence the 
associated ratios. Exhalation increases overall gas-transfer, but also maximally in-
creases capillary blood volume, which is reflected in an increasing RBC:barrier. 
 
During the initial 2-seconds of the breath-hold, 129Xe magnetization reaches a dif-
fusive steady state as 129Xe magnetization in the larger vasculature (downstream signal) 
is depleted by RF pulsing. Then, the Valsalva maneuver increases alveolar pressure, 
which decreased capillary blood volume, estimated to be 17.2% over 5 seconds by Smith 
et al. (129) . This corresponds reasonably well to our observed 11% reduction in 
RBC:barrier over 4 seconds during the Valsalva maneuver. In contrast, during the Mül-
ler maneuver Smith et al. (129) demonstrated that capillary blood volume increases by 
6.1% over 5 seconds. This again is consistent with the 5.4% increase in RBC:barrier that 
we observed. Lastly, during exhalation, as the alveolar pressure is greatly reduced, the 
transfer of 129Xe to both the barrier and the RBCs increased dramatically. Although this is 
an anecdotal study, it illustrates that the lung inflation and alveolar pressure during the 
breath-hold can affect these gas-transfer metrics.  
The reproducibility of the RBC:barrier ratio during repeat testing provides addi-
tional insights into this measurement. While intra-scan repeat testing showed 
RBC:barrier to remain stable, this ratio decreased significantly over different days (t = 2.2 
  
151 
± 1.8 months, 8.3%, p = 0.01). A large portion of this variability was contributed by sub-
jects 2 and 7, whose RBC:barrier ratios were reduced by 24.5% and 16.5% on follow-up 
(table 8). The variation in subject 7 may have been caused in part by a higher heart rate 
during the first session relative to the second (74 bpm to 55 bpm). This higher heart rate, 
and presumed greater cardiac output, may increase capillary recruitment and thereby 
present a larger capillary blood volume into which 129Xe can diffuse. However, heart rate 
cannot explain the change in RBC:barrier seen in subject 2 (52 bpm to 49 bpm). It may be 
the case that this subject had a lower resting capillary blood volume at scan 2. This could 
be attributable to differences in lung inflation, as previously discussed. As we did not 
control for subject exercise prior to the MRI study, the variability in the RBC:barrier may 
also be caused by differences in the subject’s activity profile prior to scans.  
Given these observations in healthy subjects, it appears that controlling lung in-
flation will be important to maximize reproducibility of measurements. However, the 
optimal means to do so within a 129Xe MRI study is still somewhat unclear. One possibil-
ity is to inhale 129Xe and continue on to TLC as is done for DLCO. However, at such infla-
tions it appears from our data that 129Xe gas-transfer and capillary blood volume is min-
imized and SNR is reduced. Alternatively, Diaz et al., demonstrated excellent reproduci-
bility of 3He apparent diffusion coefficient measurements, by tailoring inhaled volumes 
to 15% of subject TLC (90). However, this requires a priori knowledge of lung volumes 
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from plethysmography, and requires subjects reliably starting their inhalation from FRC. 
An alternative approach may be to make measurements at end-expiration as is common 
in contrast-enhanced perfusion MRI (130). Although this involves exhaling 15–20% of 
the 129Xe magnetization, it may be the most reliable means to minimize inter-subject var-
iability of gas-transfer measurements. 
 
6.4.3. Gas-transfer in IPF subjects 
129Xe gas-transfer to RBCs was dramatically reduced in the IPF subject group. In 
aggregate, these patients exhibited an RBC:barrier ratio that was only 29% of the mean 
value seen in healthy volunteers. In fact, the lowest ratio observed in IPF, was only 24% 
of the mean in healthy volunteers and represented just 17% of the highest ratio observed 
in a healthy subject. Although RBC:barrier can vary significantly in healthy subjects, and 
this variability is likely attributable to differences in resting perfused capillary blood 
volume, this does not seem a plausible explanation for the low gas-transfer in IPF. In 
healthy subjects, RBC:barrier exhibited a mean variability of 8.3%, with individual ex-
cursions of 20% being somewhat rare. Thus, it seems that the more than 3-fold reduction 
in RBC:barrier observed in IPF subjects cannot simply be attributed to a 3-fold reduction 
in perfused capillary blood volume. Instead, the reduced gas-transfer to RBCs must be 
caused, at least in part, by thickening of the blood gas barrier. Such thickening delays 
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the diffusive replenishment of 129Xe magnetization to the RBCs. Moreover, depending on 
129Xe solubility within the thickened barrier, the barrier signal can actually be increased. 
Both of these effects work together to reduce the RBC:barrier ratio. In fact, to significant-
ly impede the transfer of 129Xe magnetization requires only 10 microns of interstitial 
thickening (47). Thus, we suggest that significant areas of the IPF lung remain perfused 
even in the presence of a thickened blood-gas barrier. These areas would contribute sig-
nificantly to diffusion limitation, which we observe both with 129Xe spectroscopy and 
conventional DLCO. This notion is further supported by pulmonary ventilation/perfusion 
imaging using high-resolution CT showing that, even in injured or inflamed lung, perfu-
sion can be maintained to continue resolving the insult, despite the deleterious effect on 
O2 saturation (131).  
 
6.4.4. Changes in the frequency and width of 129Xe resonances 
While the amplitudes of the 129Xe RBC and barrier resonances are of primary in-
terest, their frequency and spectral width convey additional insights regarding capillary 
blood oxygenation and hemoglobin levels (132,133). A somewhat surprising finding was 
that the frequency of the RBC resonance was ~43 Hz (2.3 ppm) lower in patients with 
IPF than in healthy volunteers (table 6). This may be understood by considering the 
work of Wolber et al., who reported in vitro studies showing that the frequency of the 
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RBC resonance increases with oxygen saturation (132). The RBC frequency increases by 
5 ppm (88 Hz at 1.5 T) over an oxygen saturation range of 30 – 100% (132). Interestingly, 
our observed RBC frequency of 217.4 ppm in healthy subjects lies below the 221 ppm in 
vitro value reported by Wolber et al. for fully oxygenated blood, and suggests that aver-
age SpO2 in our healthy population is only ~0.95. The 2.3 ppm lower RBC frequency in 
our IPF patients suggests an average SpO2 of only 0.60. However, pulse oximetry in all 
our subjects revealed that healthy subjects had an SpO2 above 95%, and even IPF pa-
tients had SpO2 above 90%. This apparent discrepancy can be reconciled by recognizing 
that SpO2 is measured in the distal vasculature, whereas 129Xe spectroscopy reports from 
within the alveolar capillary bed. Hence, even in healthy subjects, a fraction of the 129Xe-
RBC resonance arises from cells that are early in their transit through the capillary bed 
and are not yet fully oxygenated. However, in healthy subjects, such oxygenation is 
largely complete within 1/3 of the blood transit time, and thus 129Xe spectra are derived 
from roughly 2/3 fully oxygenated blood and 1/3 partially oxygenated blood. By con-
trast, the diffusion limitation in IPF means that maximal oxygenation is only achieved 
towards the very end of alveolar-capillary transit. Hence, 129Xe spectra in IPF are more 
heavily weighted towards deoxygenated RBCs. Thus, the reduced 129Xe-RBC frequency 
in IPF appears to be a second indicator of diffusion limitation. Interestingly, as intersti-
tial thickness will vary across the lung, along with their attendant oxygen saturation 
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times, it may become possible to crudely image such regional oxygenation, by employ-
ing chemical shift imaging and measuring RBC frequencies locally (134). By contrast, the 
frequency of the barrier resonance did not differ significantly between IPF and healthy 
subjects, consistent with literature reports that it is independent of blood oxygenation 
(132).  
Of further note is that the spectral widths (full width at half maximum [FWHM]) 
of all three 129Xe resonances are significantly narrower in subjects with IPF than in 
healthy volunteers (table 6). For example, the width of the barrier resonance was 144.4 ± 
10.4 Hz in healthy volunteers but was reduced to 124.7 ± 6.0 Hz in the IPF subjects (p = 
0.001). The width of 129Xe resonances is driven by exchange of 129Xe between the different 
frequency environments. For the simple case of 129Xe in whole blood, the width of the 
barrier (plasma) resonance is known to increase linearly with hematocrit (133) as 129Xe 
exchanges between the RBCs and plasma. The nominal barrier width is ~127 Hz (T2 ≈ 2.5 
ms) for whole blood with hematocrit of 38 ± 2% (133). The diminished barrier width we 
observed in IPF may indicate that a greater fraction of the barrier resonance is contribut-
ed by 129Xe further removed from the RBCs in the now thickened interstitium, where ex-
change with RBCs is absent. Like the barrier resonance, the RBC resonance was also con-
siderably broader in the healthy volunteers (166.5 ± 16.5 Hz) than in IPF patients (125.8 ± 
16.8 Hz, p = 0.0002). The RBC resonance in healthy volunteers was only slightly broader 
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than reported in pure RBCs in vitro, which have a width of ~152 Hz (T2 ≈ 2.1 ms (133)). 
Thus, while the 129Xe-RBC resonance frequency is affected by oxygenation, its narrower 
width in IPF may indicate that those RBCs experience fewer susceptibility gradients as 
fibrotic processes keep them more distal from the air-tissue interfaces. Finally, the gas-
phase resonance was also broader in the healthy volunteers (30.2 ± 9.6 Hz) than in IPF 
subjects (18.6 ± 6.0 Hz, p = 0.01). This may indicate that some portion of the gas-phase 
linewidth in healthy volunteers is contributed by exchange into the dissolved-phase 
compartments, and this exchange may be impeded in the presence of fibrosis.    
 
6.4.5. Study Limitations 
There are several technical limitations that must be considered when interpreting 
the RBC:barrier and other ratios reported here. Firstly, the measurement is likely to de-
pend on the choice of RF pulse repetition time and flip angle. If a lower flip angle and/or 
longer TR were used, 129Xe magnetization in RBCs would not be depleted as much and 
significant RBC signal might arise from larger vasculature to increase the RBC:barrier 
ratio. Similarly, the opposite case of larger flip and/or shorter TR would limit RBC re-
plenishment and reduce the RBC:barrier ratio. The flip-angles used to acquire spectra in 
our study varied between 15.3° and 19.6° because they were taken prior to transmitter 
gain calibration. This variability could explain some degree of variability seen in the 
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RBC:barrier on repeat scans. Secondly, the ratio calculation is predicated on equal excita-
tion of the RBC and barrier resonances. But this can be undermined by distortion of the 
RF pulse frequency profile due to non-linearity of the power amplifier. In our system we 
estimate this to result in application of a marginally (6%) lower flip angle on the RBC 
than the barrier resonance. However, the impact of such imperfection is not immediately 
clear as it causes less depletion of the RBC magnetization, but also less excitation; these 
two effects would cancel. In any case, it should be possible to create a distortion-free se-
lective RF frequency profile, as demonstrated by Leung et al., using phase modulated 
composite RF pulses (135). However, none of the RF effects discussed above are ex-
pected to change the relative differences we observed in IPF vs. healthy volunteers; they 
would only impact the absolute magnitude of RBC:barrier obtained across different MRI 
systems. Furthermore, in this preliminary study, subject hematocrit was not measured. 
We speculate that the hematocrit will positively correlate with the RBC:barrier ratio. 
Thus, future studies should consider correcting spectroscopic metrics for potential dis-
ease-induced variations in hematocrit (136), and ensure that the RBC:barrier ratio is tru-
ly indicative of diffusion limitation.  Lastly, we note that RBC:barrier in patients with 
significant lung disease could be affected by heterogeneity of ventilation (137) and diffu-
sion-perfusion ratios (138). The heterogeneity in ventilation has been shown to change 
DLCO measurements by ~6% (137). Also, as the uptake of CO is dictated by the regional 
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diffusion-perfusion ratio (138), changes in regional perfusion will impact the uptake of 
129Xe in the RBCs.  
 
6.5. Summary 
This study has confirmed our hypothesis that spectroscopic interrogation of dis-
solved-phase HP 129Xe can detect diffusion impairment in subjects with IPF. These pa-
tients exhibited an RBC:barrier that was 3.3-fold lower than for healthy volunteers and 
this ratio was strongly correlated with the well-established DLCO measure of gas-
exchange. Given its excellent sensitivity to diffusion impairment, this metric can lend 
itself to longitudinal assessment of lung function and analyze response to a potential 
therapy. Moreover, the ability to detect variations in RBC:barrier dynamically, during 
breath-hold and exhalation, provides a fundamentally novel means to study gas ex-
change dynamics, and further improves the specificity of the technique to differentiate 
pulmonary diseases. Additionally, 129Xe transfer spectroscopy provides intriguing com-
plementary information, via the oxygenation-dependent frequency of the RBC reso-
nance, as well as the line widths of all three resonances. However, further studies are 
needed to better understand the degree to which RBC:barrier and all other parameters 
reported here depend on lung inflation and capillary blood volume. Methods must be 
developed to ensure that the ratio is measured in a way that is maximally reproducible, 
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not only at a given imaging site, but across centers. While the work in this chapter 
measures gas-exchange on a global basis, this measurement forms the fundamental basis 
for the next chapter, which extends this technique to create three-dimensional images of 
the transfer of 129Xe exclusively to the RBC.  
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7. Imaging 129Xe in the Gas-phase, Barrier and the RBCs 
in a Single Breath 
 
 The results presented in this chapter were recently submitted as a journal article: 
S.S. Kaushik et al., ‘Single-Breath Imaging of Hyperpolarized 129Xe in the Airspaces, Barrier, 
and Red Blood Cells using an Interleaved 3D Radial 1-Point Dixon Acquisition’, Magnetic 
Resonance in Medicine, 2014.  
 
7.1. Motivation 
The spectroscopic studies of patients with idiopathic pulmonary fibrosis (IPF) 
presented in chapter 6, showed the importance of separating 129Xe transfer into its barri-
er and RBC constituents. Global gas-transfer spectra demonstrated that the ratio of 129Xe 
uptake in the RBCs vs. barrier was 3.3-fold lower in IPF patients than in healthy volun-
teers. Additionally, this ratio correlated well with conventional physiologic measure-
ments of gas exchange (DLCO correlation = 0.89), provided dynamic spectroscopic infor-
mation, and in healthy subjects, the RBC:barrier was sensitive to changes in capillary 
blood volume and alveolar pressure. Beyond the overall uptake ratios, the frequency of 
129Xe in the RBC compartment appeared to reveal sensitivity to oxygenation at the alveo-
lar capillary level. Hence, based on these results, individually visualizing the RBC and 
barrier compartments could provide fundamental insights about regional gas-exchange.  
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Separating 129Xe uptake in the barrier and RBCs shares many similarities to the 
more familiar problem of fat-water separation in 1H MRI (139). Like fat and water, which 
at 1.5 T are separated by ~220 Hz, 129Xe in the barrier and RBC compartments are sepa-
rated by ~340 Hz. However, unlike 1H in fat and water, 129Xe in the RBC and barrier ex-
perience a very short T2*, which constrains the available time for typical, well-known 
Dixon techniques. Therefore, early efforts to generate separate images of 129Xe in the bar-
rier and RBCs in a rat model of fibrosis utilized the simpler 1-point Dixon technique (47). 
This approach acquires images at an echo time such that when the center of k-space is 
sampled, the two resonances are 90° out of phase. By subsequently phase-shifting the 
image, 129Xe signal from the RBC and barrier components are largely confined to the real 
and imaginary receiver channels. This first study generated only 2D projection images, 
but the approach was recently extended to acquire fully 3D isotropic images of the two 
compartments in a rat model of late-stage fibrosis (48). Both studies showed that while 
the 129Xe uptake in the barrier compartment was largely unaffected, 129Xe uptake in RBCs 
was markedly reduced in fibrotic regions.  
A significant advance in translating 129Xe gas-transfer clinically was recently 
made by Qing et al., who separated the barrier and RBC images using the hierarchical 
IDEAL algorithm (49). This extension of the original IDEAL algorithm allows data to be 
acquired at multiple (and arbitrary) echo times, while the B0 inhomogeneity is iteratively 
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calculated and removed at multiple resolution levels to enable the RBC and barrier im-
ages to be decomposed. However, one challenge of the IDEAL algorithm is that it re-
quires images to be acquired at 3 echo times (TEs). Acquiring dissolved 129Xe signal at 
longer TEs is challenging given the short T2*. However, Qing et al. overcame this by em-
ploying very high 129Xe polarizations and demonstrated well-separated images that cor-
related well with global spectroscopic measures (49).  
This chapter presents the simulation and phantom based initial validation, and 
the ultimate clinical translation of the 1-point Dixon approach to separately image 129Xe 
in the barrier and the RBCs using only a single, sub-millisecond TE. Such short TEs are 
more robust against T2* blurring and enable sampling more of k-space within a single 
breath-hold. By further acquiring an interleaved gas-phase image, we can image all 
three compartments in a single breath-hold. The availability of the gas image, allows B0 
inhomogeneity to be removed by using this image to calculate a phase map. To serve as 
an initial test of the 1-point Dixon method, the images were acquired in healthy volun-
teers and patients with IPF. This patient population is advantageous for several reasons. 
First, as already shown by 129Xe spectroscopy, IPF patients exhibit a significant diffusion 
limitation caused by interstitial thickening of the blood-gas barrier, which reduces 129Xe 
uptake in RBCs (140). Hence, 129Xe gas-transfer to RBCs was expected to exhibit focal gas 
transfer defects. Moreover, patients with IPF exhibit features of traction bronchiectasis, 
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honeycombing, reticular and ground glass opacities, and consolidation in their CT im-
ages, providing a means to conduct some qualitative validation of the 1-point Dixon im-
aging approach.  
 
7.2. 1-point Dixon Simulations 
As seen in chapter 6, the regions of fibrosis and interstitial inflammation seen in 
subjects with IPF, should limit the diffusion of 129Xe to the RBCs. With a proper choice of 
acquisition parameters, these regions in the 129Xe-RBC images are expected to show gas-
transfer ‘defects’. However, the ability to visualize such defects using the 1-point Dixon 
technique depends on a couple of factors. a) The echo time needed for a 90° phase separation 
should be accurately calibrated. b) The Dixon condition is valid only at the center of k-space (k0), 
beyond which the RBC-barrier phase difference continues to evolve. The acquisition should be 
rapid enough to minimize the impact of this continued phase accumulation. The simulation 
presented in this section tests how perfect these conditions have to be to still visualize 
defects in the 129Xe-RBC image.  
 
7.2.1. Methods 
The simulations were implemented in Matlab. A 3D mathematical phantom was 
used, and the source code for this phantom was made available by Jeff Fessler from the 
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University of Michigan. The building blocks of the phantom are the mathematical defini-
tions for common shapes (circle, cylinder, rectangle, ellipse, and triangle). By specifying 
the dimensions of these shapes, their centroid, and signal intensity, an image of the 
phantom can be obtained by calculating the sum of the signal intensities of the specified 
shapes. The primary advantage of using this approach is in obtaining its frequency in-
formation. As the phantom is mathematically defined by the various shapes, this k-space 
data is obtained by evaluating the Fourier transform at the specified coordinates. Hence, 
even if k-space were radially sampled, the frequency data will be truly representative of 
the underlying phantom, as it has the advantage of not needing any interpolation.  
The 3D phantom was defined to have complex data, with the real data represent-
ing the red blood cells, and the imaginary data representing the barrier. This ensured 
that the real and imaginary channels were inherently 90° out of phase. With a field of 
view of 40 cm, the phantom was defined to be a cylinder in both channels, with a radius 
of 15 cm, and a length of 30cm. To mimic the RBC:barrier ratio in healthy volunteers, the 
signal intensity for the real data in the phantom was 0.5, and the imaginary data was set 
to 1i. For the real component of the phantom alone, a number of 3x3x30 cm3 cuboids 
were used to define the gas-transfer defects. The phantom was treated as a 643 matrix 
and the real and imaginary components of this phantom are shown in figure 47. 
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Figure 47: Real and imaginary channels of the 3D numerical phantom showing 
the defects in the real channel which mimics the defects in the transfer of 129Xe to the 
RBCs.  
 
The k-space data for this phantom was sampled using a golden-means sampling 
strategy, with 4289 frames, which has the same 3× under-sampling factor used for the 
clinical dissolved-phase 129Xe images. This k-space data was then reconstructed onto a 
1283 matrix, using a NUFFT algorithm. Figure 48 shows a single slice of this phantom 
with the defects, and the reconstructed image.  
 
 
Figure 48: Single slice of the real channel of the numerical phantom and the 
reconstructed image.  
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We first sought to test the impact of continued phase accumulation beyond k0 on 
the Dixon images. This phase accumulation will depend on a) sampling speed (dwell 
time), which is a function of the receiver bandwidth (BW) and is given as
1
2
dwell
BW
= , 
and b) the RBC-barrier frequency difference ( f∆ ). Hence, with large frequency differ-
ences and large dwell times, over the course of sampling a ray of k-space, the RBC-
barrier phase accumulation will increase significantly beyond 90°. This phase accumula-
tion is assumed to occur independent of the gradients, and is modeled as a phase vector 
(ϕ ) as shown in equation 7.1.  
 
( )2( , ) unwrap i ftt f e πϕ ∆∆ =   (7.1) 
where t is the time vector such that t n dwell= × , where n is the k-space sample point 
n=1,2,..64. As the phase accumulation will be well beyond 180° for longer dwell times, 
the phase in the exponent was subject to an unwrapping operation. This phase accumu-
lation was further weighted down by the T2* of the dissolved-phase. As the matrix size 
was twice that of a typical dissolved-phase acquisition (643 vs. 323), the T2* was chosen to 
be 4 ms instead of 2 ms. The weighted phase equation can be written as shown below, 
and this was multiplied with each ray of k-space.  
 2/ *( , ) ( , ) t TW t f t f eϕ ϕ −∆ = ∆   (7.2) 
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To visualize the impact of dwell time, and hence phase accumulation beyond k0, 
the images were reconstructed at multiple dwell times ranging from 8 – 64μs. Figure 49 
shows a single slice of the 3D phantom, reconstructed at these dwell times. By acquiring 
64 points along a ray of k-space, with a dwell time of 8μs, the phase difference increases 
by an additional 63°. Hence, while the real and imaginary data are 90° out of phase at k0, 
at the end of k-space, they have a phase difference of 153°. In spite of this phase accumu-
lation, the rapid T2* works to attenuate the later points of k-space, and we can still visu-
alize the defects in the image. However, with an increase in dwell time, this phase ac-
cumulation worsens, and while we can somewhat visualize the defects at a dwell time of 
64μs, the image quality worsens. Hence, for 64 points along a ray of k-space, a dwell 
time of 8-16μs would be ideal to ensure that the continued phase accumulation has a 
minimal impact on the ability to identify defects. However, such small dwell times re-
quire large receiver bandwidths, which will significantly increase the noise in the imag-
es. Hence, the dwell time should be long enough to minimize image noise, and short 
enough to minimize the accumulation of phase beyond k0.  
The previous tests were done assuming that the RBC and barrier are exactly 90° 
out of phase at the start of the acquisition, that is, the TE90 is accurate. To test the impact 
of the errors in the TE90 on visualizing the defects, with a constant dwell time of 16μs, 
the images were reconstructed at different phase offsets ranging from 70 – 105°. A phase 
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separation of 70° is indicative of starting the acquisition with the TE<TE90, whereas a 
separation is 105° would be an example of TE>TE90. These phase offsets refer to the 
phase difference at k0, and were achieved by phase shifting the k-space k(x,y) as shown 
 
180( , ) ( , )p
offi
k x y k x y e
π φ  
 
∆
=   (7.3) 
where offφ∆ ranged from -20° to 15°.  One slice of the reconstructed images is shown in 
figure 49 below. 
 
 
Figure 49: The real portion of the phantom is used to show the impact of con-
tinued phase accumulation (above) and the impact of phase separation (below) on the 
ability to visualize gas-transfer defects using the 1-point Dixon acquisition. Increased 
dwell times significantly degrade image quality. Echo times that are shorter than TE90 
will result in lower phase separation between the two resonances, and defects are 
completely obscured. Defects can still be seen with larger echo times, where the phase 
separation is greater than 90°, but the signal intensity in the rest of the phantom is 
contaminated by the signal from the imaginary channel.  
 
Even with the lower phase difference (<90°) at k0, the general shape of the gas-
transfer defect is largely retained. However, a portion of the imaginary channel crosses 
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over into the real channel, increasing the signal within the defects seen in the center of 
the image. In contrast, the images reconstructed at a higher phase difference (>90°), seem 
to retain the defects in the image, but show higher signal in the rest of the image, which 
is indicative of contamination from the data in the imaginary channel.  
Based on these simulation results, one can conclude that the impact of the con-
tinued phase accumulation beyond k0 is dampened by the rapid T2* of the dissolved-
phase. Hence with a moderately fast acquisition, this effect can be minimized. As for 
TE90, it is imperative that its calculation be accurate. But qualitatively, based on the im-
ages in figure 49, one can tolerate an error of ±5° in the phase difference at k0.   
 
7.3. Phantom Experiments 
As a proof-of-principle experiment, the 3D extension of the 1-point Dixon tech-
nique was implemented on a 2T scanner, using a water-cyclohexane phantom. Cyclo-
hexane was chosen to imitate the ‘fat’ peak, as it consists of only a single resonance, and 
more importantly, has a similar chemical shift. The water-cyclohexane phantom was 
made using a ping-pong ball filled half-way with 5 mM copper sulphate solution and 
the remaining was topped off with cyclohexane. As shown in the spectrum in figure 
50A, the frequency difference between water and cyclohexane on a 2T was roughly 251 
Hz (~3 ppm). Based on the formula presented in chapter 2, this frequency difference 
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should let us calculate the echo time needed for a 90° phase separation (TE90). Assuming 
no RF based phase accumulation, this theoretical echo-time for the water-cyclohexane 
phantom was 996 μs. To validate this echo time, water-cyclohexane spectra were ac-
quired at 5 echo times. These spectra were curve fit (as discussed in chapter 6) to extract 
the phase difference between the resonances. This phase difference was plotted as a 
function of echo time, and linear regression was used to determine the empirical TE90. 
Interestingly, this empirical TE90 was calculated to be 469 μs, which was 527 μs shorter 
than the theoretical estimation. This is shown in figure 50B. This result indicates that the 
phase accumulation during the RF pulse is not negligible, and hence, the theoretical cal-
culation of TE90 is not valid. Thus, the TE90 for the phantom experiment, and the subse-
quent clinical translation (to be discussed in following sections), was calculated empiri-
cally. 
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Figure 50: (A) Spectrum from a water-cyclohexane phantom obtained on a 2T 
system. (B) Empirical calculation of the TE90. Compared to the theoretical value for 250 
Hz frequency separation, the empirical TE90 was 527 μs shorter.  
 
While the two resonances may be 90° out of phase at the calculated TE90, they 
may land on the transverse plane at an arbitrary phase with respect to the receiver. To 
determine this receiver phase offset, an additional reference spectrum was acquired at 
the TE90, which was subjected to the same curve fitting procedure to extract the phases of 
the individual resonances. Subsequently, images of the water-cyclohexane phantom 
were acquired with the echo-time set to 469 μs. The acquisition parameters were: Sinc 
pulse duration = 1200 μs, matrix = 64×64×64, field of view = 6 cm, number of views = 
12901, TE/TR = 0.469/2000 ms, gradient ramp time = 4 μs, receiver bandwidth = 31.25 
kHz. The images were reconstructed using a gridding algorithm. Post reconstruction, 
the images were re-phased to correct for the receiver phase-offset determined from the 
reference spectrum, which resulted in the real and imaginary portions of the image rep-
resenting the water and cyclohexane respectively. Figure 51A shows the magnitude im-
age, and the real and imaginary images are shown in figure 51B.  
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Figure 51: 1-point Dixon images obtained using the water-cyclohexane phan-
tom. (A) Magnitude image showing the water at the bottom and cyclohexane floating 
on top. (B) The real and imaginary channels show the water and cyclohexane images 
respectively. The real channel still contains a little cyclohexane signal, which is con-
tributed by the longer cyclohexane T1 and continued phase accumulation.   
 
As shown in figure 51, high quality images of both water and cyclohexane can be 
generated using the 3D 1-point Dixon acquisition. The residual cyclohexane signal seen 
in the water image can be explained in part, by virtue of cyclohexane’s longer T2 relaxa-
tion time (~3 s). Also, the Dixon condition is truly satisfied only at the center of k-space 
(k0). In spite of the faster ramp-times (4 μs) and higher bandwidth used to ensure a faster 
sampling of k-space, this minimizes, but does not completely eliminate the accumulation 
of phase during data acquisition. However, in spite of this minor drawback, these re-
sults, in conjunction with the results of the simulations, show promise in the clinical via-
bility of the 1-point Dixon acquisition.  
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7.4. Clinical translation 
The simulations and phantom experiments have demonstrated that the 1-point 
Dixon acquisition is indeed feasible. This section deals with the translation of this ap-
proach to the clinic, to create images of 129Xe in the airspaces, barrier and the RBCs, in a 
single breath hold.  
 
7.4.1. Subject Inclusion and Exclusion Criteria 
Studies were approved by the Duke Institutional Review Board and were con-
ducted under IND 109,490. Written, informed consent was obtained from all subjects 
prior to the scan. Data was acquired in 4 healthy volunteers, and 3 subjects with idio-
pathic pulmonary fibrosis (IPF). All subjects were at least 18 years of age (healthy volun-
teers – 3 men, 1 woman, age = 44.0 ± 19.4 years; IPF subjects – 3 men, age = 64.7 ± 8.7 
years). The healthy volunteers had less than a 5 pack-year smoking history, had not 
smoked in the last 5 years, and had no diagnosed pulmonary disorders. Subjects were 
excluded if they had a history of cardiac arrhythmias, were pregnant or lactating, or had 
a respiratory illness within 30 days of MRI.  
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7.4.2. 129Xe Polarization and Delivery 
Isotopically enriched 129Xe (85%) was polarized to 7 – 10% by rubidium-vapor 
spin-exchange optical pumping (141) using a commercially available polarizer (Model 
9800, Polarean, Inc., Durham, NC). Xenon was cryogenically accumulated and thawed 
into a Tedlar bag and polarization was determined using a polarization measurement 
station (Model 2881, Polarean, Inc.). Prior to gas inhalation, the subjects were instructed 
to inhale to total lung capacity and exhale to functional residual capacity twice. Subse-
quently, the contents of the bag were inhaled via a mouthpiece connected to the bag 
through a 6-mm ID Tygon tube, and the subjects held their breath for the duration of the 
scans (13 – 15 s). As explained below, to establish the correct echo time for Dixon imag-
ing, subjects first underwent a calibration scan, where they received a mixture of 400 ml 
of HP 129Xe and 600 ml of ultra-high-purity N2. For the subsequent gas-transfer image, 
subjects received a 1-L dose of HP 129Xe. The subject’s heart rate and oxygen saturation 
were monitored using an MR-compatible monitoring system (GE Healthcare, Helsinki 
Finland). 
   
7.4.3. Image Acquisition and Reconstruction 
The 1-point Dixon acquisition requires solving three problems. First, it is neces-
sary to find the echo time, TE90, at which the RBC and barrier resonances are 90° out of 
phase. Second, the image must be phase-shifted such that the RBC-dominant signal be-
  
175 
comes aligned with the in-phase channel of the scanner, and the barrier-dominated im-
age is aligned with the quadrature channel. And finally, once the images have been 
phase-shifted, they must be further corrected for any phase variation caused by B0 in-
homogeneity. These steps are achieved as follows. 
 
7.4.3.1. Calibration spectra to determine TE90 
In principle, the TE90 can be simply calculated by allowing the phase difference to 
accumulate based on the known RBC-barrier frequency difference (Δf), given 
by 90
1
4
TE f= ∆ . Hence, after application of a hypothetical infinitely short pulse, a fre-
quency difference of 340 Hz would yield an expected TE90 = 735 μs. However, because 
the RF pulse used to selectively excite dissolved phase 129Xe is relatively long (1.2 ms), 
significant phase evolution occurs before the magnetization reaches the transverse 
plane. Moreover, it has been shown that the TE90 varies across individual subjects with 
fibrosis and inflammation because a variable degree of 129Xe compartmental exchange 
occurs between the barrier and RBC (48). Hence, for each subject in our study the TE90 
was empirically determined as outlined in Figure 52A. In a single breath, dissolved-
phase spectra were acquired at four progressively longer echo times of 275, 375, 475, and 
575 μs. (Note: echo time has been defined from the end of the 1.2-ms 3-lobe sinc pulse to 
acquisition of the first data point.) The other acquisition parameters were: number of 
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points = 512, flip-angle = 22°, TR = 50 ms, NEX = 50. After acquisition of each spectrum, 
crusher gradients (amplitude = 3.3 G/cm, total duration = 3 ms) were played out on all 
three gradient axes to de-phase the long-lived off-resonance gas-phase signal. Once dis-
solved-phase spectra had been acquired, transmit and receive frequencies were changed 
to the gas-phase resonance (-3832 Hz) and a single gas-phase reference spectrum was 
acquired at TE = 275 μs.  
The data were processed using routines written in MATLAB (The MathWorks, 
Inc., Natick, MA). The first 25 FIDs at each TE were discarded to avoid the presence of 
“downstream magnetization” from 129Xe beyond the capillary beds, in the larger vascu-
lature, as well as to reset the magnetization in the barrier and RBCs for later quantifica-
tion. The remaining 25 FIDs were averaged, exponentially line-broadened by 50 Hz, and 
Fourier transformed to generate a dissolved-phase spectrum with a small gas-phase ref-
erence peak. The complex spectrum was then fit using a non-linear least squares optimi-
zation algorithm to a sum of Lorentzian and Dispersive functions to extract the ampli-
tude, frequency, width, and phase of each resonance at each TE (140). The RBC-barrier 
phase-difference at each TE was fit by linear regression to determine the TE90. Addition-
ally, the spectrum acquired at a TE of 275 μs was used to calculate the area under the 
curve of each resonance, which was then used to calculate the ratio of the RBC and the 
barrier signals (RBC:barrier). As described later, this ratio was used in calculations that 
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determine the phase offset used to align the RBC and barrier components of the dis-
solved-phase image to the real and imaginary channel. 
 
 
Figure 52: The phase calibration scan shown in (A) acquires dissolved-phase 
129Xe spectra at 4 echo times (275, 375, 475, 575 μs) with a NEX of 50. Crusher gradients 
are played out on all three gradient axes to de-phase any off-resonant gas-phase sig-
nal. The last 25 dissolved-phase FIDs are averaged together and fit to a sum of 
Lorentzian and Dispersion functions to extract the phase difference between the RBC 
and barrier resonances. These phase differences are plotted as a function of echo time 
(B) and fit to a line to calculate the TE90.  
 
7.4.3.2. Image acquisition and workflow 
Images were acquired on a 1.5-T scanner (GE EXCITE 15M4). Subjects were fitted 
with a quadrature vest coil tuned to the 129Xe resonance frequency at 17.66 MHz (Clinical 
MR Solutions, Brookfield, WI). The coil was proton-blocked to enable 1H imaging with 
the scanner’s body coil.  
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Single-breath gas and dissolved-phase images were acquired during a 15-s 
breath-hold using 1-L of HP 129Xe and a 3D radial sequence (119). Dixon images were 
acquired with the echo time set to TE90. Transmit and receive frequencies were alternat-
ed between the gas and RBC resonance (+3832 Hz) to acquire each radial ray of k-space, 
which were distributed pseudo uniformly in both k-space and time using a 3D golden-
means sampling strategy (49,142). [Acquisition parameters: 1200-μs sinc pulse, ma-
trix=32×32×32, flip-angles = 0.5/22°, number of rays = 2002 (1001 each resonance), FOV = 
40 cm, TE/TR = TE90/7.5 ms, receiver bandwidth = 15.625 kHz]. The data were then split 
and separately reconstructed onto a 64×64×64 matrix using a NUFFT reconstruction al-
gorithm (99) to generate isotropic, 3D gas and dissolved-phase images.  
To help delineate the thoracic cavity a 3D radial 1H image was acquired over the 
course of a separate 15-s breath-hold. In order to achieve approximately the same lung 
inflation as during the 129Xe scan, the subject inhaled 1L of air from a polyethylene bag. 
These images were acquired using: 274-μs hard pulse, TE/TR = 0.199/2.4 ms, matrix = 
64×64×64, frames = 5647, 512 dummy pulses, flip-angle = 5°, bandwidth = 15.625 kHz, 
and FOV = 40 cm.  
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7.4.4. Image Processing and Analysis  
7.4.4.1. Image registration and segmentation 
In order to confine the analysis to the thoracic cavity, the 1H images were regis-
tered to the 129Xe gas-phase images via a multi-resolution affine transformation using the 
Image Registration Toolkit (101). The registered 1H images were then segmented using 
seed-based region growing using 3DSlicer (36) to generate the thoracic cavity mask. The 
thoracic cavity mask was morphologically closed using a spherical structuring element 
with a 7-voxel diameter. The mask was further ‘filled’ to remove any additional holes in 
the mask, and was then manually segmented to remove the major airways in MATLAB.   
 
7.4.4.2. Determining the receiver phase offset 
Although imaging at TE90 ensures that RBC and barrier signals are 90° out of 
phase relative to one another, the two compartments are not necessarily aligned with the 
real and imaginary channels because the scanner imparts an arbitrary phase shift φ0 to 
the data. Assuming the images were acquired at exactly TE90, the signal at k0 can be writ-
ten as 
 0( 0) ( ) iRBC BarrierS t S iS e φ= = +   (7.4) 
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Applying a phase shift, ∆φ, that is exactly opposite to φ0 would align the RBC and barrier 
signals with the real and imaginary channels, but unfortunately φ0 is not known a priori. 
Applying ∆φ yields a signal   
 0( )( 0) ( ) iRBC BarrierS t S iS e φ φ+∆= = +   (7.5) 
We now use the additional constraint that when the correct phase shift ∆φ has 
been applied, the sum total RBC:barrier within the thoracic cavity obtained from imag-
ing, must be the same as that measured by spectroscopy (140). We designate this ratio as 
R for brevity, and solve for ∆φ using ( ) ( )Re imS S Rφ φ =∆ ∆ . To compute the real to im-
aginary ratio from the phase-shifted image, we expand the complex signal in Equation 2 
into its real (SRe) and imaginary (SIm) components. By defining SRBC=R×Sbarrier, the resulting 
ratio of the real and imaginary image data within the thoracic cavity can then be written 
as a function only of the phase shift ∆φ applied, and the ratio R.  
 
( )
( )
Re 0 0
Im 0 0
cos( ) sin( )
sin( ) cos( )
S R
S R
φ φ φ φ φ
φ φ φ φφ
∆ + ∆ − + ∆
=
+ ∆ + + ∆∆
  (7.6) 
Note that when the correct phase shift ∆φ=-φ0 has been applied, Equation 3 re-
duces to SRe/SIm=R, as required. This phase shift ∆φ was determined by plotting SRe/SIm 
over a range of receiver phase offsets [0, π] and fitting it to Equation 3 using a non-linear 
least squares optimization algorithm. The dissolved image was then phase shifted by 
∆φ=-φ0 to isolate the RBC image to the real channel, and the barrier to the imaginary 
channel of the receiver.   
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7.4.4.3. Correcting for local phase inhomogeneity  
The acquisition described thus far assumes that the only source of phase evolu-
tion between RBC and barrier is their frequency difference. However, phase differences 
can also be imparted by B0 inhomogeneity, which must be corrected. Fortunately, the 
inherently co-registered gas-phase 129Xe image is comprised of only a single resonance 
and therefore, any phase variation in the gas-phase image is largely attributable to B0 
inhomogeneity. Because gas-phase images were acquired at only a single echo time, a 
phase-map was first generated, and then its mean was subtracted to create a ‘differential 
phase map’. This differential phase map was then applied on a pixel-by-pixel basis to 
the phased dissolved images for B0 inhomogeneity correction of the RBC and barrier im-
ages. 
 
7.4.4.4. Maps of lung function 
In addition to the native 129Xe-barrier and 129Xe-RBC images, several additional 
maps were found to be helpful in visualizing regional function. First, analogous to the 
spectroscopic RBC:barrier ratio, the RBC image was divided by the barrier image on a 
voxel-by-voxel basis to create an RBC:barrier map. Similarly, to gauge subtle differences 
in the RBC and barrier intensity, the RBC and barrier images were divided by the gas-
phase images to yield the barrier:gas and RBC:gas maps (49). To prevent long high-
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intensity tails in these maps, they were scaled by the 99th percentile of their cumulative 
distribution function (143) to limit the range between 0 and 1.  
Similar to ventilation images, the 129Xe-RBC gas-transfer images were expected to 
show regional gas-exchange defects in areas of fibrosis, and therefore gas-transfer defect 
maps were also generated. The 129Xe-RBC images were first thresholded to create an RBC 
mask. The threshold was chosen from a slice that purely depicted the background sig-
nal. The resulting RBC mask was subtracted from the thoracic cavity mask to yield the 
gas-transfer defect map. The volume of gas transfer defects was divided by the thoracic 
cavity volume to calculate the gas-transfer defect percentage.  
 
7.4.5. Study Results 
Single-breath images of 129Xe in the gas and dissolved-phases were successfully 
acquired in all the subjects scanned. The dissolved-phase images were then decomposed 
into the 129Xe-barrier and 129Xe-RBC images. Subject demographics are summarized in 
table 9, along with spectroscopic and imaging-derived RBC:barrier ratios, RBC-barrier 
frequency differences, and the TE90.    
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Table 9: Subject demographics, spectroscopic and imaging-derived parameters. 
Subject # 
Age 
(years) 
RBC:barrier ∆f 
(Hz) 
TE90 
(µs) Spectroscopy Imaging 
Healthy Volunteers 
1 56 0.49 0.48 349.9 411 
2 65 0.53 0.52 328.9 407 
3 29 0.46 0.47 323.0 470 
4 26 0.64 0.63 330.1 427 
IPF Subjects 
1 72 0.16 0.17 311.8 285 
2 67 0.16 0.18 303.4 163 
3 55 0.14 0.14 307.5 256 
 
As seen by the variability in TE90 and lack of correlation to RBC-barrier frequency 
difference, the phase calibration scan was important to accurately calculate the TE90 for 
each subject. Interestingly, although the RBC-barrier frequency difference was 40 Hz 
smaller in the IPF group than the healthy group, the TE90 was actually shorter in the IPF 
group than in the healthy group (0.24 ± 0.06 ms for IPF, 0.43 ± 0.03 ms for healthy). As 
shown in Figure 52B, increasing TE resulted in a commensurate linearly increasing 
phase difference between the RBC and barrier resonances, as expected. For healthy vol-
unteers, the relative phase accumulation with TE (slope) agreed reasonably well with 
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theoretical predictions (132.6 ± 4.7° ms-1 vs 119.8 ± 4.2° ms-1 expected). The IPF patients, 
despite exhibiting a smaller RBC-barrier frequency difference, experienced a rate of 
phase accumulation that was slower than expected (155.5 ± 18.2° ms-1 vs 110.7 ± 1.5° ms-1 
expected). Additionally, the linear regression of differential RBC-barrier phase as a func-
tion of TE yielded a negative intercept for all subjects; the intercept was moderately low-
er in the healthy volunteers (-46.3 ± 5.6°) than in the IPF subjects (-39.5 ± 15.7°).  
 
 
Figure 53: Phase correcting the dissolved-phase images. (A) shows the ratio of 
the sum of the real and imaginary channels as a function of receiver phase applied. 
For this subject, a receiver phase offset of -89.4° makes the ratio of real and imaginary 
channel signals equal to the spectroscopic ratio R=0.46. (B) shows magnitude images 
of the real and imaginary channel after applying the calculated receiver phase offset. 
As shown by the white arrow, this subject exhibits a low intensity stripe at the base of 
the lung in the real channel. This may be partly caused by the abrupt change in the 
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regional phase as shown by the difference phase map (C). Once the regional inhomo-
geneity was applied, this apparent defect was removed (D). Additionally, the negative 
values seen in the histogram after applying the phase offset (B) have been largely 
minimized after regional inhomogeneity correction (D).   
 
The calculation of phase shifts and their effects on the real and imaginary images 
are shown in Figure 53. The calculation of the overall phase shift is illustrated in Figure 
53A. For this healthy subject with R=0.46, a phase shift of Δϕ = 89.4° (inset) was needed 
to match the image-derived SRe/SIm=0.46, to the spectroscopically-derived RBC:barrier 
ratio. After applying only the -89.4° phase shift, the real channel exhibits an apparent 
‘defect’ in the basal portion of the left lung (white arrow in Figure 53B). However, this 
apparent defect can be seen to originate from B0 inhomogeneity shown in Figure 53C, 
which shows the spatial phase variation seen in the single-resonance gas-phase image. 
The phase map ranged from about -45° to 45° across the lung, with the highest phase 
accumulation observed in the basal lung near the diaphragm. After correcting for this B0 
inhomogeneity, the low intensity region previously present in the real channel image at 
the base of the lung has resolved (Figure 53D). Despite the visually apparent change in 
real and imaginary signal distribution seen in Figure 53, phase correction only increased 
the image-derived RBC:barrier ratio minimally (0.46 to 0.47). In fact, the RBC:barrier ra-
tio after phase-map correction decreased by only -0.99 ± 1.51% in healthy subjects. For 
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the IPF subjects, phase-map correction caused the RBC:barrier ratio to increase slightly 
(4.59 ± 2.86%).  
Figure 54 shows fully phase-corrected Dixon images depicting the 129Xe-barrier 
and 129Xe-RBC uptake along with the gas-phase 129Xe distribution in a healthy volunteer 
and subject with IPF. For the healthy volunteer, all three images are largely homogene-
ous with the signal intensity increasing moderately in the dependent lung. For the IPF 
subject, while the ventilation and barrier images are similarly homogenous, the signal 
intensity of the RBC images is generally lower, and the images show widespread signal 
voids, or gas-transfer defects. Interestingly, these gas-transfer defects in the RBC channel 
were present even in regions with seemingly normal gas-phase and barrier signal. Alt-
hough gas-transfer defects were far more prominent in the IPF subject, the healthy vol-
unteer also exhibits some defects in the RBC map, most of which are located in well ven-
tilated regions. The gas-transfer defect percentage was 5.6 ± 0.7% in the healthy volun-
teers, with these defects were predominantly located in the anterior, non-dependent por-
tion of the lung. By contrast for the IPF subjects, the gas transfer defect percentage was 
4-fold higher (22.7 ± 6.3%), and these defects were distributed throughout the lung.  
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Figure 54: Representative single breath images of 129Xe in the gas-phase 
(grayscale), barrier tissues (green), and red blood cells (RBC, red). The healthy volun-
teer showed a homogeneous distribution of 129Xe in all three resonances. The IPF sub-
ject showed largely uniform gas-phase and barrier images, but exhibited widespread 
gas-transfer defects in the RBC image.      
 
It is useful to compare the 129Xe-RBC images, and their associated defect maps 
(yellow outline) to the representative CT images available in the IPF subjects (Figure 55). 
Qualitatively, regions of fibrosis and opacification visible on CT, while generally remain-
ing ventilated, exhibit prominent 129Xe-RBC gas-transfer defects. In these IPF subjects, 
gas transfer defects in both the posterior and anterior lung corresponded well to fibrosis 
seen on CT. Because 129Xe-RBC transfer is strongest in the posterior lung, these defects 
are most striking. Gas transfer defects in the anterior lung, although also corresponding 
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well to CT images, could also be a result of lower SNR. Also of note, are the 129Xe-RBC 
transfer defects in regions where the CT scan appears normal.   
 
Figure 55: The 129Xe-RBC images show numerous gas-transfer defects (yellow 
outline) that qualitatively correlate with regions of fibrosis seen on CT (blue arrows). 
Gas-transfer defects were also found in regions that had no visible fibrosis on CT. 
These could point to regions of subtle inflammation or early fibrosis that could still 
respond to therapy.  
 
Additional quantitative insights can be gained by examining the various ratio 
maps—barrier:gas, RBC:gas, and RBC:barrier shown in Figure 56. In the healthy volun-
teer, both the barrier:gas and RBC:gas maps appear relatively homogeneous, whereas 
the RBC:barrier map seems to exhibit significantly increased ratios in the mid-lung grav-
itational plane. In the IPF subject, only the barrier:gas map remains moderately homo-
geneous. However, the RBC:gas map exhibits significantly reduced overall intensity 
compared to the healthy volunteer, as well as numerous gas transfer defects. The 
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RBC:barrier map is also quite striking in the IPF subject, and appears to exhibit just a 
few focal regions of high gas transfer, while RBC:barrier is low in most of the lung.  
 
 
Figure 56: Ratios of the 129Xe-barrier:gas, 129Xe-RBC:gas, and the RBC:barrier 
images. Unlike the 129Xe-RBC images seen in figure 3, compared to the healthy volun-
teer, the RBC:gas images, in addition to showing focal defects, has significantly lower 
signal intensity than the IPF subject. Similarly, the RBC:barrier maps in the IPF sub-
ject show dramatically reduced 129Xe uptake by the RBCs. 
 
7.4.6. Inferences about Dixon Imaging 
This work demonstrates that it is feasible to produce isotropic 3D images of 129Xe 
distribution in the airspaces and its transfer to the barrier and RBC compartments using 
a single-breath, 1-point Dixon technique. This acquisition offers a simple alternative to 
the IDEAL algorithm to create separate images of 129Xe uptake in the RBC and barrier 
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compartments, through its utilization of only a single echo-time. While this approach 
requires an additional scan to calibrate the TE90 in its current implementation, its ad-
vantage over the hierarchical IDEAL algorithm previously employed by Qing et al. is 
that it does not require two additional TEs, and their concomitantly smaller signals (49). 
A direct comparison of these two approaches in the same patient population should il-
luminate the relative benefits of each approach for routine clinical gas-exchange MRI.  
The success of the 1-point Dixon approach lies in accurately calibrating the echo 
time required for a 90° RBC-barrier phase separation. It was interesting to note the vari-
ability of this TE90 relative to the calculated value and across groups. Such variability has 
been observed in prior studies of Dixon imaging including transgenic mice expressing 
human hemoglobin (144) and bleomycin-instilled rats (48). For healthy volunteers TE90 
was almost 300 μs shorter (429 μs) than the theoretical predictions. Moreover, for IPF 
subjects, the calibrated TE90 was 194 µs shorter than for healthy volunteers, even though 
their RBC-barrier frequency difference was 40 Hz lower. Moreover, the RBC-barrier 
phase evolution varied linearly with TE, and the fit exhibited a negative intercept (-46.3°, 
healthy volunteers; -39.5° in IPF subjects). This suggests significant phase evolution oc-
curred during the RF pulse, with the phase of the barrier compartment oddly leading 
the RBC. All this, along with lower TE90 in the IPF subjects may be in part explained by 
the different nature of susceptibility gradients and the variability in compartmental ex-
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change in lungs affected by interstitial thickening and fibrosis. Ultimately, as discussed 
by Cleveland et al., these observations must be investigated by simulating the Bloch 
equations to better understand the phase accumulation during the RF pulse (48).  
The 1-point Dixon acquisition has typically required additional reference scans to 
determine the receiver phase offset (phase error) and correct for the effects of field in-
homogeneity (139). While, in principle, the receiver phase offset could be determined 
using the phases of the spectra from the calibration scan, we have found that significant 
phase receiver phase shifts can occur over time. On our scanner, we have seen receiver 
phase drift by as much as 100° in 10 minutes. Hence, we developed an approach that 
was immune to such drift by constraining the RBC:barrier ratio derived from imaging to 
match the spectroscopic ratio. This is somewhat similar to the ‘virtual shimming’ meth-
od introduced for the single-point Dixon based fat-water separation (145). In addition to 
determining the receiver phase offset, most multi-point Dixon methods (IDEAL, hierar-
chical IDEAL) correct for regional phase inhomogeneity by iteratively solving for a 
phase map (49,146). Here, 129Xe Dixon MRI actually provides some unique advantages 
because the single-resonance gas-phase image acquired in the same breath can be used 
to provide a map of regional inhomogeneity. While Qing et al. also acquired the gas-
phase image in the same breath, the phase image was used only as an initial estimate for 
the iterative decomposition algorithm (49). Their final field map showed less than 10 Hz 
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difference from the initial estimate, which indicates that the initial phase map is repre-
sentative of the regional inhomogeneity. Moreover, an additional advantage of the rela-
tively low 129Xe gyromagnetic ratio combined with imaging at 1.5 T and relatively short 
TE is that phase did not change by more than 90° across the lung and hence did not re-
quire phase unwrapping (139). Thus, other than requiring a calibration scan, the strategy 
proposed here uses the acquired data to correct the receiver phase offset and the region-
al field-inhomogeneity and provides images of all three 129Xe compartments in the lung 
in a single breath.  
As shown in Figure 55, separation of 129Xe transfer to the RBCs depicted defects 
that qualitatively corresponded to regions of fibrosis seen on CT. Additionally, gas-
transfer defects were also noted in regions where the CT appeared normal. These defects 
could indicate regions of subtle inflammation that cause diffusion limitation. It is con-
ceivable that such regions represent earlier-stage disease that may potentially respond to 
therapy. Because 129Xe transfer into the capillary bed follows Fick’s first law, it depends 
on the alveolar surface-volume ratio and interstitial thickness, but additionally, 129Xe 
transfer also depends on the local capillary blood volume (140). While the defects in the 
129Xe-RBC image are presumably caused by a thickened barrier in IPF, other conditions 
such as loss of alveolar surface area associated with chronic obstructive pulmonary dis-
ease (COPD), may equally impact the barrier image (49). Hence, RBC:barrier maps pro-
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vide a potentially useful means to distinguish the two conditions. While our current hy-
pothesis assumes that all signal voids in 129Xe-RBC images are caused by limited diffu-
sion of xenon across the thickened blood-gas barrier, this is difficult to distinguish from 
regional changes perfusion and thus, capillary blood volume. To this end, 129Xe-RBC im-
ages acquired at multiple TRs may allow for regions that are purely diffusion-limited to 
show a moderate increase in signal at longer TRs. Alternatively, such discrimination 
could be done by also acquiring a high-resolution Gd-enhanced perfusion image (20).  
 
7.5. Summary 
The 1-point Dixon strategy was successfully used to create isotropic 3D images of 
129Xe in the airspaces, barrier, and the red blood cells within a single breath-hold. The 
method we propose is a simpler alternative to the hierarchical IDEAL algorithm (49), 
and has been shown to effectively depict focal gas transfer defects in IPF patients. While 
the current hypothesis assumes that the primary reason for reduced 129Xe-RBC signal is 
diffusion limitation, future experiments will include an additional Gd-perfusion scan to 
quantify potential changes in regional capillary blood volume. Furthermore, the choice 
in RF pulse will play an important role in minimizing the off-resonant excitation of the 
gas-phase resonance, and mainly, minimize the RBC-barrier phase evolution during the 
RF pulse. Additionally, understanding the root cause of the phase evolution may negate 
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the need to calibrate the TE90, leading to a simpler single scan exam. Additionally, be-
cause the Dixon condition is satisfied only at the center of k-space, future studies will 
employ an iterative means to estimate the barrier and RBC images to correct for the con-
tinued phase accumulation during data acquisition (146). Given the good correlation be-
tween the 129Xe-RBC and CT images, these preliminary results show that the 129Xe-RBC 
images offer an ionizing-radiation-free, non-invasive means to visualize diffusive gas-
exchange in the lung. 
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8. Future Directions 
 
The work done over the last few years have shown that the unique resonances of 
hyperpolarized xenon in the airspaces, barrier tissue and the red blood cells (dissolved-
phase) provide a world of information about lung structure and function. My thesis has 
followed xenon from the airspaces to the blood using diffusion-weighted imaging, sin-
gle-breath gas and dissolved-phase imaging, and has culminated in creating distinct 3D 
images of all three resonances of 129Xe in a single breath (chapter 7). The immediate fu-
ture of dissolved-phase 129Xe MRI lies in first obtaining a deeper understanding of the 
frequencies, widths and exchange processes between the different resonances of xenon. 
Furthermore, a greater focus should also be on improving the image quality through op-
timization of the pulse sequence and reconstruction. While an increase in 129Xe polariza-
tion should help the cause, this boost in signal can be properly leveraged if the image 
quality improvements are achieved with a focus in the following areas –  
a) Improvements to the RF frequency profile and the B1 field. The RF pulse shape 
and the associated B1 field significantly impact the image quality. As discussed in chap-
ters 4 and 6, the RF frequency profile is imperfect. This frequency profile can be warped 
significantly by the distortion introduced by the mixers in the exciter board, and addi-
tionally by the non-linearity of the RF amplifier. This distortion imparts different flip-
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angles to the RBC and barrier resonances. While this differential excitation of the RBC 
and barrier will not affect our results, these measurements may change if there are sub-
tle frequency shifts, or when measured at different sites. To overcome this drawback, it 
is essential to look at alternate RF pulse shapes (Gaussian, Hyperbolic Secant) that may 
be less susceptible to the vagaries of the amplifier, and ensure uniform and selective ex-
citation of the dissolved-phase. Alternatively, the RF pulses can be ‘pre-warped’ by de-
termining the gain profile of the amplifier (97), which will ensure that clean RF pulses 
are delivered to the coil regardless of the distortion in transmit chain. In addition to the 
warped shape, the work done by He et al. has reiterated that the B1 field generated by 
the vest coil is inhomogeneous (143). While this inhomogeneity can be corrected using a 
Bias field correction algorithm, this method uses the signal intensity distribution to de-
termine the bias field, which may in fact reflect the underlying physiological gradients 
in ventilation and gas-exchange (chapter 5). While this Bias field correction may be a 
good first step, it is important to understand the independent contributions to the signal 
intensity distribution made by physiology, and inhomogeneous B1 fields.  
b) Optimized non-Cartesian reconstruction and noise mitigation. The need to 
complete the acquisition of HP gas images within a 16-second breath hold has been sat-
isfied by obtaining fewer samples of k-space. To this end, the radial sequence has been 
advantageous, as it is robust against this k-space under-sampling. However, the broader 
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acceptance of the radial sequence requires overcoming several technical problems. First-
ly, the rapid acquisition requires the fast switching of gradients which induces Eddy 
current artifacts, and additionally, it was recently noted that the ramping of gradients 
induces noise spikes in the FIDs by coupling switching noise from the gradient amplifi-
ers into the large 129Xe vest coil. The source of these noise spikes need to be investigated 
and their mitigation will significantly improve image quality. Secondly, as the number of 
k-space samples is progressively reduced below the Nyquist limit, subtle streaking arti-
facts are introduced in the image, and the robustness of the radial sequence to under-
sampling begins to fade. Recently, the concepts of compressed sensing (CS) have crossed 
over from information theory to aid in reconstructing MR data (147). CS takes advantage 
of the sparsity of the MR data, typically in the Wavelet domain, and provided the data is 
incoherently sampled, images can be reconstructed with significantly fewer samples 
than predicted by the Nyquist theorem. More recently, these concepts have been adopt-
ed by the HP community to create ventilation images, and were extended even further 
to simultaneously image ventilation and the thoracic cavity (148). As an extension to this 
approach, if the RBC and barrier images were considered to be images of the same re-
gion of interest, but of different contrast, CS reconstruction can also be extended using 
Bayesian methods to exploit this ‘redundancy’ of information and reconstruct images 
with lower error and higher quality (149). Further, as shown in (150), one can also ex-
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ploit the high mutual information between the RBC and barrier to reconstruct images 
with significantly fewer samples. With optimized RF pulses, mitigated gradient noise, 
CS reconstruction, and improved polarization, the next few years should see a signifi-
cant improvement in 129Xe image quality.   
While the utility of 129Xe-RBC and 129Xe-barrier images has initially been tested in 
subjects with idiopathic pulmonary fibrosis (IPF) and have shown to be sensitive to their 
characteristic diffusion-limitation, they can be applied to any pulmonary disease that 
may have impaired gas-exchange. This broader dissemination of 129Xe MRI will help es-
tablish regional metrics that are sensitive to early changes in pulmonary function. Broad-
ly, achieving this goal and establishing the sensitivity of 129Xe MRI in longitudinal thera-
peutic studies would require that future work be focused in the following areas – 1) Ob-
taining information about capillary perfusion 2) Understand the specificity of 129Xe MRI by 
scanning multiple disease groups (COPD, Autoimmune conditions, Sickle cell disease, Pulmo-
nary hypertension).  
 
8.1. The need for perfusion imaging 
To first order, the origin and replenishment of the dissolved-phase xenon mag-
netization has been assumed to be primarily impacted by the diffusion of xenon across 
the pulmonary barrier. However, we have not rigorously tested the influence of capil-
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lary perfusion. As mentioned in chapter 7, future studies should acquire the 129Xe-RBC 
image in conjunction with a perfusion image, to tease out the contributions of diffusion-
limitation and the absence of regional perfusion. These perfusion images can be ac-
quired using well established sequences that use an external bolus of a Gd-based con-
trast agent. Recently, Bauman et al. have obtained 3D isotropic dynamic contrast en-
hanced perfusion images high spatial and temporal resolution using a UTE sequence in 
conjunction with compressed sensing reconstruction (20). This method takes advantage 
of the T1 shortening induced by the contrast agent to dynamically quantify the pulmo-
nary blood flow, blood volume, and the mean transit time. With a perfusion image, we 
should be poised to study all the aspects of lung function – ventilation, perfusion, and 
diffusive gas-exchange.  
In lieu of a perfusion image that uses an external contrast agent, the dissolved-
phase of 129Xe can also be used to probe regional perfusion. If the 129Xe-RBC images are 
acquired at incrementally longer TRs, regions that are purely diffusion limited will have 
more time to replenish the RBC signal, and at longer TRs, should see an increase in their 
signal intensity. By contrast, regions that completely lack capillary perfusion, even at the 
longest TRs, will experience no increase in signal intensity. While Gd-based perfusion 
sequences probe the larger vasculature, this approach is sensitive to the presence of per-
fusion at the capillary level. This can be made feasible with subtle modifications to the 
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existing pulse sequence to enable multi-TR acquisition, and with significant under-
sampling (~10-fold) of k-space. As shown by Bauman et al., the streaking artifacts that 
will be induced by the under-sampling of k-space can be overcome using compressed 
sensing reconstruction (20). In fact, there is a precedent for this in the hyperpolarized 
literature, as the SPARSE reconstruction algorithm has been used with HP helium, to 
reconstruct 3D ventilation images with an 8-fold fewer samples (151). With the availabil-
ity of open source packages for compressed sensing reconstruction and working with 
Wavelet transforms, these approaches are within reach, and the dissolved-phase of xen-
on can be used to identify regions of diffusion limitation, and perfusion deficit.     
    
8.2. Looking beyond IPF 
As seen in chapters 6 and 7, the amplitude, frequency, and width of the dis-
solved-phase of 129Xe has the sensitivity to pick up subtle changes in pulmonary func-
tion. However, it is important to look beyond IPF and study different disease groups to 
help identify the specificity of the current spectroscopy and imaging biomarkers. An 
immediate application can be seen in subjects with chronic obstructive pulmonary dis-
ease (COPD). As COPD hosts a range of disease phenotypes that impact the airways and 
the alveolar surface area (chapter 3), this disease group could benefit from every 129Xe 
imaging method available. Ventilation and ADC imaging have been the mainstay in the 
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HP community to study and phenotype COPD (31,78). Ventilation imaging with HP 3He 
has recently been extended to image the dynamic changes in ventilation during a breath 
hold (152). This has assisted in identifying collateral pathways of ventilation which are 
prevalent in COPD and with improvements in the polarization HP 129Xe can also be used 
in the study of collateral ventilation. In addition to ventilation based advances, the RBC 
and barrier resonances can be used to study COPD. Unlike IPF, where the major impact 
was seen in the RBC images and the barrier images were largely unaffected, in subjects 
with emphysema, regions that have reduced surface area will have an increased ADC, 
which should correlate with reduced barrier and RBC signal intensity.  
 
8.2.1. Autoimmune Diseases 
Autoimmune diseases are initiated by genetic or environmental factors and tar-
get the reactivity of the immune system (153). While most of the diseases such as Type I 
diabetes or Graves’ disease affect a particular organ system, some autoimmune diseases 
also affects the lung, such as Rheumatoid arthritis, which also causes the fibrosis of the 
interstitial tissue of the lungs (154). Recently, we had the opportunity to scan a subject 
who was diagnosed with an autoimmune condition – Dermatomyositis. This is an in-
flammatory disease of unknown origin that largely affects the striated muscles in the 
body, but may potentially give rise to interstitial lung disease (155). This subject had a 
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clean CT scan, and a ventilation scan that rivaled that of a healthy volunteer (figure 57A 
below), but the gas-exchange as shown by the RBC:barrier ratio in figure 57B, was sig-
nificantly diminished (0.15, 27% of normal). While this number is indicative of the in-
flammation associated with ILD, the barrier:gas in this subject was not elevated (0.007, 
97% of normal). This warrants further investigation into the factors that impact the bar-
rier:gas ratio. By scanning multiple subjects with autoimmune conditions longitudinally, 
xenon MRI has the potential to be an early predictor of the onset of ILD. Interestingly, it 
was also noticed that this subject was anemic, which may reduce the hematocrit. As it 
has been demonstrated that the widths of the barrier resonances are governed by the 
hematocrit (133), as a related project, future studies could use the width of the barrier 
resonance to non-invasively determine hematocrit and study their effect on the spectro-
scopic ratios.  
 
 
Figure 57: (A) Multi-slice GRE ventilation image from the subject with 
Dermatocyositis showing no ventilation defects. (B) Gas-transfer spectrum showing a 
significantly diminished (arrow) RBC signal. 
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8.2.2. Pulmonary vascular disease 
Pulmonary vascular diseases are caused by the occlusions in the arterioles or 
venules of the pulmonary vasculature. Among these diseases, pulmonary arterial hyper-
tension (PAH) is a rare yet deadly disease that roughly affects 15-50 people per million 
and is primarily characterized by a stark increase in the pulmonary artery pressure 
(156). This increase in pressure is brought on by the decrease in the cross sectional area 
of the pulmonary arteries. A change in this pressure is used to assess response to thera-
py, and is measured invasively, using a catheter inserted into the right heart. To make 
matters worse, there are no viable therapies that can cure PAH, and the current treat-
ments are merely palliative (156). Much like IPF, the current clinical trials do not use 
strong end points to test treatment effectiveness. In addition to the arterial side, pulmo-
nary vascular disease can also affect the venous side. Pulmonary veno-occlusive disease 
(PVOD) is a pathological disease that causes the pulmonary vein to be occluded by fi-
brotic tissue (157). It is a rare disorder of unknown origin, and affects only 0.1 or 0.2 per 
million people. While DLCO, CT scans and ventilation-perfusion scans have been used to 
identify this disease, PVOD is often misdiagnosed as pulmonary hypertension, and the 
definitive diagnostic test is an invasive open lung biopsy (157). Given its sensitivity to 
subtle changes at the capillary level, 129Xe MRI can offer a non-invasive alternative to di-
agnose and potentially differentiate PAH and PVOD.  
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Recently, we used 129Xe gas-transfer spectroscopy and imaging to scan a subject 
who was suspected to have ILD. This subject worked at a tire plant for 30 years, and his 
symptoms included exercise induced shortness of breath and lowered oxygen satura-
tion, a clean CT scan, and prior to the xenon scan, had no clear diagnosis. 129Xe gas-
transfer spectroscopy showed reduced gas-transfer and delayed oxygenation at the ca-
pillary level (table 10). While the numbers shown were consistent with IPF, the 129Xe gas-
transfer spectra acquired at end exhalation resembled a healthy volunteer with all the 
spectroscopic metrics showing an increase at exhalation (figure 58). Thus, this subject 
had impaired gas-transfer, but normal lung compliance. Furthermore, the Dixon images 
acquired in this subject (figure 59) showed largely normal ventilation, and few regions 
of lowered barrier signal. The RBC signal was lower on the whole, and in poorly venti-
lated regions showed subtle gas-transfer defects. Based on these results, the subject was 
referred for a VATS lung biopsy. This reported multiple vascular lesions, and extensive 
vascular thickening, which led to the diagnosis of pulmonary arterial hypertension, with 
associated ILD. Dedicated studies of PAH using xenon may help identify biomarkers of 
the disease which may eliminate the need for an invasive biopsy.  
We also had an opportunity to scan a subject with unexplained hypoxemia, and 
this subject had one of the lowest RBC:barrier ratios (0.07, 12.7% of normal), and as 
shown in table 10, the RBC:gas was 0.0013 (33% of normal) and the barrier:gas was sig-
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nificantly higher than normal at 0.019 (264% of normal). However, the most striking 
finding for this subject was the significantly lowered widths of the barrier and RBC res-
onances. Subsequently, this subject received a dual lung transplant, and a pathology re-
port of the native lungs had features indicative of pulmonary veno-occlusive disease. 
These results warrant further study of pulmonary veno-occlusive disease and pulmo-
nary hypertension using 129Xe gas-transfer MRI. 
 
 
Figure 58: 129Xe gas-transfer spectra acquired during a breath hold and at end 
exhalation, in a healthy volunteer (A) and an IPF subject (B). The barrier:gas and 
RBC:gas metrics in a healthy volunteer showed a massive increase during exhalation. 
These metrics in the IPF subject however, showed no increase upon exhalation. (C) 
Subject with PAH that shows increase in the RBC and barrier signal at exhalation, 
which would indicate normal lung compliance. 
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Table 10: Gas-transfer metrics for pulmonary vascular disease subjects 
Ratios 
RBC 
Frequency 
(Hz) 
Width (Hz) 
Inference 
RBC:barrier RBC:gas barrier:gas RBC Barrier 
PAH 0.23 0.0023 0.01 -305.5 134.2 131.0 
Ratios indicate 
reduced gas-
transfer, and the 
lower RBC fre-
quency suggests 
delayed capillary 
oxygenation. Low-
ered barrier width 
may indicate a re-
duced hematocrit. 
PVOD 0.07 0.0013 0.019 -302.0 78.3 107.1 
RBC:barrier is the 
lowest seen in our 
study. Lower RBC 
frequency points to 
delayed capillary 
oxygenation. 
Width of the RBC 
resonance is ap-
proximately a fac-
tor of 2 lower than 
that in healthy 
volunteers. 
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Figure 59: Dixon images acquired in a subject with pulmonary arterial hyper-
tension. The barrier images show subtly reduced signal in the apices of the lung, po-
tentially indicative of emphysema, and the RBC show spotty defects.  
 
The thesis has shown the feasibility of using HP 129Xe MRI to create images of 
pulmonary gas-exchange. In addition to diffusion-weighted imaging using the gas-
phase of 129Xe, the dissolved-phase of xenon fundamentally probes the diffusive gas-
exchange in the lung. The examples shown in this thesis and more so in this chapter, 
suggest that xenon spectroscopy and imaging has the capability to be extended to study 
a plethora of pulmonary diseases. Bolstered by the imminent advances in polarization 
technology that will provide liter quantities of xenon with high polarization (40 – 50%), 
one can envision the use of an integrated MRI exam that can probe ventilation, alveolar 
microstructure using the gas-phase of 129Xe, perfusion and tissue-density using 1H UTE 
sequences, and most importantly, using the dissolved-phase of 129Xe to image gas-
exchange. This arsenal of imaging and spectroscopy tools can be further expanded to 
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study the fundamental processes of the lung dynamically, and these tools and future 
advances will help provide a non-invasive and ionizing radiation free approach to fur-
thering the care of patients with pulmonary disease.   
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Appendix 
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) was created 
in 1998 to help in the management and diagnosis of Chronic Obstructive Pulmonary 
Disease (COPD) (4). Based on their recommendations, COPD is stratified using 
spirometric indices (FEV1/FVC and FEV1) into four different stages. These are shown in 
the table below.  
Table 11: GOLD classification of COPD 
Classification Spirometric reference values 
Stage I: Mild 
FEV1/FVC<0.7 
FEV1>80% of predicted 
Stage II: Moderate 
FEV1/FVC<0.7 
50%≤FEV1<80% of predicted 
Stage III: Severe 
FEV1<FVC<0.7 
30%≤FEV1<50% of predicted 
Stage IV: Very Severe 
FEV1/FVC<0.7 
FEV1<30% of predicted 
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